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Abstract
RNA-dependent Selenocysteine Biosynthesis in Eukaryotes and Archaea

Sotiria Palioura
Yale University
2010

Selenocysteine (Sec), the 21 st genetically encoded amino acid, is the major metabolite of
the micronutrient selenium. Sec is inserted into nascent proteins in response to a UGA
codon. The substrate for ribosomal protein synthesis is selenocysteinyl-tRNASec. While
the formation of Sec-tRNASec from seryl-tRNA 5 ^ by a single bacterial enzyme
selenocysteine synthase (SelA) has been well described, the mechanism of Sec-tRNASec
formation in archaea and eukaryotes remained poorly understood. Herein, biochemical
and genetic data provide evidence that, in contrast to bacteria, eukaryotes and archaea
utilize a different route to Sec-tRNASec that requires the tRNA Sec -dependent conversion
of O-phosphoserine (Sep) to Sec. In this two-step pathway, O-phosphoseryl-tRNA
kinase (PSTK) first converts Ser-tRNASec to Sep-tRNASec. This misacylated tRNA is the
obligatory precursor for a Sep-tRNA: Sec-tRNA synthase (SepSecS); this protein was
previously annotated as Soluble Liver Antigen/Liver Pancreas (SLA/LP). SepSecS genes
from Homo sapiens, the lower eukaryote Trypanosoma brucei and the archaea
Methanocaldococcus jannaschii and Methanococcus maripaludis complement an Escherichia
coli AselA deletion strain in vivo. Furthermore, genetic analysis of selenoprotein
biosynthesis in T. brucei in vivo demonstrated that eukaryotes have a single pathway to

Sec-tRNASec that requires Sep-tRNASec as an intermediate. Finally, purified recombinant
SepSecS converts Sep-tRNASec into Sec-tRNASec in vitro in the presence of sodium selenite
and purified E. coli selenophosphate synthetase.
The final step in Sec biosynthesis was further investigated by a structure-based
mutational analysis of the M. maripaludis SepSecS and by determining the crystal
structure of human SepSecS complexed with tRNAScc, phosphoserine and thiophosphate
at 2.8 A resolution. In vivo and in vitro enzyme assays support a mechanism of SectRNASec formation based on pyridoxal phosphate, while the lack of active site cysteines
demonstrates that a perselenide intermediate is not involved in SepSecS-catalyzed Sec
formation. Two tRNA 5 " molecules, with a fold distinct from other canonical tRNAs,
bind to each human SepSecS tetramer through their unique 13 base-pair acceptor-T^C
arm. The tRNA binding induces a conformational change in the enzyme's active site that
allows a Sep covalently attached to tRNA 5 ", but not free Sep, to be oriented properly for
the reaction to occur.
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INTRODUCTION
A. Selenocysteine, a versatile amino acid
Selenium is a dietary trace element required for animal and human health. The
antioxidant properties of selenium are thought to offer protection from diverse human
ailments including adverse mood states, cardiovascular disease, viral infections and
cancer (Rayman, 2000). Selenium carries out its functions in proteins in the form of
selenocysteine (Sec), in which the sulfur-containing thiol group of cysteine has been
replaced by the selenium-containing selenol moiety (Figure 1) (Cone et al., 1976).
Although selenium and sulfur belong to the same group of elements in the periodic
table and hence share some chemical properties (for example, electronegativity and
major oxidation state), it is the different electronic structure of these two elements that
makes the selenolate anion more stable than the thiolate one and gives selenoproteins
their unique selenium-derived catalytic efficiencies. Indeed, the low pKa of selenol
relative to a thiol (5.2 versus 8.0, respectively) and selenol's lower redox potential (- 488
mV, versus - 233 mV for the thiol) render it fully ionized at the physiological pH range
and causes selenocysteine to be substantially more reactive than cysteine (Figure 1)
(Ambrogelly et al., 2007). Thus, it is not surprising that most known selenoproteins are
oxidoreductases with an essential (for efficient catalysis) selenocysteine active site
residue. A selenocysteine-to-cysteine (Cys) mutation in such cases results in a >100-fold
reduction in catalytic turnover (Axley et al., 1991; Johansson et al., 2005).
Biochemical studies and genomic analyses have established that selenocysteine
and selenoproteins are found in organisms from all three domains of life - bacteria,
1

,«u\\H
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„»u\\H

COOH

HoN

COOH

Cysteine
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pK a =8.0
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Figure 1: The chemical structures and ionization states of cysteine and selenocysteine at
physiological pH.
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archaea and eukaryotes — though not in all species. In fact, most organisms do not use
this amino acid. Except for its occurrence in Chlamydomonas spp. (Fu et al., 2002) and
green algae of the Ostreococcus and the Volvox spp. (Lobanov et al v 2009), selenocysteine
is notably absent from fungi and higher plants. Although the mammalian
selenoproteome (Kryukov et al., 2003) consists of more than 20 selenoproteins, only a
limited number of prokaryotes contain selenocysteine (Kryukov and Gladyshev, 2004).
For instance, within the archaea with known genomes (currently representing 43
genera), selenoproteins are restricted to two genera, Methanococcus and Methanopyrus
(Stock and Rother, 2009).
Selenocysteine is the principal metabolite of selenium in the human body and the
means for exerting its various health benefits (Rayman, 2000). Like the rest of the 20
canonical amino acids selenocysteine is delivered to the ribosome for protein synthesis
by its cognate transfer RNA (tRNA) molecule, tRNASec. Knockout of tRNASec in the
mouse is embryonic lethal, which underscores the importance of Sec-containing proteins
(or selenoproteins) in mammalian development (Bosl et al., 1997). Mutations and
polymorphisms in several of the currently known 25 human selenoproteins have been
implicated in cancer and diseases of the muscular, nervous, immune and endocrine
systems (Bellinger et al., 2009). Most human selenoenzymes (i.e. thioredoxin reductase,
glutathione peroxidase, thioredoxin/glutathione reductase and methionine sulfoxide
reductase) safeguard the cell from the detrimental effects of reactive oxygen species and
regenerate important antioxidants such as vitamin C, vitamin E and coenzyme Q (Lu
and Holmgren, 2009). Selenocysteine is also the catalytic residue in iodothyronine
3

deiodinase, the enzyme that enables circulating thyroid hormone to exert its prometabolic actions in peripheral tissues. The erroneous replacement of the active site Sec
with the chemically similar serine (Ser) or Cys diminishes the activity of several
selenoenzymes (Zhong and Holmgren, 2000; Kuiper et al., 2003).

B. Selenocysteine, the 21st genetically encoded amino acid
Ribosomal protein synthesis is the pathway to most natural proteins. The genetic code
serves as the 'alphabet' used by the translation machinery to ensure faithful decoding of
the genetic message into the specified amino acid sequence each cellular protein is
comprised of. The code is usually represented as the assortment of mRNA codons that
specify each amino acid (Figure 2). With the exception of tryptophan and methionine,
the code is redundant such that more that one mRNA triplet specifies each canonical
amino acid. At the same time it is not ambiguous; each codon has only one meaning
since it specifies only one particular amino acid or a translational stop (codons UGA,
UAA and UAG). Since the discovery of the code in the mid 1960s (Nirenberg et al., 1965;
Soil et al., 1965) the canonical amino acids that participate in protein synthesis across all
species were known to be twenty in number. Given the unambiguous nature of the code,
the prospect for additional genetically encoded amino acids being discovered seemed
very faint.
Nevertheless, in the late 1980s and early 1990s selenocysteine was established as
the 21 st genetically encoded amino acid and UGA as the only codon with an ambiguous
meaning (Zinoni et al., 1986 ; Leinfelder et al., 1988; Soil, 1988). Although the occurrence
4

Figure 2: Circular representation of the genetic code (Adapted from Ambrogelly et al.,
2007). The genetic code maps each trinucleotide sequence (or codon) found in mRNA to
a specific amino acid. The first nucleotide of each codon lies in the inner circle and
moving outward are the second and the third ones. The code is composed of 64 codons;
61 specify one of the 20 canonical amino acids and three are stop codons (UGA, UAG,
UAA) that indicate translational termination. In selenoprotein-containing organisms
UGA also codes for Sec (red). Similarly, in the Methanosarcinacea and in
Desulfitobacterium hafniense UAG also codes for pyrrolysine (Pyl).
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of Sec as the selenium moiety in naturally occurring proteins was discovered in 1976
(Cone et al., 1976), Sec was thought to be the result of a post-translational modification
event (Forstrom et al., 1978). Apart from its most common function to signal
translational termination, an in-frame UGA codon within the coding region of certain
proteins also codes for selenocysteine in organisms from all three domains of life (Figure
2). An elegant recoding mechanism allows the translation machinery to accurately
discriminate between a Sec UGA and a Stop UGA codon (Bock et al., 2005). The presence
of a stem-loop structure in the mRNA of selenoproteins signals the insertion of
selenocysteine to the translation apparatus (reviewed in Introduction, section D).
Currently, the repertoire of genetically encoded amino acids has expanded to
include 22 members. UAG is also ambiguous in the Methanosarcinaceae and in the
bacterium Desulfitobacterium hafniense, where in addition to serving as a translational
stop it also encodes pyrrolysine (Pyl) (Figure 2), the 22nd cotranslationally inserted
amino acid (Hao et al., 2002; Srinivasan et al., 2002).

C. Selenocysteine is the universal exception to Crick's adapter hypothesis
Faithful protein synthesis relies on the presence of an aminoacyl-tRNA (aa-tRNA) with
an anticodon that matches the mRNA codon by the rules of the wobble hypothesis at the
ribosome (Crick, 1966; Soil et al., 1966), and the cognate amino acid esterified to the
tRNA's 3'-terminal adenosine (Ibba and Soil, 2000). Thus, synthesis of the correct
aminoacyl-tRNA is critical in enabling the genetic code. Aminoacyl-tRNA synthesis is
the task of a family of enymes called aminoacyl-tRNA synthetases (aaRSs); each enzyme
6

esterifies its cognate amino acid to the corresponding tRNA species (Ibba and Soil, 2000).
AARSs ultimately "read" the genetic code since they are responsible for selecting the
right amino acid out of the cellular pool of amino acids and pairing it with its cognate
tRNA (Figure 3).
According to Crick's adapter hypothesis postulated 40 years ago, there should be
one aaRS for each amino acid (Crick, 1958). Indeed, this is the case for the twenty
canonical amino acids and for the most recent addition to the set of genetically encoded
amino acids, pyrrolysine. Pyrrolysyl-tRNA synthetase is a newly discovered aaRS,
responsible for the synthesis of pyrrolysyl-tRNA (Blight et al., 2004; Polycarpo et al.,
2004). A prerequisite for the acylation of a tRNA with its cognate amino acid by the
corresponding aaRS is the presence of a cellular pool of free amino acids synthesized
prior to this step. Indeed, biochemical experimental efforts of the last century have
identified biosynthetic pathways for all 20 canonical amino acids and recently for
pyrrolysine as well (Longstaff et al., 2007).
Selenocysteine is the only exception; there is no biosynthetic pathway for free Sec
formation within the cell and a selenocysteinyl-tRNA synthetase (SecRS) does not exist
(Figure 3). Instead, selenocysteine synthesis occurs on its cognate tRNA in a route that is
based on misacylation and subsequent tRNA-dependent amino acid transformation. The
selenocysteine-specific tRNA has a UCA anticodon (thus, it pairs with UGA at the
ribosome according to the wobble rules) and is denoted as tRNASec (Leinfelder et al.,
1988). According to common convention in the tRNA field, the superscript (in this
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Figure 3: Synthesis of an aminoacyl-tRNA and its role in ribosomal translation. Each aminoacyl-tRNA synthetase (aaRS) is
responsible for selecting its cognate tRNA and the corresponding amino acid from the available cellular pools of these molecules.
The aminoacyl-tRNA is delivered to the ribosome by elongation factor Tu (EF-Tu) in bacteria and its anticodon can then interact with
the corresponding codon in mRNA. The example shown illustrates how this leads to the translation of the codon GCA as threonine
during the elongation phase of protein synthesis (Adapted from Ibba and Soil, 2000). According to Crick's adapter hypothesis there
should be twenty aaRSs, one for each of the twenty canonical amino acids. Sec is the only exception; there is no cellular pool of free
Sec and a selenocysteinyl-tRNA synthetase (SecRS) has never evolved.
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case Sec) denotes the anticodon that is specific for the cognate amino acid (in this case
Sec). The prefix before the tRNA denotes the amino acid attached to the 3' end of the
tRNA; for example, Sec-tRNASec denotes that selenocysteine is acylated to the 3' end of
tRNASec, while Ser-tRNASec denotes that serine is attached (or misacylated) to the 3' end
of tRNASec.

D. Biosynthesis of selenocysteine and UGA recoding in bacteria
Pretranslational amino acid modification is the path to Sec-tRNASec in bacteria (Figure 4).
Selenocysteine biosynthesis begins with SerRS acylating tRNASec with serine, but
because of its unusual structure SerRS does so with only 1% efficiency as compared with
the other five tRNASer isoacceptors (Baron et al., 1990). Based on the requirement of
Escherichia coli formate dehydrogenase for the presence of selenocysteine for activity, a
genetic system was developed that led to the identification of four E. coli genes (selA,
selB, selC and selD), all of which are essential for selenocysteine insertion (reviewed in
Yoshizawa and Bock, 2009). In addition to tRNASec (SelC), selenocysteine synthase
(SelA) and selenophosphate synthase (SelD) are needed for conversion of Ser-tRNASec to
Sec-tRNASec. SelA is a pyridoxal phosphate (PLP)-dependent enzyme with a conserved
lysine (Lys) residue that catalyzes the formation of an enzyme-bound dehydroalanyl
intermediate with elimination of a water molecule (Forchhammer et al., 1991). SelD
synthesizes (from selenide and ATP) the selenium donor selenophosphate (Tormay et
al., 1998). This compound reacts with the SelA-bound dehydroalanyl-tRNA Sec to form
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Sec-tRNASec. Thus, selenocysteine is made by a tRNA-dependent amino acid
modification process (Figure 4).
Recoding of UGA as selenocysteine requires the presence of an mRNA stem-loop
structure known as the selenocysteine insertion sequence (SECIS) element (reviewed in
Yoshizawa and Bock, 2009). In bacteria, the SECIS element is located immediately
downstream of the UGA codon within the selenoprotein coding region. The general
translation elongation factor Tu (EF-Tu) does not recognize Sec-tRNASec effectively
neither in vivo (Leinfelder et al., 1989) nor in vitro (Forster et al., 1990). Instead, the
specialized elongation factor SelB performs two functions that are crucial for proper
UGA recoding as selenocysteine: (i) its N-terminal domain, which is homologous to EFTu, binds to Sec-tRNASec with high specificity but not to any other aa-tRNAs including
Ser-tRNASec (Forchhammer et al., 1989); and (ii) the binding of SelB to the SECIS element
through its C-terminal domain is required for delivery of Sec-tRNASec to the ribosomal A
site, by outcompeting release-factor binding to the UGA codon. Thus, the dual
properties of SelB guard the fidelity of protein translation by ensuring that only UGA
codons in selenoprotein mRNAs are recoded (Allmang et al., 2009).

E. Selenocysteine biosynthesis in eukaryotes and archaea: the last riddle in
aminoacyl-tRNA synthesis
Because a selenocysteinyl-tRNA synthetase (an enzyme that would directly
esterify selenocysteine to its cognate tRNASec) has never evolved, tRNA-dependent
conversion of serine has been assumed to be the route to selenocysteine in eukaryotes
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Figure 4: The bacterial pathway to selenoprotein synthesis. Serine is initially attached to tRNASec by seryl-tRNA synthetase (SerRS).
The resulting Ser-tRNASec is then converted to Sec-tRNASec by selenocysteine synthase (SelA) in the presence of the selenium donor
selenophosphate. The resulting Sec-tRNASec is delivered to the ribosome bound to the specialized elongation factor SelB. A
Selenocysteine Insertion Sequence (SECIS) element immediately downstream of the mRNA UGA codon to be recoded interacts with
SelB and directs the release of Sec-tRNASec during selenoprotein translation.
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and archaea. Indeed, serylation of tRNASec by SerRS has been shown in vitro in both
eukaryotes (Wu and Gross, 1993; Ohama et al., 1994; Stiirchler-Pierrat et al., 1995;
Geslain et al., 2006) and archaea (Rother et al., 2000; Bilokapic et al., 2004; Kaiser et al.,
2005) and is likely to occur in vivo as well (Allmang and Krol, 2006; Geslain et al., 2006).
However, the search for a selenocysteine synthase activity that would convert SertRNASec to Sec-tRNASec proved futile (Kaiser et a l , 2005), suggesting an alternative
synthetic pathway in eukaryotes and archaea.
An elegant bioinformatic analysis revealed the enzyme 0-phosphoseryl-tRNA Sec
(Sep-tRNASec) kinase (PSTK) to be present only in genomes of organisms that have a
selenoproteome. The activity was characterized in vitro both for the mouse (Carlson et
al., 2004) and the Methanocaldococcus jannaschii (Kaiser et al., 2005) enzymes; this kinase
phosphorylates Ser-tRNASec to form Sep-tRNASec in the presence of ATP and
magnesium. PSTK exhibits a remarkable specificity for Ser-tRNASec. It does not
phosphorylate free Ser or Ser attached to its cognate tRNASer (Carlson et al., 2004). Thus,
only tRNASec binding can appropriately position Ser in the active site of PSTK for
phosphorylation to occur. Moreover, in contrast to most aaRSs that bind their cognate
tRNAs with micromolar affinities, PSTK binds both unacylated and serylated tRNASec
with nanomolar affinity (Sherrer et al., 2008b). Such tight binding of tRNASec to PSTK
may compensate for the significantly lower abundance of tRNASec than tRNASer even in
selenocysteine-rich tissues such as liver, kidney and testis (Diamond et al., 1993).
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While the discovery of PSTK lent credence to the old finding of Sep-tRNASec in
mammalian cell extracts (Maenpaa and Bernfield, 1970), the concomitant discovery of
Sep-tRNA:Cys-tRNA synthase (SepCysS) in some methanogenic archaea (Sauerwald et
al v 2005) paved the way for the elucidation of the route to selenocysteine synthesis in
archaea and eukarya (Figure 5). SepCysS uses PLP as a cofactor and a sulfur donor to
convert Sep attached to tRNAcys to Cys. Given the similar chemistries of Cys and Sec, the
presence of Sep-tRNAcys as an intermediate of Cys biosynthesis in certain methanogenic
archaea suggested Sep-tRNASec as an intermediate in the anabolic cycle of Sec (Su et al.,
2009) and further supported the quest for an archaeal and eukaryal enzyme that would
perform the Sep to Sec conversion (Figure 5). From a chemical standpoint, Ophosphoserine would provide a better leaving group (phosphate) than serine (water) for
replacement with selenium.
Regarding UGA recoding on the ribosome, several distinguishing features
account for a more complex picture and a still-hazy understanding of the process in
archaea and eukaryotes. In particular, the established presence of the eukaryotic and
archaeal SECIS elements in the 3' untranslated region of the mRNA, the inability of the
eukaryotic and archaeal homolog of SelB to bind to the SECIS element, and the
identification of other SECIS-binding proteins have led to the proposition of at least two
unconfirmed models (Allmang et al., 2009) that may explain how the ribosome
distinguishes a selenocysteine UGA from a termination codon and how the eukaryotic
and archaeal selenoprotein mRNAs elude nonsense-mediated decay.
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Figure 5: The eukaryotic pathway to selenoprotein synthesis shares a similar phosphorylated intermediate with the tRNA-dependent
cysteine biosynthesis pathway in methanogenic archaea. In archaea and eukaryotes Ser-tRNASec is converted to O-phosphoseryltRNASec (Sep-tRNASec) through the action of O-phosphoseryl-tRNA kinase (PSTK). The activity that converts Sep-tRNASec to SectRNASec has been elusive for the past twenty years. In methanogenic archaea, Cys-tRNAcys synthesis proceeds in two steps. First, Ophosphoseryl-tRNA synthetase (SepRS) acylates tRNAcys with Sep and then Sep-tRNA: Cys-tRNA synthase (SepCysS) converts Sep
to Cys in a PLP-dependent reaction. An enzyme analogous to SepCysS is likely to be performing the Sep to Sec conversion in
eukaryotes and archaea.
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F. Scope of Dissertation
1. Solving the riddle of selenocysteine formation in eukaryotes and archaea
Sec-encoding organisms have 21 genetically encoded amino acids, but have acquired
only 20 aminoacyl-tRNA synthetases during their evolution. The biosynthetic route of
aa-tRNA formation is understood for all genetically encoded amino acids except for
selenocysteine in archaea and eukarya (Allmang and Krol, 2006; Hatfield et al., 2006).
Given that a PLP-dependent selenocysteine synthase activity (as manifested by E. coli
SeLA (Tormay et al., 1998) for the conversion of Ser-tRNASec to Sec-tRNASec) has been
elusive, we considered other proteins. The most promising enzyme candidate to exhibit
such an activity is the human protein soluble liver antigen/liver pancreas (SLA/LP). This
protein was first identified in the early 1990s as it co-precipitated with tRNASec when
mammalian cell extracts were treated with serum from patients with autoimmune
hepatitis (Gelpi et al., 1992). Through a computational approach SLA/LP was classified
as a PLP-dependent serine hydroxymethyltransferase (Kernebeck et al., 2001) and its
archaeal orthologs are merely found in known Sec-containing archaea. Interestingly, the
closest homologue of SLA/LP is SepCysS, the only known tRNA-dependent enzyme that
converts Sep to Cys (Yuan et al., 2006; Su et al., 2009).
We used biochemical and molecular genetic studies to establish that human
SLA/LP, as well as its Methanococcus maripaludis orthologue, convert Sep-tRNASec to SectRNASec in vivo and in vitro. Thus, this enzyme is a Sep-tRNA: Sec-tRNA synthase
(SepSecS), filling in the question mark in Figure 5 (Yuan et al., 2006).
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2. The PSTK/SepSecS pathway is the only route to Sec in Trypanosomas, and likely in
all eukaryotes
The identification of the human SLA/LP and the M. maripaludis MMP0595 proteins as
SepSecS enzymes that convert Sep-tRNASec —> Sec-tRNASec was done by in vivo
complementation assays in a heterologous bacterial system and by in vitro activity
assays using purified components. However, earlier RNA interference results in
mammalian cells could not exclude the existence of an alternative SepSecS-independent
pathway of Sec-tRNASec formation (Xu et al v 2005). In that study, RNAi-mediated
ablation of SepSecS had only a marginal effect on mammalian selenoprotein synthesis.
We investigated the potential presence of an alternative pathway to Sec-tRNASec
in eukaryotes in the insect form of the parasitic protozoon Trypanosoma brucei, which is a
highly tractable genetic system. Double allelic knockout cell lines can easily be produced
in T. brucei by homologous recombination-directed gene replacements (Beverley and
Clayton, 1993), while RNAi-based methods for highly efficient inducible ablation of
proteins are also available (UUu et al., 2004). Moreover, in silico screens by several
groups identified tRNASec, SerRS, PSTK, SepSecS, SPS2 (the eukaryotic orthologue of the
T.coli selenophosphate synthase SelD) and EFSec (the eukaryotic orthologue of the E.coli
elongation factor SelB) in the T. brucei genome (Cassago et al., 2006; Lobanov et al.,
2006). Genetic knockouts and in vivo selenoprotein analysis in T. brucei revealed the
presence of a single pathway for Sec-tRNASec synthesis involving the SerRS, PSTK and
SepSecS sequence and strengthened the notion that all eukaryotes have a single
route to Sec.
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3. Insights into archaeal Sec synthesis from the structure of M. maripaludis SepSecS
The initial characterization of SepSecS revealed that this protein is a PLP-dependent
enzyme (Yuan et al., 2006; Xu et al., 2007). In nature such enzymes are abundant; in
some microbial genomes, they represent as much as 1.5% of all genes (Percudani and
Peracchi, 2003). They have many diverse functions and are often involved in amino acid
biosynthesis (Eliot and Kirsch, 2004). The structures of three other PLP-dependent
enzymes that use substrates (selenocysteine, cysteine) chemically similar to those of
SepSecS have been solved. One is the Archaeoglobus fulgidus SepCysS (Fukunaga and
Yokoyama, 2007), while another one is the E. coli selenocysteine lyase (CsdB) (Lima,
2002), an enzyme that converts selenocysteine to alanine and elemental selenium
(Mihara et al., 1999). The last enzyme is the E. coli cysteine desulfurase (IscS) that
catalyzes the desulfuration of cysteine (Cupp-Vickery et al., 2003). The reactions
catalyzed by these enzymes are illustrated in Figure 6; SepSecS and SepCysS carry out |3replacements on tRNA-bound Sep, while selenocysteine lyase removes the |3-substituent
of Sec to form elemental selenium, and cysteine desulfurase catalyzes the fragmentation
of cysteine to alanine and elemental sulfur. The lack of structural and biochemical data
on SepSecS prompted us to further characterize this enzyme. The crystal structure of M.
maripaludis SepSecS (MMPSepSecS) at 2.5 A resolution was solved and a structural
comparison with E. coli CsdB (ECCsdB) and A. fulgidus SepCysS (AFSepCysS) was
performed. I identified active site residues important for the enzymatic function of
MMPSepSecS by employing a combination of mutational in vivo and in vitro activity
analyses.
17

HSe

O3PO

0

CO e

CO

CO e

CO e

HOPOf^

HOPof^

HOPOf^

HOPof^

NH,

CO

CO

NH:

©

0

CO e

Y

NH

©

CO e

+

Se c

.©

HS

HSe 0
HSe

CO

CO

©

©

18

Figure 6: Graphic representation of the reaction schemes (Taken from Araiso et al v 2008). (A) M. maripaludis SepSecS catalyzes the
conversion of tRNA Sec -bound Sep to Sec. (B) A. fulgidus SepCysS mediates the tRNACys-dependent transformation of Sep to Cys. (C)
E. coli CsdB converts selenocysteine to alanine and elemental selenium. (D) E. coli IscS converts cysteine to alanine and elemental
sulfur.
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4. The mechanism of tRNASec recognition and Sec formation by the human SepSecS
Despite the crystal structures of the archaeal and murine SepSecS apo-enzymes several
questions remained unanswered. SepSecS acts on phosphoserine that is linked to
tRNASec and not on free phosphoserine or Ser-tRNASec (Yuan et al., 2006; Xu et al v 2007;
Ganichkin et al v 2008). However, the molecular basis for substrate discrimination and
the roles of PLP and tRNASec in the mechanism of Sep to Sec conversion were still poorly
understood. Moreover, in contrast to its closest homologue SepCysS, which functions as
a dimer to perform a similar reaction on Sep-tRNAcys (Sauerwald et al., 2005; Fukunaga
and Yokoyama, 2007), SepSecS forms a stable tetramer (Araiso et al., 2008; Ganichkin et
al., 2008). The tertiary structure of tRNASec itself and the mode of binding to the
tetrameric SepSecS had yet to be discovered as well. In fact, the unique structure of
tRNASec is thought to be critical for binding to all the enzymes of the Sec biosynthesis
and translational incorporation machinery, i.e. SerRS, PSTK, SepSecS, and EFSec
(Leinfelder et a l , 1988; Baron and Bock, 1991; Wu and Gross, 1993; Wu and Gross, 1994;
Ohama et al., 1994; Sriirchler-Pierrat et al., 1995; Rudinger et al., 1996; Rother et al., 2000;
Bilokapic et a l , 2004; Geslain et al., 2006; Sherrer et al., 2008a).
To provide answers to these questions, we determined the crystal structure of the
quaternary complex between human SepSecS, unacylated tRNASec, thiophosphate and
free Sep to 2.8 A resolution. Unlike the physiologic selenium donor of SepSecS,
selenophosphate, which is stable only under anaerobic conditions, thiophosphate is not
oxygen-sensitive. Thiophosphate is a surrogate substrate for SepSecS in vitro (Araiso et
al., 2008) and was, thus, used in the co-crystallization experiment. The structure
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demonstrated the basis of SepSecS substrate specificity for Sep-tRNASec versus SertRNASec and free Sep, while additional structure-guided genetic and biochemical
experiments suggested a detailed PLP-dependent mechanism for the Sep-tRNASec to SectRNASec conversion.
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MATERIALS AND METHODS
A. General
Oligonucleotide synthesis and DNA sequencing were performed by the Keck
Foundation Biotechnology Resource Laboratory at Yale University. The pET15b, pET20b
and pACYCDuet-1 vectors were from Novagen (San Diego, CA, USA). The QuikChange
site-directed mutagenesis kit was from Stratagene (Lajolla, CA, USA). [75Se]selenite was
purchased from the University of Missouri Research Reactor Facility (Columbia, MO).
[14C]Serine (163 mCi/mmol) and [a-32P]ATP (10 mmol/uCi) were obtained from
Amersham Pharmacia Biosciences (Piscataway, NJ, USA). The polyethyleneimine (PEI)
cellulose 20 cm * 20 cm thin layer chromatography (TLC) plates were from Merck
(Darmstadt, Germany). Nickel-nitriloacetic acid (Ni-NTA) agarose and the MaxiPrep
plasmid purification kit were from Qiagen (Valencia, CA, USA). The Ni- iminodiacetic
acid (Ni-IDA) pre-packed column, the Resource-Q pre-packed column and the Sephadex
G25 Microspin columns were from GE-Healthcare (Piscataway, NJ, USA). The protease
inhibitor cocktail (Complete EDTA-free) was from Roche (Indianapolis, IN).

B. Bacterial strains and plasmids
The selA deletion strain was constructed by replacing the gene with the kanamycin
cassette in BW25113 E. coli strain as described (Datsenko and Wanner, 2000). The T7
polymerase gene was inserted in the genome by PI transduction. The E. coli BL21CodonPlus (DE3)-RIL strain and the pUC18 vector were from Stratagene (Lajolla, CA,
USA). SepSecS genes from Methanococcus maripaludis (MMP0595) and
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Methanocaldococcus jannaschii (MJ0610) were amplified from genomic DNA, and the
human SepSecS gene (GenBank accession no. BX648976) was amplified from an EST
clone [clone ID: DKFZp686J1361, obtained from the RZPD German Resource Center for
Genome Research, Berlin, Germany (Wiemann et al., 2001)] followed by cloning into the
pET15b vector. E. coli selD was cloned into pET15b vector. The M. jannaschii PSTK gene
was cloned into the pACYCDuet-1 vector. The T. brucei PSTK and SepSecS genes were
cloned into the pACYCDuet-1 and the pET15b vectors, respectively.
The M. maripaludis SepSecS mutants R72A, R72Q, R72K, R94A, R94Q, H166A,
H166F, H166Q, R307A, R307Q, R307K, Q102A, K278A, N247A, D277A, and K278A were
generated using the QuikChange site-directed mutagenesis kit (Stratagene) and cloned
into the pET15b vector with an N-terminal His-tag. An N-terminal A1-34 M. maripaludis
SepSecS deletion mutant was constructed by PCR using the primers 5'-CCGCTCGAGC
ATCGGAAAATTCCTGAAAACGGAATTGATGACG-3' and 5'- GCTAGTTATTGCTCA
GCGGTGGCAGC-3' and the pET15b-sepsecS plasmid DNA as the template. The
resulting DNA fragment was digested with BamHI and Xhol and re-inserted into the
pET15b vector.
The human SepSecS mutants (R26A, R26E, K38A, K38E, R75A, R97A, S98A,
Q105A, K173A, K173M, K284T, N252A, N252D, R271A, R271E, R313A, T397A, T397E,
T397V, R398A and R398E) were generated using the QuikChange site-directed
mutagenesis kit and cloned into the pET15b vector with an N-terminal His-tag. An Nterminal A1-37 human SepSecS deletion mutant was constructed by PCR with the pET15bsepsecS plasmid as template and the following primers: 5'-GGAATTCCATATGAAGG
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GCAAGTGTCCAGAGAATGGCTGGGATGAAAGTACAC-3', and 5'-CGCGGATCCTC
ATGAAGAAGCATCCTGGTATGTGTCAAGAAGTACATTATC-3'. The resulting
DNA fragment was subcloned into the pET20b vector (Novagen) with a C-terminal His6tag.

C. In vivo SepSecS assay
The M. jannaschii SepSecS gene, the M. maripaludis wild-type and mutant SepSecS genes,
the T. brucei SepSecS gene and the human wild type and mutant SepSecS genes were
transformed into the E. coli AselA strain with or without the M. jannaschii PSTK gene.
The T. brucei PSTK gene was transformed into the E. coli AselA strain in the presence of
T. brucei SepSecS, M. jannaschii SepSecS or human SepSecS. In strains expressing only one
gene, the corresponding empty plasmid was cotransformed as a control.
Aerobic overnight cultures were streaked in aerobic conditions on LB-agar plates
and/or M9 minimal medium-agar plates supplemented with 0.01 mM IPTG, 1 uM
Na2Mo04,1 uM Na2SeG*3 and 50 mM sodium formate. The plates were placed in an
anaerobic incubation jar that was flushed with an Nr. CO2: H2 (90 : 5 : 5) gas mix three
times to give an anaerobic atmosphere and then grown for 5 h at 37 °C and 20 h at 30 °C.
The plates were then overlaid with agar containing 1 mg/ml benzyl viologen (BV), 0.25
M sodium formate and 25 mM KH2PO4 adjusted to pH 7.0. The appearance of a
blue/purple color is the indication of active formate dehydrogenase H.
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D. Metabolic labeling with [75Se]selenite
A total of 5 x 107 T. brucei cells from each transgenic strain were resuspended in 0.5 mL
of FCS-supplemented SDM-79 medium (Bran and Schonenberger, 1979). The cultures
were labeled with 9.6 uCi of Hepes-neutralized [75Se]selenite in the presence of 100
ug/mL cysteine at 27 °C for 3 h (for the Tb-SepSecS and Tb-PSTK knock-out strains) or 1
h (for the RNAi cell lines). Cells were harvested, washed with phosphate buffered saline
p.H 7.4, and lysed by heating to 100 °C for 10 min in buffer containing 100 mM Tris-Cl
p H 6.8, 8% (w/v) SDS, 24% glycerol, and 0.02% Coomassie blue G-250. The cell lysates
were subjected to Tris-tricine SDS/PAGE gels and analyzed by autoradiography.

E. Protein expression and purification
The M. maripaludis wild-type and mutant SepSecS proteins and the E. coli SelD were
purified using Ni-NTA column chromatography. The respective constructs were
transformed into the E. coli BL21-CodonPlus (DE3)-RIL strain. Cells were grown at 37 °C
to A600 nm = -0.6 at which point the culture was induced with 0.5 mM IPTG for an
overnight expression at 15 °C. The cells were harvested by centrifugation at 5,000 rpm
for 15 minutes and resuspended in 50 mM Hepes (pH 8.0), 300 mM NaCl, 10 mM
imidazole, 3 mM DTT, 10 uM PLP in the presence of a protease inhibitor cocktail
(Complete EDTA-free, Roche). Following sonication and centrifugation at 14 OOOg
for 1 h, the supernatant was applied to Ni-NTA resin (Qiagen). Any non-specifically
bound protein was washed away with 50 mM imidazole, while the His6-tagged proteins
were eluted with 300 mM imidazole. Proteins were then thoroughly dialyzed against 50
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mM Hepes (pH 8.0), 300 m M NaCl, 10 mM DTT,10 uM PLP, and 50% glycerol. PLP was
omitted from the lysis, wash, elution and dialysis buffers during the purification of E.coli
SelD.
Purification of the human SepSecS used for crystallization involved two
chromatographic steps. Briefly, pET15b-sepsecS was transformed into the E. coli BL21CodonPlus (DE3)-RIL strain, cells were grown to A600 nm = 0.6 and gene expression
was induced with 0.5 mM IPTG. After growth for 17 h at 15 °C, cells were harvested
and resuspended in 20 mM Tris, p H 8.0, 50 mM NaCl, 10% (v/v) glycerol, 1 mM 2mercaptoethanol, 10 uM PLP in the presence of the protease inhibitor cocktail (Complete
EDTA-free, Roche).The cell paste was lysed using a microfluidizer, the insoluble
material was separated by centrifugation at 32,000 rpm for 40 minutes, and the cleared
supernatant was loaded onto a Ni-IDA (GE-Healthcare) column pre-equilibrated with 20
mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole, 1 mM 2-mercaptoethanol and 10
\JLM PLP. The column was then washed with 50 mM imidazole and the His6-SepSecS was
eluted with 500 mM imidazole. The protein sample was diluted three-fold with 20 mM
Tris-HCl, p H 8.0,100 mM NaCl, 1 mM DTT, 10 uM PLP, concentrated to 3 mL and
loaded onto a S-200pg size-exclusion column. The protein eluted as a tetramer, it was
concentrated to ~2 mg/mL, flash frozen in liquid nitrogen and stored at -80 °C.

F. Preparation and purification of tRNA gene transcripts
The M. maripaludis tRNASec and the human tRNASec used as substrates in the in vitro
assays were synthesized by in vitro T7 RNA polymerase run-off transcription as
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described (Milligan et al., 1987). In particular, the M. maripaludis tRNASec and the human
tRNASec genes together with the T7 promoter were constructed from overlapping
chemically synthesized oligonucleotides, cloned into the pUC18 and pUC19 plasmids,
respectively, and purified from E. coli DH5a transformants using a MaxiPrep plasmid
purification kit (Qiagen). The purified plasmids were digested with BstNl at 55 °C for
16 h. The in vitro transcription reactions were performed at 37 °C for 5 h in buffer
containing 40 mM Tris-HCl (pH 8.0), 22 mM MgCL, 25 mM DTT, 2 mM spermidine, 50
ug/ml BSA, 0.1 mg/ml pyrophosphatase, 4 mM of each nucleoside triphosphate, BstNIdigested vector containing the tRNASec gene (60 ug/ml) and 1 mM T7 RNA polymerase.
The tRNASec transcripts were purified by electrophoresis on a 12% denaturing
polyacrylamide gel. Full-length tRNASec was eluted and desalted on Sephadex G25
Microspin columns (Amersham). The tRNASec transcripts were refolded by heating for 5
min at 70 °C in buffer containing 10 mM Tris-HCl (pH 7.0), followed by addition of
5 mM MgCL and immediate cooling on ice.
The human tRNASec used for crystallization was cloned into pUC19, expressed in
E. coli DH5a and synthesized by in vitro T7 RNA polymerase run-off transcription as
described above. The transcription reaction was performed at 37 °C for 2 h in buffer
containing 40 mM Tris-HCL p H 8.1, 22 mM MgCh, 10 mM DTT, 1 mM spermidine,
0.01% Triton X-100, 50 ug/ml BSA, 4 mM of nucleoside triphosphates, 16 mM GMP,
BstNI-digested vector containing the tRNASec gene (70 ug/ml) and 3 mM T7 RNA
polymerase. The reaction was briefly centrifuged to pellet the formed pyrophosphate,
the supernatant reaction mixture was loaded onto a Resource-Q column (GE-Healthcare)
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and tRNASec was purified using a linear gradient of NaCl (0.2-1 M) in 20 mM Tris-HCl
p H 8.0. Human tRNASec eluted at -0.6 M NaCl. The purity of the tRNASec-containing
fractions was checked by electrophoresis on a 12% denaturing polyacrylamide gel. Pure
tRNASec fractions were ethanol precipitated and kept at -80 °C until use.

G. Purification and crystallization of the SepSecS-tRNASec complex
The complex was prepared by mixing human SepSecS with a 1.5-fold molar excess of
tRNASec. Thus, for each SepSecS tetramer there were 6 molecules of tRNASec available.
The mixture was concentrated to ~1 mL, loaded onto a S-200pg column (XK 16/60) and
eluted with 20 mM Tris-HCl, p H 8.0,100 mM NaCl, 1 mM DTT, 10 uM PLP. The first
peak contained the SepSecS-tRNASec complex, whereas the second peak contained the
unbound tRNASec. The complex was concentrated to -7.5 mg/mL. The complex was
crystallized by the sitting-drop vapor-diffusion method at 12 °C by mixing equal
volumes of the complex sample with the well buffer containing 0.3 M tri-lithium citrate
and 18% (w/v) PEG 3,350. Addition of various additives to the mother liquor such as
sorbitol, D-galactose, NDSB-201, Cymal-7, MPD and phenol improved both the crystal
size and the quality of diffraction.

H. Ligand soaks and data collection
A mixture of thiophosphate and O-phosphoserine was added to the binary complex
crystals to the final concentration of 1 mM and incubated for 1 h prior to freezing.
Crystals were cryoprotected for 5 minutes in the presence of 20% (v/v) ethylene-glycol
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and then frozen in liquid propane. Data were collected at the NE-CAT 24IDE beamline
(APS, Argonne National Laboratory, Chicago) and processed using HKL2000.

I. Preparation of 32P-labeled Sep-tRNASec
Refolded tRNASec transcript was 32P-labeled on the 3' terminus by using the E. coli CCAadding enzyme and [a-32P]ATP (Amersham) as previously described with some
modifications (Oshikane et al., 2006). Briefly, 6 pg of tRNASec transcript was incubated
with the CCA-adding enzyme and [a-32P]ATP (50 uCi) for 1 h at room temperature in
buffer containing 50 mM Tris-HCl p H 8.0, 20 mM MgCh, 5 mM DTT and 50 uM sodium
pyrophosphate. After phenol/chloroform extraction the sample was passed over a
Sephadex G25 Microspin column (GE Healthcare) to remove excess ATP (Bullock et al.,
2003).
The recovered [32P]-labeled tRNASec was serylated and phosphorylated by
M. maripaludis SerRS (5 uM) and M. jannaschii PSTK (1 uM) for 75 min at 37 °C in buffer
containing 50 mM HEPES (pH 7.5), 10 mM MgCb, 20 mM KC1,1 mM DTT, 1 mM serine
and 10 mM ATP. After phenol/chloroform extraction aminoacylated Sep-tRNASec was
ethanol precipitated at -20 °C for 45 min and collected as a pellet by centrifugation at
10,000 g at 4 °C for 30 min. After washing the pellet with 70% ethanol, it was allowed to
dry on ice in order to avoid deacylation.
To check levels of serylation and Ser—»Sep conversion, 1 pi aliquots at the start
and end of the reaction were quenched on ice with 3 pi of 100 mM sodium citrate (pH
4.75) and 0.66 mg/ml of nuclease PI (Sigma). Following nuclease PI digestion at room
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temperature for 1 h, 1.5 \A of the sample was spotted onto PEI cellulose 20 cm x 20 cm
TLC plates (Merck). To separate the Sep-[32P]AMP spot from [32P]AMP and any
remaining Ser-[32P]AMP the plates were developed for 75 min in buffer containing
100 mM ammonium acetate, 5% acetic acid. The plates were exposed on an imaging
plate (FujiFilms) for 14 h, scanned using a Molecular Dynamics Storm 860 scanner and
quantified using the ImageQuant densitometry software. The amount of Sep-tRNASec
formed can be calculated by dividing the intensity of the Sep-[32P]AMP spot by the sum
of the intensities of all spots (Sep-[32P]AMP, [32P]AMP and Ser-[32P]AMP).

J. In vitro conversion of Sep-tRNASec to Cys-tRNASec
Purified wild-type or mutant M. maripaludis SepSecS (1 uM) was incubated with 1 uM
32

P-labeled Sep-tRNASec in buffer containing 50 mM HEPES (pH 7.0), 20 mM KC1,10 mM

MgCL, 5 mM DTT, 2 uM PLP and 500 \JLM sodium thiophosphate. Reactions were
carried out anaerobically at 37 °C over 40 min. At each time point taken, 1 ul reaction
aliquots were quenched on ice with 3 \A of 100 mM sodium citrate (pH 4.75) and 0.66
mg/ml of nuclease PI (Sigma). Following nuclease PI digestion, 1.5 ul of the sample was
spotted onto PEI cellulose TLC plates that were developed, scanned and quantified as
described above. To separate the Cys-[32P]AMP spot from the Sep-[32P]AMP, the
[32P]AMP and any remaining Ser-[32P]AMP spots the plates were developed for 75 min
in buffer 100 mM ammonium acetate, 5% acetic acid. The plates were exposed on an
imaging plate (FujiFilms) for 14 h, scanned using a Molecular Dynamics Storm 860
scanner and quantified using the ImageQuant densitometry software. The amount of
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Cys-[32P]AMP formed was calculated by dividing the intensity of the Cys-[32P]AMP spot
by the sum of the intensities of all spots (Cys-[32P]AMP, Sep-[32P]AMP, [32P]AMP and
Ser-[32P]AMP). The added elevated concentration of PLP was used to assure that the
mutant enzymes were saturated with the cofactor.
For the human in vitro SepSecS assay, refolded tRNASec (10 |aM) was serylated
and phosphorylated by M. maripaludis SerRS (5 uM) and M. jannaschii PSTK (3 uM) for
75 min at 37 °C in buffer containing 50 mM HEPES p H 7.2,10 mM MgCk, 20 mM KC1,1
mM DTT, 10 mM ATP and 300 uM [14C]Ser. After phenol/chloroform extraction SeptRNASec was purified by application on a Sephadex G25 Microspin column and ethanol
precipitation. The conversion of Sep to Cys was done under anaerobic conditions using
wild-type human SepSecS and human SepSecS treated with either hydroxylamine or
NaBH4. For the hydroxylamine treatment, the SepSecS sample was dialyzed for 5 hours
against buffer containing 50 mM HEPES pH 7.2, 250 mM NaCl, 1 mM DTT, 7.5 mM
hydroxylamine, whereas for the borohydride treatment the SepSecS sample was
incubated in the dark for 1 hour in the presence of 100 mM NaBHi. The excess of
hydroxylamine and borohydride was removed from the samples by dialysis against 50
mM HEPES p H 7.2, 250 mM NaCl, 1 mM DTT. SepSecS (20 ug) was incubated with 10
uM Sep-tRNASec in buffer containing 50 mM HEPES pH 7.2, 20 mM KC1,10 mM MgCh,
1 mM DTT and 250 |aM sodium thiophosphate. All buffers were prepared anaerobically
and the reaction was carried out at 37°C inside an anaerobic chamber over 40 min. The
reaction was stopped by phenol/chloroform extraction, the aqueous phase was applied
to a Sephadex G25 Microspin column and the eluted aminoacylated-tRNAs were
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ethanol precipitated. The purified aa-tRNAs were deacylated in 20 mM NaOH for 10
min at 22 °C. The released amino acids were oxidized with per formic acid as described
previously (Sauerwald et al., 2005). The final samples were spotted onto silica gel 60
TLC aluminium sheets (Merck) that were developed in 85% ethanol. To detect the
labelled amino acids, the TLC plate was dried and then exposed on an imaging plate
(FujiFilms) for 60 hours. The imaging plate was scanned using a Molecular Dynamics
Storm 860 scanner.
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RESULTS
A. The missing step of selenocysteine biosynthesis in archaea and eukaryotes
This part of my research was done in collaboration with Jing Yuan, Juan Salazar and Dan Su.
1. SepSecS rescues selenoprotein biosynthesis in an E. coli AselA deletion strain
When grown anaerobically, E. coli produces the selenium-dependent formate
dehydrogenase H ( F D H H ) . Its activity enables the cells to reduce benzyl viologen (BV) in
the presence of formate; this is usually observed by a blue/purple color in agar overlay
plates under anaerobic conditions (Lacourciere et al., 2002). An E. coli AselA deletion
strain was constructed in which selenoprotein production is abolished.
Complementation of this strain with archaeal SepSecS genes from M. maripaludis
(MMP0595) and M. jannaschii (MJ0610) and with the human homologue allowed testing
of the ability of these genes to restore selenoprotein biosynthesis as detected by F D H H
activity (Yuan et al., 2006). The E. coli cells were grown under anaerobic conditions for
24 h and overlaid with top agar containing BV and formate. Blue-colored cells indicated
that BV was reduced and, therefore, F D H H activity was present, whereas cells without
FDHH

activity remained colorless.
Complementation was achieved when the SepSecS genes were cotransformed

with the gene encoding M. jannaschii PSTK (Figure 7). Neither PSTK alone nor the
archaeal and human SepSecS genes alone were able to restore Sec synthesis in the E. coli
AselA deletion strain (Yuan et al., 2006). These data imply that Sec formation was
achieved by a two-step process: PSTK phosphorylates the endogenous Ser-tRNASec to
Sep-tRNASec, and then this misacylated aa-tRNA species is converted to Sec-tRNASec by
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Figure 7: SepSecS genes restore F D H H activity in an E. coli AselA deletion strain (Taken from Yuan et al., 2006) . The E. coli AselA
deletion strains complemented with the indicated SepSecS genes were grown anaerobically on glucose minimal medium plates
supplemented with 0.01 mM IPTG at 30 °C for 2 days. F D H H activity was observed by overlaying top agar containing formate and
BV. Colonies with active F D H H reduced BV to a blue color. The SepSecS genes were from Methanocaldococcus jannaschii (MJ),
Methanococcus maripaludis (MMP), human (HS), and E. coli selA (EC). K284T denotes a mutant human SepSecS where the Lys residue
critical to PLP binding is changed to Thr.

SepSecS. Moreover, Ser-tRNASec, present in the E. coli AselA deletion strain, cannot be
converted to Sec-tRNASec in the absence of PSTK and, therefore, is not a substrate for
SepSecS (Yuan et al., 2006). Finally, PSTK from the parasitic protozoon T. brucei in
combination with either T. brucei SepSecS (Tb-SepSecS) or the corresponding archaeal or
human enzymes reconstituted selenoprotein synthesis in the E. coli AselA deletion strain
(Figure 8) (Aeby et al., 2009). Likewise, archaeal PSTK and Tb-SepSecS also restored
FDHH

activity in the E. coli AselA deletion strain (Figure 8) (Aeby et al., 2009). Taken

together, these results underscore the conserved nature of the PSTK/SepSecS pathway of
Sec-tRNASec formation in archaea and eukaryotes.
The bacterial SelA is a PLP-dependent enzyme with a critical Lys residue
engaged in PLP binding (Tormay et al., 1998). As the archaeal and eukaryal SepSecS
proteins also have PLP binding domains (Kernebeck et al., 2001), I constructed Lys to
Ala or Thr mutations that replaced the critical lysine position in these enzymes (M.
maripaludis SepSecS K278A, and human SepSecS K284T). Even in the presence of PSTK,
the mutant SepSecS genes were no longer able to complement the bacterial selA deletion
strain (Figure 7) (Yuan et al., 2006). This finding strengthens the notion that the SepSecS
proteins need PLP to carry out the Sep —> Sec conversion.

2. SepSecS converts Sep-tRNASec to Sec-tRNASec in vitro
To prove that SepSecS is a SelA that catalyzes a tRNA-dependent Sep —> Sec synthesis
we analyzed the conversion of [ ,4 C]Sep-tRNA to [14C]Sec-tRNA in vitro. To this end,
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Figure 8: Expression of SepSecS together with PSTK restores F D H H activity in an
anaerobically-grown E. coli AselA deletion strain (Taken from Aeby et al., 2009). The
indicated genes of the following organisms were tested: T. brucei (Tb-PSTK, Tb-SepSecS),
M. jannaschii (Mj-PSTK, Mj-SepSecS), and human (Hs-SepSecS).
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M. maripaludis tRNASec was acylated with [14C]Ser by using pure M. maripaludis SerRS
(Kim et al v 1998). Phosphorylation was performed with pure M. jannaschii PSTK. We
then incubated the isolated [14C]Sep-tRNA under anaerobic conditions with purified
recombinant SepSecS and E. coli SelD in the presence of selenite. After the reaction,
aminoacyl-tRNA was deacylated, and the amino acid products were identified by thin
layer chromatography (TLC) (Figure 9) (Yuan et al v 2006). The data show that SepSecS
from both M. maripaludis (Figure 9, lane 3) and human (Figure 9, lane 4) were able to
form Sec-tRNASec from Sep-tRNASec, but not from Ser-tRNASec (Figure 9, lane 5) (Yuan et
al., 2006). Thus, Sep-tRNASec is the crucial precursor for Sec-tRNASec formation in
archaea and eukarya.

B. In vivo evidence for a single pathway of Sec-tRNASec formation in T. brucei
This part of my thesis research was done in collaboration with EricAeby, who constructed the
T. brucei RNAi and knock-out strains.
A bioinformatic analysis of the T. brucei genome predicted 3 selenoproteins. They
include distant homologs of mammalian selenoprotein K (SelK) and selenoprotein T
(SelT) and a selenoprotein, termed SelTryp, that is specific for the kinetoplastid line
(Lobanov et al., 2006). Moreover, all major components of the eukaryotic Sec-inserting
system have trypanosomal orthologues. Thus, Tb-tRNASec, Tb-SerRS, Tb-PSTK, TbSepSecS, Tb-SPS2, and Tb-EFSec have been identified in silico (Cassago et a l , 2006).
However, of these only Tb-SerRS, Tb-tRNASec (Cassago et al., 2006; Bouzaidi-Tiali et al.,
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Figure 9: Conversion of in yz'fro-synthesized Sep-tRNASec to Sec-tRNASec (Taken from
Yuan et al., 2006). Phosphorimages of TLC separation of [14C]Sep and [14C]Sec recovered
from the aa-tRNAs of the SepSecS activity assay. Sec was analyzed in its oxidized form
as selenocysteic acid (Secya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, Sep-tRNASec
with M. maripaludis SepSecS; lane 4, Sep-tRNASec with human SepSecS; lane 5, SertRNASec with M. maripaludis SepSecS; lane 6, reaction of lane 3 without selenite.
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2007; Geslain et al., 2006), and Tb-SPS2 (Sculaccio et al., 2008) have been subject to
preliminary experimental analyses. To analyze the SeotRNA Sec formation pathway in
vivo and establish its physiological importance for T. brucei, RNAi cell lines that allow
inducible ablation of Tb-SerRS, Tb-SPS2, and Tb-EFSec were constructed. Moreover, we
prepared knock-out cell lines that lack either Tb-PSTK or Tb-SepSecS, the two core
components of the eukaryotic Sec-tRNASec formation pathway. I analyzed all cell lines
for selenoprotein synthesis by labeling with radioactive 75Se (Figure 10) (Aeby et al.,
2009).
Labeling of uninduced Tb-SerRS-RNAi cells with 75Se and subsequent analysis by
Tris-Tricine polyacrylamide gels revealed three bands whose molecular masses are
consistent with the three predicted trypanosomal selenoproteins SelK, SelT, and SelTryp
(Figure 10A) (Lobanov et al., 2006). Induction of Tb-SerRS RNAi causes, in line with the
role of SerRS in serylation of tRNASec, a significant reduction in selenoprotein labeling
(Figure 10A) (Aeby et al., 2009). Similarly, RNAi-mediated ablation of Tb-SPS2 (Figure
10C) and of Tb-EFSec (Figure 10D) severely impairs selenoprotein synthesis (Aeby et al.,
2009). Most importantly, though, labeling of the three selenoproteins was abolished in
the Tb-PSTK and the Tb-SepSecS knock-out cell lines (Figure 10B). Moreover,
tetracycline-inducible ectopic expression of Tb-SepSecS in the Tb-SepSecS knock-out cell
line restored 75Se labeling of all three proteins (Figure 10B) (Aeby et al., 2009). Taken
together, these results show that both Tb-PSTK and Tb-SepSecS are indispensable for
selenoprotein synthesis and imply that eukaryotes have a single pathway of Sec-tRNASec
synthesis that requires Sep-tRNASec as an intermediate
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Figure 10: Selenoprotein expression in T. brucei cell lines (Taken from Aeby et al., 2009). Expression was analyzed by 75Se labeling of
living cells and subsequent analysis of the labeled proteins by 10-20% polyacryamide Tris-Tricine gels. The following cell lines were
analyzed. (A) Uninduced and induced Tb-SerRS-RNAi cells. (B) WT 427 cells, Tb-PSTK KO cells ( T b - P S T K - / - ) , Tb-SepSecS KO
cells (Tb-SepSecS—/—), and a Tb-SepSecS KO cell line allowing inducible ectopic expression of Tb-SepSecS (Tb-SepSecS—/—
complem.). (C) Uninduced and induced Tb-SPS2-RNAi cells. (D) Uninduced and induced Tb-EFSec-RNAi cells. For the RNAi and
the complemented Tb-SepSecS —/— cell lines days of induction (d) by tetracycline are indicated. The putative identity of the three
labeled selenoproteins and their molecular mass as predicted in silico are indicated on the left. Molecular mass markers are indicated
on the right. Segments of the tubulin region (50-80 kDa) of the corresponding Coomassie-stained gels are shown as loading controls.
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C. Structural insights into archaeal RNA-dependent selenocysteine biosynthesis
This part of my thesis research was done in collaboration with Yuhei Araiso, who crystallized and
solved the structure of SepSecS from Methanococcus maripaludis.
1. Experimental Approach
In order to investigate the mechanism of selenocysteine formation in archaea, I
performed a structure-based biochemical characterization of SepSecS from M.
maripaludis. The crystal structure of MMPSepSecS with covalently-bound PLP was
determined at 2.5 A resolution (Araiso et al., 2008). To assess the activity of wild-type
and mutant MMPSepSecS proteins, I used genetic complementation of the E. coli AselA
deletion strain as an in vivo test (described in Results, section A.l) as well as two in vitro
tests. The first detects the enzyme's final reaction product, Sec-tRNASec, as determined by
TLC of Sec released from tRNASec (Yuan et al., 2006). Given the difficulty in working
with selenophosphate (availability and oxygen sensitivity), I used thiophosphate as a
surrogate substrate to measure the time course of Cys-tRNASec formation by SepSecS. In
this assay, I incubated
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P-labeled Sep-tRNASec anaerobically with wild-type or mutant

SepSecS proteins and thiophosphate. After nuclease PI digestion of the tRNA in the
reaction mixture, the product Cys-[32P]AMP was separated from Sep-[32P]AMP by TLC
and quantified.

2. Overall structure of SepSecS from Methanococcus

maripaludis

The MMPSepSecS protein adopts an L-shaped structure consisting of the N-terminal
extension domain (1-130), a catalytic domain (131-309) and a C-terminal domain (353-

40

436) (Figure 11A). Long, kinked helices (310-352) connect the catalytic and C-terminal
domains. The PLP molecule is covalently bound to the conserved Lys residue K278
(Figure 12) at the active site. As can be seen in Figure 11 (Araiso et al v 2008), the overall
architecture of MMPSepSecS is similar to the Fold Type I (Eliot and Kirsch, 2004) PLP
enzymes, A.fulgidus SepCysS (Fukunaga and Yokoyama, 2007) and E. coli selenocysteine
lyase (Lima, 2002). These enzymes consist of a catalytic domain similar to that of
MMPSepSecS, and a 'small domain', formed by the N-terminal and C-terminal
polypeptides, which also resembles the MMPSepSecS C-terminal domain (Figure 11B
and C) (Fukunaga and Yokoyama, 2007; Lima, 2002). We used a structure-based
sequence alignment (Figure 12) to compare MMPSepSecS to three PLP enzymes,
AFSepCysS, ECCsdB and ECIscS, that act upon chemically similar substrates (Araiso et
al., 2008). SepCysS, CsdB and IscS share 24 identical residues while these proteins have
only 8 residues in common with SepSecS (Figure 12). The alignment also shows that the
archaeal SepSecS proteins lack the C-terminal extension that has been identified as the
major antigenic region for the human SLA/LP autoantibodies (Herkel et al., 2002).

3. Archaeal SepSecS is active only as a tetramer
The crystal of the apo-MMPSepSecS contains four SepSecS molecules in the asymmetric
unit that are related by non-crystallographic symmetry (Figure 13A). This is in
agreement with our gel-filtration results that have shown that SepSecS forms a
homotetramer (dimer of homodimers) in solution (Figure 13E). The N-terminal
extension domain of each subunit plays a pivotal role in the tetrameric organization of
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Figure 11: The overall architectures of SepSecS and related enzymes (Taken from Araiso
et al v 2008). (A) Stereo view of the M. maripaludis SepSecS (MMPSepSecS) structure. The
N-terminal domain (residues 1-130), the catalytic domain (residues 131-309), the linker
helix (310-352) and the C-terminal domain (residues 353-434) are colored yellow, green,
blue and pink, respectively. The carboxy-terminal two residues are disordered. The PLP
molecule bound to the active site is shown as a ball and stick model. (B) Stereo view of
the Archaeoglobus fulgidus SepCysS (AFSepCysS) structure in the same orientation as (A)
(Fukunaga and Yokoyama, 2007). The small domain, the linker helices and the catalytic
domain are colored pink, blue and green, respectively. (C) Stereo view of the E. coli
selenocysteine lyase (ECCsdB) structure in the same orientation as (A) (Lima, 2002).
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Figure 12: Structure-based sequence alignment (Taken from Araiso et al v 2008). The
alignment includes SepSecS sequences from two archaea (Methanococcus maripaludis and
Methanopyrus kandleri) and two eukaryotes (Homo sapiens and Tetrahymena thermophila) as
well as Archaeoglobus fulgidus SepCysS, E. coli cysteine desulfurase (IscS) and E. coli
selenocysteine lyase (CsdB). Amino acids are colored according to residue types, and
strictly conserved residues are marked (*). The secondary structure of MMPSepSecS is
shown above the alignment, and the active site arginines are highlighted in blue. The
autoimmune antigenic region of human SepSecS (Herkel et al, 2002) and a eukaryotic
specific insertion are shown in gray boxes and green, respectively.
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Figure 13: The oligomeric states of SepSecS and related enzymes (Taken from Araiso et
al., 2008). (A) The overall architecture of the MMPSepSecS tetramer. Chains A and B,
and chains C and D form dimers, respectively. Chain A, chain B, chain C and chain D
are colored pink, blue, green and yellow, respectively. (B) The N-terminal extension
domains of chains B and C form a hydrophobic core that stabilizes the tetrameric state of
MMPSepSecS. Three a-helices (1, 2, 4) are labeled. Chains B and C are colored blue and
green, respectively. (C) Stereo view of the AFSepCysS dimer in the same orientation as
(A) (Fukunaga and Yokoyama, 2007). Chains A and B are colored pink and blue,
respectively. The PLP molecules are shown as ball and stick models. (D) Stereo view of
the ECCsdB dimer in the same orientation as (A) (Lima et al, 2002). The coloring scheme
and the PLP representation are the same as in (C). (E) Gel filtration of MMPSepSecS on
Sephacryl S-300. Absorbance at 280 nm is shown as a blue line. The elution volumes of
other oligomeric proteins are indicated in the chromatogram. The molecular weight of
the MMPSepSecS monomer is 50 kDa. MMPSepSecS eluted at the size expected for a
tetrameric species.
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SepSecS (Araiso et al., 2008). These domains interact with each other to form a
hydrophobic core (chain A with chain D, and chain B with chain C), which involves
inward-facing hydrophobic residues protruding from the helices, a l , al and a 4 (Figure
13B). Thus, the N-terminal extension facilitates tetramer formation and its deletion is
predicted to produce a dimeric SepSecS. Interestingly, AFSepCysS (Fukunaga and
Yokoyama, 2007) and ECCsdB (Lima, 2002) lack the N-terminal extension domain and
form dimers (Figure 13C and D).
In order to investigate whether SepSecS would be active in a homodimeric form I
assayed the enzymatic activity of an MMPSepSecS protein that lacks the N-terminal
extension residues 1-34. The A1-34 SepSecS mutant did not form Sec-tRNASec in vivo
(Figure 14) since it did not rescue selenoprotein biosynthesis in the complementation test
of the E.coli AselA deletion strain (Araiso et al., 2008). Since the active site of SepSecS, like
other PLP enzymes, is formed at the dimer interface it is clear that SepSecS would not
function as a monomer. Why the tetrameric organization of SepSecS is critical for
function remained unclear until the determination of the human SepSecS-tRNASec cocrystal structure (reviewed in Results, section D) (Palioura et al., 2009).

4. Active site mutants define PLP recognition
As in other Fold Type I PLP enzymes, the active sites of MMPSepSecS lie on the dimer
interface with each monomer contributing essential residues (Eliot and Kirsch, 2004).
The active site of chain A is formed by chains A and B that both recognize the PLP
molecule (Figure 15) (Araiso et al., 2008). The catalytic domain harbors a seven-stranded
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Figure 14: In vivo assays of MMPSepSecS mutants (Taken from Araiso et al v 2008). Formation of Sec-tRNASec in vivo is assayed by the
ability of the wild-type MMPSepSecS and its mutant variants (N-terminal deletion Al-34, R72A, R72Q, R72K, R94A, R94Q, H166A,
H166F, H166Q, K278A, N247A, D277A) to restore the BV reducing activity of the selenoprotein F D H H in the E.coli AselA deletion
strain. Cotransformation of the PSTK gene (indicated with +) from M. jannaschii is required for the formation of the Sep-tRNASec
intermediate.

Figure 15: PLP recognition (Taken from Araiso et al., 2008). Stereo views of (A) Ribbon
representation of the active site of MMPSepSecS in the dimer interface between chains A
and B that are colored pink and blue, respectively. The PLP molecule is covalently
bound to Lys278 of chain A. The Fo-Fc omit map of the PLP molecule, contoured at 3.5
a, is shown. (B) The amino acid residues that recognize the PLP molecule. The residues
of chains A and B are colored pink and blue, respectively. The Fo-Fc omit map
(contoured at 3.5 a) of all of the residues and PLP is shown.
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|3-sheet, with only the sixth (3-strand being antiparallel; this is a common feature of Fold
Type IPLP enzymes (Eliot and Kirsch, 2004; Jansonius, 1998) including AFSepCysS
(Fukunaga and Yokoyama, 2007) and ECCsdB (Lima, 2002). In the MMPSepSecS
structure, PLP is covalently bound via a Schiff base to the strictly conserved Lys278
(chain A) (Figure 12), which is located between the sixth and seventh (3 strand in the
active site (Figure 15A) (Araiso et al., 2008). Indeed, a Lys278Ala mutation abolishes
MMPSepSecS catalytic activity as shown both in vivo by the lack of BV reduction by
FDHH

(Figure 14), and in vitro by the inability of the Lys278Ala mutant to form Cys-

tRNASec (Figure 16) (Araiso et al., 2008).
All known Fold Type I PLP enzymes possess a critical aspartate that forms a
hydrogen bond with the N l atom of the pyridine ring (Schneider et al., 2000), which is
thought to increase the electron sink character of the PLP cofactor. SepSecS is an
exception to this paradigm; Asn247 is found in the corresponding position, and it forms
a hydrogen bond with the pyridinium nitrogen (Figure 15). The other 'nonconforming'
enzyme is SepCysS where the structure also reveals a similar Asn contact with PLP
(Fukunaga and Yokoyama, 2007). To test whether Asn247 is responsible for the
discrimination that MMPSepSecS exhibits towards Ser-tRNASec, we mutated it to Asp
and Ala. Though still fully active towards Sep-tRNASec, the Asn247Asp MMPSepSecS
mutant is inactive towards Ser-tRNASec (Figure 17) (Araiso et al., 2008). Finally, the
replacement of Asn247 with the uncharged Ala yields an enzyme that is only partially
active (Figure 14). Asn247, thus, plays the role of the highly conserved Asp247 in the
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Figure 16: In vitro conversion of Sep-tRNASec to Sec-tRNASec or Cys-tRNASec (Taken from Araiso et al., 2008). (A) Phosphorimages of
TLC separation of [ u C]Sep and [14C]Sec recovered from the aa-tRNAs of the SepSecS activity assay. Sec was analyzed in its oxidized
form as selenocysteic acid (Secya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, Sep-tRNASec with wild-type MMPSepSecS; lane 4,
Sep-tRNASec with the R72Q MMPSepSecS mutant. (B) Representative phosphorimage for the H166A SepSecS mutant of the
separation of Ser-[32P]AMP, Cys-[32P]AMP, [32P]AMP and Sep-[32P]AMP. At the indicated time points aliquots of the SepSecS reaction
were quenched, digested with nuclease PI and spotted onto PEI-cellulose TLC plates. (C) Plot of Cys-tRNASec formed versus time
with 1 uM of wild-type and mutant SepSecS enzymes using Sep-tRNASec (1 uM) and thiophosphate (500 [_iM) as substrates.
Following quantification of the intensities of Ser-[32P]AMP/ Cys-[32P]AMP, [32P]AMP and Sep-[32P]AMP using ImageQuant, the
concentration of Cys-tRNASec formed at each time point was calculated by dividing the intensity of the Cys-[32P]AMP spot by the
total intensity.

1

Sep |

Ser

Secya

B
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Figure 17: In vivo assays of MMPSepSecS mutants (Adapted in part from Araiso et al v 2008). Formation of Sec-tRNASec in vivo is
assayed by the ability of the wild-type MMPSepSecS and its mutant variants (N247D, Q102A, Q102E, R307A, R307K, R307Q, S95A,
S95T, S168A, S168T) to restore the BV reducing activity of the selenoprotein F D H H in the E.coli selA deletion strain. Cotransformation
of the PSTK gene (indicated with +) from M. jannaschii is required for the formation of the Sep-tRNASec intermediate.

Fold Type IPLP enzymes. The protonated PLP is critical for the stabilization of the
covalently attached carbanion intermediate in the reaction pathway.
The aromatic pyridine ring of PLP is sandwiched between Hisl66 (chain A) and
Ala249 (chain A) through hydrophobic interactions at the floor of the catalytic site
(Figure 15). This recognition mode is commonly observed in the structures of Fold Type
I PLP enzymes where the His residue increases the electron sink character of PLP's
pyridine ring through the stacking interactions with it and may also play a role in
substrate activation and acid base catalysis. In the latter case, the His residue makes a
direct hydrogen bond with the critical aspartate that contacts the N l atom of the
coenzyme pyridine ring in all Fold Type I PLP enzymes and is, thus, thought to assist in
the dissipation of the negative charge generated around PLP's ring during catalysis
(Yano et al., 1991). Furthermore, the phosphate moiety hydrogen bonds with the mainchain amide and carbonyl groups of Glyl40 and Serl68, respectively (Figure 15B). The
MMPSepSecS mutant Hisl66Ala was partially active in forming Sec-tRNASec in vivo
(Figure 14). In vitro, the Hisl66Ala MMPSepSecS mutant was partially active in forming
Cys-tRNASec as can be seen by the increase in intensity of the Cys-[32P]AMP spot and the
concomitant decrease of the Sep-[32P]AMP spot during the course of the reaction (Figure
16B) (Araiso et al., 2008). Obviously, the mutant enzyme with Alal66 has PLP still in a
partially functional position. A mutation of the corresponding His residue (position 143)
in E. coli aspartate aminotransferase also led to a functional enzyme (Yano et al., 1991).
In contrast, both the Hisl66Gln and Hisl66Phe mutants were inactive in vivo (Figure 14).
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Since the catalytic pocket is formed at the dimerization interface, chain B also
contributes residues that participate in PLP recognition. In particular, the guanidinium
group of Arg72 and the main-chain amide group of Arg307 (from chain B) hydrogen
bond to the phosphate moiety of PLP (Figure 15B). Mutations of Arg72 and Arg307 to
Ala, Gin or Lys resulted in MMPSepSecS mutants that were significantly less active in
Sec-tRNASec formation in vivo (Figures 14 and 17) and Cys-tRNASec formation in vitro
(Figure 16C). Such PLP recognition differs from that of AFSepCysS (Fukunaga and
Yokoyama, 2007) and ECCsdB (Lima, 2002). Unlike in the MMPSepSecS structure, the
adjacent subunit of ECCsdB does not come close to the active site (Figure 18A, B) (Araiso
et al., 2008). In ECCsdB, an additional |3a(3 structural motif covers the active site,
presumably to stabilize the PLP and Sec substrates inside the pocket. This motif also
precludes interaction between residues from the neighboring subunit and the active site
(Figure 18B). Although the active site of AFSepCysS is formed by residues from chains A
and B, the chain B amino acids are located too distant for PLP recognition (Figure 18C).
The active sites of MMPSepSecS and AFSepCysS are spacious enough to accommodate
the Sep-CCA end of the tRNASec or tRNAcys species, respectively.

5. The active site
The crystallization solution contained 10 mM magnesium sulfate. In the present
structure, we observed a strong electron density peak (4.5 a), presumably corresponding
to a sulfate ion, adjacent to the PLP molecule of chains A and B (Figure 18A). The sulfate
ion may be mimicking the position of the phosphate moiety of Sep attached to tRNASec.
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Figure 18: The active site in MMPSepSecS, ECCsdB, and AFSepCysS (Adapted from
Araiso et al., 2008). Chains A and B are colored pink and blue, respectively. PLP is
covalently bound to chain A. (A) The sulfate ion is shown as a ball-and-stick model in
the active site of MMPSepSecS. (B) In the active site of ECCsdB PLP is covalently bound
to Lys226 of chain A and is covered by the |3a(3 structural motif. (C) In the active site of
AFSepCysS, PLP is covalently bound to Lys209 of chain A. The orientation of PLP is the
same as that in (A). The chain A residues that recognize PLP and sulfate are shown.
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Indeed, the quaternary structure of the human SepSecS complexed with tRNASec, Sep
and thiophosphate revealed that the phosphate moiety of Sep occupies the same
position in the active site of the human enzyme as the sulfate ion in the MMPSepSecS
structure (reviewed in Results, section D) (Palioura et al., 2009). Mutations of Arg94,
Glnl02 and Arg307 of chain B that recognize the sulfate ion (Figure 18A) significantly
decreased the catalytic activity of MMPSepSecS both in vivo (Figures 14 and 17) and in
vitro (Figure 16) (Araiso et a l , 2008).
The MMPSepSecS structure reveals three conserved arginines (Arg72, Arg94 and
Arg307) that are located in proximity of each other and close to the active site; they
recognize the phosphate groups of PLP and presumably of Sep acylated to tRNASec
(Figures 12 and 18A). Mutations of Arg72, Arg94 and Arg307 to Ala, Gin or Lys yielded
MMPSepSecS enzymes that were unable to form Sec-tRNASec in vivo (Figures 14 and 17)
(Araiso et al., 2008). Asp277 interacts electrostatically with Arg72, and the Asp277Ala
enzyme was also inactive in vivo (Figure 14). The Arg72Gln, Arg94Gln and Arg307Gln
MMPSepSecS mutants were inactive in forming Cys-tRNASec in vitro (Figure 16) (Araiso
et al., 2008). In addition to the PLP-conjugated Lys278, the side chains of the Sep-binding
arginines may also facilitate general acid/base catalysis as was shown for the tRNA
modification enzyme TrmH where an arginine activated by a phosphate group acts as a
general base (Nureki et al., 2004).
Finally, to investigate whether the reaction proceeds through an enzyme-bound
phosphorylated intermediate I mutated the two Ser residues located close to the active
site, Ser95 and Serl68. Ser95 interacts with the sulfate ion, while Serl68 recognizes the
54

PLP phosphate moiety. Since the Ser95Ala, Ser95Thr and Serl68Ala mutants are active
in forming Sec-tRNASec in vivo (Figure 17), a phosphorylated state of the enzyme is
unlikely to be part of the reaction mechanism.

D. The human SepSecS-tRNA Sec complex
This part of my thesis research was done in collaboration with Miljan Simonovic. I crystallized
the human SepSecS-tRNASec complex and performed in vivo and in vitro activity assays and Dr.
Simonovic solved the structure.
1. SepSecS can bind tRNASec only as a tetramer
In order to investigate the mode of binding of tRNASec to SepSecS and the role of
PLP in the catalytic mechanism, we determined the crystal structure of the quaternary
complex between human SepSecS, unacylated tRNASec, Sep and Thiophosphate to 2.8 A
resolution. In this complex, SepSecS forms a tetramer that is bound to two tRNASec
molecules (Figure 19) (Palioura et al., 2009). The physiological tetramer in this crystal is
the same as that found in studies of the archaeal and murine apo-enzyme (Figure 19)
(Araiso et al., 2008; Ganichkin et al., 2008). Each monomer has a PLP cofactor covalently
linked to the Ne-amino group of the conserved Lys284 via formation of a Schiff base
(internal aldimine). Two SepSecS monomers form a homodimer, and two active sites are
formed at the dimer interface. The two homodimers associate into a tetramer through
interactions between the N-terminal al-loop-a2 motifs (Figure 19C, D). Given that
SepCysS, the closest PLP Fold Type I homologue of SepSecS that also acts on tRNAbound Sep (Sep-tRNAcys), is a dimer and that the active sites of one homodimer do not
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Figure 19: Structure of human SepSecS in complex with unacylated tRNASec (Adapted
from Palioura et al., 2009). (A, B) Surface representation of the complex of SepSecS with
tRNASec. The subunits of the catalytic dimer are dark and light blue, those of the
noncatalytic dimer are dark and light red; the backbone and bases of tRNASec are green
and gray, respectively. (C, D) Ribbon diagram of the SepSecS-tRNASec complex. The
catalytic dimer interacts with the acceptor arm of tRNASec through helices a l 4 and a l 5
(blue). The a l helix (red) of the noncatalytic dimer interacts with the rest of the acceptorTWC arm. The variable arm of tRNASec interacts with helix a9 (red) of the noncatalytic
dimer. The al-loop-a2 motif is important for the tetramerization of the enzyme and is
annotated in both dimers. The regions of tRNASec that interact with SepSecS are shown
in orange; the rest is green. One tRNASec molecule is shown for clarity. The view in B and
D is rotated -90° clock-wise around the vertical axis relative to that in A and C.
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communicate with the active sites of the other homodimer in the apo-SepSecS tetramer
(Araiso et al v 2008; Ganichkin et al., 2008), the reason for the tetrameric organization of
SepSecS was not known. The mode of tRNASec binding to SepSecS provides an answer to
this question.
The CCA-ends of both tRNASec molecules point to the active sites of the same
homodimer, which will be referred to as the catalytic dimer (Figure 19). The other
homodimer, which will be referred to as the noncatalytic dimer, serves as a binding
platform that orients tRNASec for catalysis (Figure 19) (Palioura et al., 2009). The
structure reveals that SepSecS binds only to the acceptor-, TWO and variable arms of
tRNASec (Figure 19C, D). The tip of the acceptor arm interacts with the C-terminus of the
catalytic dimer, whereas the rest of the acceptor-, TWC- and variable arms wrap around
a monomer from the non-catalytic dimer (Figure 19). The most important binding
element is an interaction between the discriminator base G73 of tRNASec and the
conserved Arg398 of the catalytic dimer (Figure 20A) (Palioura et al., 2009). The
guanidinium group of Arg398 forms hydrogen bonds with the Hoogsteen face of G73.
The discriminator base G73 of tRNASec is universally conserved in archaea and
eukaryotes. Neither adenine nor cytidine in position 73 could form hydrogen bonds
with Arg398 because they have amino-groups instead of the keto-group. Also, if a
cytidine or uridine was in position 73, the C5 and C6 atoms of the pyrimidine ring
would clash with the side-chain of Thr397, thus, preventing the interaction of these
bases with Arg398.
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Figure 20: Close-up view of interactions between human SepSecS and tRNASec (Adapted from Palioura et al., 2009) (A) Interactions
between the discriminator base G73 and the conserved Arg398 in the al4-|311 loop. In A, B and C, tRNASec is green and the protein
side-chains are gold. (B) The side-chains of Lys38 and Lys40 (al-a2 loop) interact with the T ^ C arm. Lys38 and Lys40 interact with
C64 and G50, respectively. (C) Arg271 (a9) in the noncatalytic dimer interacts with the variable arm (nucleotides C46L-A47).

The majority of interactions between the enzyme and tRNASec, however, occur
between the highly conserved basic residues in the N-terminal al helix of the
noncatalytic dimer and the phosphate-sugar backbone of the acceptor-TWC arm (Figure
19C, D). For instance, the side-chain of Arg26 forms hydrogen bonds with the phosphate
backbone of C2-C3 of the acceptor arm, the Ne-amino group of Lys38 forms a hydrogen
bond with the 2'-hydroxyl group of C64 (Figure 20B), whereas the side-chain of Lys40
interacts with the phosphate oxygen of G50 from the TWC arm (Figure 20B). Moreover,
the 13-base pair (bp) length of the acceptor-T^C arm is important for positioning the
variable arm to interact with the neighboring noncatalytic dimer. The nucleotides C46A
and C46L interact with Ser260 and Arg271 from the noncatalytic dimer, respectively
(Figure 20C) (Palioura et al., 2009).
The interactions between SepSecS and tRNASec observed in the crystal are
consistent with in vivo activity assays of SepSecS mutants (Figure 21) (Palioura et al.,
2009). Replacing Arg398 with either alanine or glutamate renders the enzyme
completely inactive suggesting that the interaction between the discriminator base and
the highly conserved Arg398 of the catalytic dimer is critical for tRNASec recognition
(Figure 21). Furthermore, Thr397Ala is completely active, Thr397Val is partially active
and Thr397Glu is inactive in vivo (Figure 21). Thus, Thr397 strengthens the interaction of
the acceptor arm with the a l 4 helix. In addition, the Arg271Glu mutant is partially
active suggesting that the interaction between the variable arm and the noncatalytic
dimer is important for complex formation as well (Figure 21). When Lys38 is replaced by
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Figure 21: In vivo assays of SepSecS mutants (Taken from Palioura et al v 2009). Formation of Sec-tRNASec in vivo is assayed by the
ability of the wild-type human SepSecS and its mutant variants (N-terminal deletion Al-37, R398A, R398E, R26A, R26E, K38A, K38E,
T397A, T397E, T397V, R271A, R271E, K173A, K173M, S98A, R97A, Q105A, R313A and R75A) to restore the benzyl viologen reducing
activity of the selenoprotein F D H H in the E. coli AselA deletion strain. The M. jannaschii PSTK is co-transformed, except where
indicated with a "-", to provide the necessary Sep-tRNASec intermediate.

Glu, the enzyme is partially active in vivo, whereas both the Arg26Ala and Arg26Glu
mutants are completely active (Figure 21), suggesting that the Arg26-C2 interaction
alone is not critical for complex formation. Finally, both the human and archaeal
SepSecS enzymes are completely inactive in vivo when the a l helix is deleted (Figure 21)
(Araiso et al., 2008; Palioura et al., 2009).

2. The antigenic region
In the structure of the SepSecS-tRNASec binary complex, the first twelve residues of the
proposed antigenic region (residues 452-463) form the C-terminal helix al5. The
remaining residues of the antigenic region (residues 463-501) form the extreme Cterminal tail of SepSecS and have been disordered in all crystal structures of the enzyme
determined to date (Araiso et al., 2008; Ganichkin et al., 2008). Interestingly, helix a l 5 is
spatially located near the entrance to the active-site cleft and it is proximal to helix a l 4
(Figures 19B and 22A) (Palioura et al., 2009; Palioura et al., 2010). Both a l 4 and a l 5
interact with distinct parts of the acceptor arm (Figure 22) (Palioura et al., 2010). The side
chains of Thr397 and Arg398 from helix a l 4 interact with the discriminator base G73
and, thus, establish the identity of the bound tRNA molecule (Figure 22B). The
importance of Thr397 and Arg398 for tRNASec binding has been confirmed in the in vivo
assays (Figure 21) (Palioura et al., 2009). On the other hand, the residues Arg453, Arg456
and Lys463 in a l 5 form the 5'-phosphate binding groove and they interact with the
tRNA backbone atoms (Figure 22B) (Palioura et al., 2010).
Since autoantibodies from patients with autoimmune hepatitis can precipitat
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Figure 22: The proposed antigenic region in SepSecS or SLA/LP (Taken from Palioura et al., 2010). (A) The putative antigenic region
of SepSecS is located near the active site of the enzyme (arrow). This region interacts with the tip of the acceptor arm of tRNASec and
is critical for tRNA recognition. The catalytic dimer of SepSecS is in shades of blue, the non-catalytic dimer is colored in shades of
pink, two molecules of tRNASec are green, and the antigenic region is orange and demarcated with a box. (B) A close-up view of the
interactions at the enzyme-tRNA interface. Residues from helices a l 4 and a l 5 interact with the tip of tRNASec. The helix a l 4 residues
interact with the discriminator base G73: Arg398 forms hydrogen bonds with the Hoogsteen face of G73, while Thr397 stabilizes this
interaction. The C-terminal helix a l 5 interacts with the tRNA backbone and with the 5' phosphate. Arg453 and Arg456 are within
hydrogen bonding distance from the 5' phosphate, whereas Lys463 interacts with the non-bridging oxygens of C69 and G70.

A

the ribonucleoprotein SepSecS-tRNASec complex, such autoantibodies would bind to an
interface that lies between the a l 4 and al5 helices of SepSecS and the tip of the acceptor
arm of tRNASec (Figure 22B). Binding of the antibody near the active site of SepSecS may,
in fact, inhibit the enzyme's function directly or indirectly by stabilizing the entire
protein-RNA complex and preventing release of tRNASec. The inhibitory effect of
antibodies would resemble the mechanism by which LKM-1 autoantibodies inhibit
cytochrome P450 isoenzyme 2D6 (CYP2D6) in a subgroup of autoimmune hepatitis
patients (Manns et al., 1989).

3. The unique 9/4 fold of tRNASec is recognized by the Sec-specific proteins
Human tRNASec contains 90 nucleotides rather than the conventional 75 nucleotides of
canonical tRNA molecules. The structure shows that human tRNASec adopts a unique 9/4
fold with a 13 bp acceptor-TWC arm (where 9 and 4 reflect the number of base pairs in
the acceptor and TWC arms, respectively) and a long variable arm (Figure 23) (Palioura
et al., 2009). This resolves a controversy between conflicting models in which the 7/5
model suggested 12 bp in the acceptor-T^C arm as found in all known tRNA structures
(Ioudovitch and Steinberg, 1998), whereas the 9/4 model suggested a unique 13 bp
acceptor-T^C arm (Sturchler et al., 1993).
In the 9/4 fold of the human tRNASec, the linker between the acceptor- and the Dstem is two residues long (A8-U9) as was proposed earlier (Sturchler et al., 1993). The
base of A8 does not participate in any tertiary interactions, while the base of U9 stacks
with A49 from the variable arm-T^C linker. The first pair of the D-arm is a C10-G2
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Figure 23: Structure of human tRNASec compared to the canonical tRNASer (Adapted from Palioura et al., 2009). (A) Ribbon diagram
of the human tRNASec molecule observed in complex with SepSecS. The major structural elements are colored as follows: the
acceptor arm is red, the D-arm is blue, the anticodon arm is light blue, the variable arm is orange and the T ^ C arm is dark red. (B)
The view is rotated by -90° clockwise around the vertical axis. Secondary structure diagram of (C) human tRNASec and (D) tRNASer.
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couple followed by a C11-G24 pair (Figure 23C) (Palioura et al., 2009). Four nucleotides
U16, G18, G19 and U20 form the D-loop and interact with U55, C56, A57 and A58 from
the V¥C loop closing the cloverleaf structure as proposed (Sturchler et al., 1993). The
rest of the tRNASec structure agrees well with the proposed model (Sturchler et al., 1993).
The 13 bp acceptor-T^C arm and a long variable arm are distinct structural
features that serve as major recognition motifs for binding to SepSecS (Figure 19).
The structure of the human SepSecS in complex with tRNASec along with the in vivo
mutagenesis data reveal that SepSecS can bind tRNASec only as a tetramer. The
interaction between Arg398 and G73 along with the longer 13 bp acceptor-T^C arm and
the variable arm of tRNASec secure binding of the tRNA to the enzyme. The only tRNA
with a G73 discriminator base and a long variable arm yet with a 12 bp acceptor-T^C
arm is tRNASer. However, neither unacylated tRNASer nor Ser-tRNASer is able to bind to
SepSecS (Xu et al., 2007). To examine the importance of the length of the acceptor-TWC
arm for SepSecS binding, we superimposed tRNAAsP (Eiler et a l , 1999) onto tRNASec
(Figure 24) (Palioura et al., 2009). The tRNAAsP was chosen because it is a canonical
tRNA molecule with G73 as the discriminator base and because the complete structure
of tRNASer is not available. Two approaches were used for superimposing the two
tRNAs. In the first approach, the atoms of the sugar-phosphate backbone of the
acceptor-, T ^ C - and anticodon arms were superimposed. Although the secondary
structure elements of tRNAAsP were oriented as observed in tRNASec, G73 of tRNAAsP
could not reach Arg398 due to its shorter acceptor-T^C arm (Figure 24B). In the second
approach, the discriminator base of tRNAAsP was first modeled to form hydrogen bonds
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Figure 24: Selectivity of SepSecS towards tRNASec (Taken from Palioura et al, 2009). (A) Modeling of the complex between SepSecS
and canonical tRNAs. tRNAAsP (orange) was superimposed onto tRNASec (green) using the sugar-phosphate backbone atoms of the
acceptor, T ^ C and anticodon arms. The long variable arm of tRNASec interacts with the noncatalytic dimer of SepSecS (shades of
red). The box delineates the close-up view shown in B. (B) The short acceptor-TWC arm of canonical tRNAs prevents binding to
SepSecS. G73 of tRNAAsP (orange) cannot reach Arg398. (C) Steric clashes (asterisk) between the a l helix of the noncatalytic dimer of
SepSecS (shades of red) and the V¥C arm of tRNAAsP (orange) prevent the SepSecS-tRNAAsP complex formation. G73 from tRNAAsP
was modeled to form hydrogen bonds with Arg398 using its Hoogsteen face. Only the tip of the acceptor arm (nucleotides 1-3 and
70-73) was used in the superposition. Arrows show the movement of both the anticodon and TWC arms in tRNAAsP relative to its
orientation shown in A.

with Arg398 using its Hoogsteen face, and then the tips of the acceptor arms
(nucleotides 1-3 and 70-73) were superimposed. In this case, the anticodon and variable
arms of tRNAAsP are positioned away from the enzyme, whereas its TWC arm clashes
with the al helix of the noncatalytic dimer (Figure 24C), thus preventing the formation
of the SepSecS-tRNAAsP complex. In addition, the absence of a long and properly
oriented variable arm in tRNAAsP diminishes further its capacity for interaction with
SepSecS (Figure 24A, C) (Palioura et al., 2009). Thus, modeling of the SepSecS-tRNAAsP
complex suggests that tRNASer is not able to bind to SepSecS due to its shorter acceptorW C arm.
Further, it has been proposed that the variable arm of tRNASec serves as the major
recognition motif for its binding to SerRS, which allows Ser-tRNASec formation to occur
(Bilokapic et al., 2004; Geslain et al., 2006; Leinfelder et al., 1988; Ohama et al., 1994;
Rother et al., 2000; Sherrer et al., 2008a; Sturchler-Pierrat et al., 1995; Wu and Gross, 1993,
1994). Modeling of the SerRS-tRNASec complex based on the crystal structure of the
bacterial SerRS complexed with tRNASer (Biou et al., 1994) suggests that SerRS can
recognize the variable arm of tRNASec similarly to tRNASer providing an explanation for
the inability of SerRS to discriminate between tRNASer and tRNASec (Figure 25).

4. Sep binds to the active site only in the presence of tRNASec
To explore the mechanism by which the phosphoryl group is converted to the
selenocysteinyl moiety, I soaked crystals of the binary SepSecS - tRNASec complex in a
solution containing a mixture of O-phosphoserine and thiophosphate. I used Sep and
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Figure 25: Modeling of the SerRS-tRNASec complex (Taken from Palioura et al v 2009).
tRNASec was superimposed onto the tRNASer that is in complex with SerRS. SerRS is a
non-discriminating aminoacyl-tRNA synthetase because it recognizes variable arms of
both tRNASer (red) and tRNA s « (green)
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and thiophosphate as mimics of the phosphoseryl group attached to tRNASec and
selenophosphate, respectively. Although both ligands were used in the soaking
experiments, Sep bound only to the active sites of the catalytic dimer (Figure 26A)
(Palioura et al., 2009), whereas thiophosphate bound only to the active sites of the noncatalytic dimer (Figure 26B), i.e. Sep can bind to an active site only in the presence of
£RNASec. Both thiophosphate and the phosphoryl group of Sep bound to the same
binding pocket (Figure 26) suggesting that a specific active site can accommodate only
one ligand at a time (Palioura et al., 2009).
Sep binds to the catalytic active site in either of two different orientations (Figure
26A). The phosphoryl group occupies a similar location in the two orientations, whereas
the seryl moieties are rotated by -90° around the phosphate group. In what appears to
be a non-productive orientation of Sep (SepN), its seryl group is sandwiched between the
side-chains of Arg97 and Lysl73 at the catalytic dimer interface, while its amino group
lies -12 A away from the PLP Schiff base (Figure 27A) (Palioura et al., 2009). Thus, it is
unlikely that SepSecS would act on Sep N , unless a PLP-independent mechanism is
utilized. In the productive-like orientation of Sep (Sepp), the amino-group of Sep is -3.5
A away from the Schiff base yet it is not positioned for attack due to a hydrogen bond
with Glnl72 (Figure 27B). The carboxyl group of Sep p also forms a hydrogen bond with
the side-chain of Glnl72. Electron density for both the amino and the carboxyl groups of
Sep p is weak suggesting higher mobility in this part of Sep p . This is presumably due to
free rotation around the Ca-C[3 bond. The interactions of the phosphoryl group of Sep p
69

Non-catalytic active site
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Figure 26: Ligand binding to the active sites in the SepSecS-tRNASec complex (Taken from Palioura et al v 2009). (A) Phosphoserine
binds to the catalytic sites in two orientations (Sepp and SepN). The catalytic PLP-monomer is purple, the P-loop monomer is light
blue, Sep is gold, tRNA is green and PLP is magenta. Simulated annealing omit electron density map (green mesh) is contoured at
3.5 a. (B) Thiophosphate (Thiop) binds only to the non-catalytic site. The PLP-monomer is brown and the P-loop monomer is pink.

Catalytic active site

Productive binding of Sep

Catalytic site conformational
change
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Figure 27: Phosphoserine binds to the active site of the SepSecS-tRNASec complex in two orientations (Taken from Palioura et al.,
2009). The catalytic PLP-monomer is purple, the P-loop monomer is light blue, Sep is gold, tRNA is green and PLP is magenta. (A)
The Sep N amino-group is -12 A away from the Schiff base. Arg97, Glnl05 and Arg313 coordinate phosphate and the carboxyl group
interacts with Lysl73. (B) The amino group of Sep p interacts with Glnl72 and is 3.5 A away from the Schiff base. The carboxyl group
interacts with Glnl72, while Ser98, Glnl05, and Arg313 coordinate phosphate. (E) The P-loop adopts a different conformation upon
tRNASec binding. The noncatalytic dimer is pink, the catalytic dimer is light blue. Steric clashes between the noncatalytic P loop and
Sep N are shown (double arrow).

Non-productive binding of Sep

with the side-chains of Ser98, Glnl05 and Arg313 anchor Sep in the active site. That the
phosphoryl group is required to properly position the ligand for catalysis explains why
the obligate substrate for SepSecS is Sep-tRNASec and not Ser-tRNASec, which is the
physiological substrate for the bacterial selenocysteine synthase.
A comparison of the catalytic and noncatalytic sites reveals that Sep binds to the
active site only in the presence of tRNASec because the conformation of the P-loop
(residues Gly96-Lysl07) differs between the two active sites (Figure 27C). In the
noncatalytic dimer the guanidinium group of Arg97 and the side-chain of Glnl05 are
rotated towards the phosphate-binding groove where they coordinate thiophosphate
(Figures 26B and 27C) (Palioura et al., 2009). In the catalytic dimer, the side-chain of
Arg97 rotates away from the phosphate-binding groove, and forms a hydrogen bond
with the 2'-OH group of C75. Glnl05 also rotates away from the phosphate and this
concerted movement of Arg97 and Glnl05 in the P-loop upon tRNASec binding allows
Sep to bind to the active site (Figure 27C). Free Sep enters the active site through the gate
formed by the side-chains of Arg97, Glnl05 and Lysl73. The affinity for the Sep N is high
enough to trap the free ligand in this orientation as well. Moreover, the free amino
group of Sep p cannot be positioned appropriately for attack onto the Schiff base
probably due to free rotation around the Ca-C(3 bond explaining why the reaction does
not occur in the crystal. Thus, the covalent attachment of Sep to tRNASec is necessary for
the proper placement of the Sep moiety into the active site and for orienting the aminogroup of Sep for attack onto the Schiff base of PLP.
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5. SepSecS utilizes a PLP-dependent mechanism for Sec-tRNASec formation
I used both in vivo and in vitro activity assays to investigate the mechanism of SeptRNASec to Sec-tRNASec conversion by human SepSecS. Several lines of evidence suggest
that SepSecS catalyzes the Sep-tRNASec to Sec-tRNASec conversion in a PLP-dependent
reaction. First, the reduction of the Schiff base by sodium borohydride to form a
chemically stable secondary amine and, thus, cross-link PLP to Lys284 renders SepSecS
completely inactive in vitro (Figure 28) (Palioura et al., 2009). The catalytic activity of
SepSecS is also quenched upon removal of PLP by treatment with hydroxylamine
(Figure 28) (Palioura et al., 2009). Some residual activity that is observed upon
hydroxylamine treatment is probably due to an incomplete removal of PLP (Figure 28).
Second, we show that the Arg75Ala, Glnl05Ala and Arg313Ala mutants are inactive in
vivo (Figure 21) (Palioura et al., 2009). These residues are involved in coordinating either
the phosphate group of PLP or that of Sep. Finally, the in vivo activities of the Arg97Ala,
Arg97Gln, Lysl73Ala and Lysl73Met mutants are indistinguishable from that of the
wild-type enzyme confirming that Arg97 and Lysl73 are involved only in the nonproductive binding of free Sep (Figure 21). Therefore, a PLP-dependent mechanism for
the Sep to Sec conversion is proposed (Figure 29) (reviewed in Discussion, section D)
(Palioura et al., 2009).
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Figure 28: In vitro conversion of Sep-tRNASec to Cys-tRNASec by wild type and PLP-crosslinked SepSecS (Taken from Palioura et al., 2009). Phosphorimages of TLC separation of
[14C]Sep and [14C]Cys recovered from the aminoacylated-tRNAs of the SepSecS activity
assays. Cysteine was analyzed in its oxidized form as cysteic acid (Cya). Lane 1, Ser
marker; lane 2, Sep marker; lane 3, Cys marker; lane 4, Sep-tRNASec with human SepSecS
in the absence of thiophosphate; lane 5, Sep-tRNASec with wild-type human SepSecS;
lane 6, Sep-tRNASec with human SepSecS treated with 7.5 mM hydroxylamine; lane 7,
Sep-tRNASec with human SepSecS treated with 100 mM sodium borohydride.
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Figure 29: The PLP-dependent mechanism of Sep to Sec conversion (Taken from
Palioura et al v 2009). (A) The phosphoseryl moiety of Sep-tRNASec is bound to the active
site similarly to Sep p . The amino group is oriented for attack onto the Schiff base
(internal aldimine), while the phosphoryl group is stabilized by the side-chains of Ser98,
Glnl05 and Arg313. Hydrogen bonds are shown in dashed lines. (B) After the formation
of the external aldimine, the side-chain of Lys284 rearranges and abstracts the C a proton
from Sep. The protonated pyridine ring of PLP stabilizes the carbanion. (C) Electron
derealization leads to a rapid |3-elimination of phosphate and to the formation of
dehydroalanyl-tRNA Sec . Free phosphate dissociates and selenophosphate binds to the
active site. (D) An unidentified base (~B) activates water that hydrolyzes
selenophosphate. Free phosphate dissociates again, and selenium attacks the
dehydroalanyl-tRNA Sec . Lys284 returns the proton to the Ca carbon and the
selenocysteinyl moiety is formed. (E) The reaction of reverse transaldimination is shown.
Lys284 forms the Schiff base with PLP leading to a release of the oxidized form of SectRNASec (red box). (F) The free amino-group of Sec-tRNASec is protonated, and the active
site of SepSecS is regenerated.
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DISCUSSION
A. SepSecS: the missing step in Sec biosynthesis in eukaryotes and archaea
We used in vivo complementation assays and in vitro activity assays to establish the
human SLA/LP and its archaeal and trypanosomal orthologs as SelA analogs able to
catalyze Sec-tRNASec formation. However, in contrast to bacterial SelA that converts SertRNASec directly to Sec-tRNASec, SepSecS acts on the phosphorylated intermediate, SeptRNASec (Figure 30) (Palioura et al., 2009). Therefore, the bacterial SelA is replaced by
PSTK and SepSecS in archaea and eukaryotes. Thus, archaeal and eukaryal Sec
biosynthesis requires three enzymes, SerRS, PSTK, and SepSecS, whereas bacteria
accomplish the same task without PSTK. Interestingly, both SelA and SepSecS are PLPdependent enzymes. From a chemical standpoint, a Sep —»• Sec conversion is desirable,
as Sep would provide a better leaving group (phosphate) than Ser (water) for
replacement with selenium. Sep-tRNA is reported to be more stable than Ser-tRNA
(Carlson et al., 2004), which is known to deacylate faster than any other aa-tRNA species
(Matthaei et al., 1966). This would presumably improve the overall efficiency of the
selenocysteinylation reaction and the rate of production of Sec-tRNA in all organisms
that possess an extended selenoproteome. Most selenoprotein-containing bacteria only
have one to three selenoproteins that are expressed under specific environmental
conditions and a nonessential tRNASec (Kryukov and Gladyshev, 2004). In contrast,
humans have an essential tRNASec and an extended selenoproteome whose 25 members
have been variously implicated in health and disease (Lobanov et al., 2009).
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Figure 30: Selenocysteine biosynthesis in eukaryotes (Taken from Palioura et al., 2010). Following serylation of tRNASec (red) by
SerRS (light and dark blue), PSTK (light and dark grey) phosphorylates Ser-tRNASec into Sep-tRNASec. SepSecS (gold and olive) then
binds Sep-tRNASec and catalyzes the conversion of Sep into Sec using selenophosphate. Sec-tRNASec is delivered to the 80S ribosome
(orange and beige) by the specialized elongation factor EFSec (green). Once the Sec residue is inserted into the nascent polypeptide
chain, free tRNASec is released. Crystal structures of the bacterial SerRS (Biou et al., 1994), the archaeal PSTK (Araiso et al., 2009), the
human SepSecS-tRNASec complex (Palioura et al., 2009), the human tRNASec (Itoh et al., 2009), the archaeal SelB (Leibundgut et al.,
2005) and that of the bacterial 70S ribosome in complex with EF-Tu (Schmeing et al., 2009) were used for modeling.

rlbosome:EFSec:Sec-tRNA Sec

SerRS

B. The indirect RNA-dependent PSTK/SepSecS pathway is the only route to Sec
Despite the in vitro experiments that indicated that PSTK and SepSecS are the core
components for selenocysteine biosynthesis in eukaryotes (Xu et al v 2007; Yuan et al.,
2006), the in vivo analysis of Sec-tRNASec formation in eukaryotes has been hampered by
the lack of a suitable system. Using T. brucei to produce knock-out cell lines for the
trypanosomal orthologues of PSTK and SepSecS and RNAi strains of Tb-SerRS, Tb-PSTK
and Tb-EFSec, I carried out analysis of the eukaryotic selenoprotein synthesis machinery
in vivo. Formation of Sec-tRNASec in T. brucei requires the sequential action of Tb-PSTK
and Tb-SepSecS along with Tb-SerRS, Tb-SPS2 and Tb-EFSec.
These results also reveal the existence of a single pathway to Sec-tRNASec that
requires Sep-tRNASec as an intermediate. While RNAi knock-down of SepSecS in
mammalian cells had only a minor effect on selenoprotein synthesis (Xu et al., 2005), in
T. brucei there is no alternative route to Sec-tRNASec independent of SepSecS. However,
the results obtained in T. brucei might not be readily comparable with the study in
mammalian cells. In T. brucei, selenoprotein synthesis was assayed in a double knockout cell line completely devoid of Tb-SepSecS, whereas in mammalian cells the RNAimediated knock-down may have not completely depleted the human SepSecS protein;
western blot analysis of SepSecS protein levels in the mammalian knock-down strains
would confirm this hypothesis. Nevertheless, it is likely that even in mammalian cells,
just as in T. brucei, only a single pathway for Sec-tRNASec formation exists.
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C. M. maripaludis SepSecS structure: insights into the reaction mechanism
SepSecS is a PLP enzyme catalyzing a (3-replacement (Figure 6), leading to the exchange
of a phosphate group for a selenol moiety. The active site of MMPSepSecS lacks a Cys
residue. In contrast, the crystal structures of ECCsdB (Lima, 2002) and of AFSepCysS
(Fukunaga and Yokoyama, 2007), which are close homologs of SepSecS and catalyze
similar reactions, reveal Cys364 and Cys247 in the active sites of ECCsdB and
AFSepCysS, respectively (Figure 18) (Araiso et al., 2008). The Cys364 residue of ECCsdB
recognizes Sec and withdraws its selenium to form perselenide as an intermediate
(Lima, 2002). Cys364 of ECCsdB resides in the (3a|3 structural motif which does not exist
in MMPSepSecS. On the other hand, Cys247 of AFSepCysS is the candidate residue that
forms a persulfide, which is the sulfur source for the enzyme-catalyzed Cys-tRNAcys
formation (Fukunaga and Yokoyama, 2007). The absence of such a Cys active site
residue that could be involved in the formation of a catalytically important perselenide
intermediate indicates that the reaction mechanisms and chemistries of SepSecS are
fundamentally different from those of CsdB and SepCysS. Thus, SepSecS and SepCysS,
two related PLP enzymes that perform chemically analogous tRNA-dependent
transformations of Sep to Sec or Cys, respectively, proceed with different selenium and
sulfur transfer mechanisms.

D. The human SepSecS-tRNA Sec complex reveals the mechanism of Sec formation
The structure of the quaternary complex of SepSecS-tRNASec with Sep and
thiophosphate along with the in vivo and in vitro activity assays suggest the following
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PLP-based mechanism of Sep-tRNASec to Sec-tRNASec conversion. The reaction begins by
the covalently attached Sep being brought into the proximity of the Schiff base when
Sep-tRNASec binds to SepSecS. The amino group of Sep can then attack the Schiff base
formed between Lys284 and PLP, which yields an external aldimine (Figure 29A, B)
(Palioura et al., 2009). The reoriented side chain of Lys284 abstracts the Ca proton from
Sep (Figure 29C), and the electron derealization by the pyridine ring assists in rapid (3elimination of the phosphate group, which produces an intermediate dehydroalanyltRNASec (Figure 29C, D). After phosphate dissociation and binding of selenophosphate,
the concomitant attack of water on the selenophosphate group and of the nucleophilic
selenium onto the highly reactive dehydroalanyl moiety yield an oxidized form of SectRNASec (Figure 29D). The protonated Lys284 returns the proton to the Ca carbon and
then attacks PLP to form an internal aldimine (Figure 29E). Finally, Sec-tRNASec is
released from the active site (Figure 29F) (Palioura et al., 2009).
This mechanism is clearly distinct from the persulfide-intermediate mechanism
in the Sep-tRNAcys to Cys-tRNAcys reaction (Hauenstein and Perona, 2008) and explains
why SepSecS does not group together with its closest homologue, SepCysS, in the family
tree of fold-type I PLP enzymes (Araiso et al., 2008). Moreover, the proposed mechanism
for SepSecS is similar to the one used by the bacterial SelA that also proceeds through a
dehydroalanyl-tRNA Sec intermediate (Forchhammer and Bock, 1991). SepSecS,
therefore, uses a primordial tRNA-dependent catalytic mechanism in which the PLP
cofactor is directly involved, while using a tetrameric Fold Type I architecture as the
scaffold for binding the distinct structure of tRNASec.
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Comprised of 90 nucleotides, tRNASec is the largest eukaryotic tRNA. Its
acceptor-TWC 'helix' contains an additional base pair resulting in a 9/4 fold, in contrast
to the 7/5 fold adopted by all known canonical tRNAs (Figure 23) (Palioura et al., 2009;
Ithoh et al., 2009). Except for tRNASec, all tRNAs are transferred to the ribosome bound
to either EF-Tu in bacteria or eEFIA in eukaryotes. The atypical 9/4 fold of tRNASec
accounts for the evolution of the specialized elongation factor SelB in bacteria
(Forchhammer et al., 1989) and EFSec in eukaryotes (Fagegaltier et al., 2000), which
binds only Sec-tRNASec and not other aminoacyl-tRNAs. Both the variable and D arms of
tRNASec are longer than the corresponding elements in canonical tRNAs, while the
eighth position in tRNASec is occupied by adenine instead of the highly conserved
uridine that is found in all canonical tRNAs. In a striking contrast to U8, the base of A8
does not form any tertiary interactions with the D- and TWC arms leaving a hole in the
core of the tRNA molecule (Palioura et al., 2009; Itoh et al, 2009; Yuan et al, 2010). All
these features result in a distinct three-dimensional structure of tRNASec, which is likely
to be recognized by all Sec-specific enzymes.
In fact, while SerRS recognizes common structural features of tRNASer and
tRNASec (Figure 25), it is thought that PSTK, SepSecS and EFSec recognize the distinct
structural elements of tRNASec instead. The structure of the human SepSecS in complex
with tRNASec and the in vivo mutagenesis data reveal that SepSecS does exactly that. It
binds the longer acceptor-T^C 'helix', the long variable arm, the 5' phosphate and the
acceptor-T^C-variable elbow (Figure 19). The tRNASec molecule is anchored to the
SepSecS tetramer on one end by interactions between the tip of its acceptor arm (G73)
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and the catalytic dimer (Arg398), and on the other end by interactions between its
variable arm (C46L) and the non-catalytic dimer (Arg271) (Figure 20). The rest of the
interactions between the a l helix of the non-catalytic dimer of SepSecS (Arg26, Lys38
and Lys40) and the acceptor-TWC arm (C2, G50, and C64) further stabilize the complex
(Palioura et al., 2009). Practically, SepSecS measures the length of the acceptor-TWC
'helix' as the distance between the variable arm and the acceptor tip of tRNASec.
Modeling of canonical tRNAs onto the human SepSecS showed that the length of their
acceptor-T^PC 'helix' is too short to reach the active site of the enzyme (Figure 24A, B).
Even if a productive interaction between the tip of the acceptor arm and the enzyme
were forced to form, multiple steric clashes between the P F C arm and the N-terminal a l
helix would prevent binding of the canonical tRNA to SepSecS (Figure 24C).
The mode of tRNASec recognition by human SepSecS is reminiscent of the tRNAdependent amidotransferases GatDE and GatCAB that also recognize only the acceptor
stem of the cognate tRNA (tRNAGln) (Nakamura et al., 2006; Oshikane et al., 2006). Given
that SepSecS only binds to one side of the acceptor-TM/C arm of tRNASec, it is plausible
that PSTK would bind to a different side of the acceptor-TWC arm or to the D-stem as it
is proposed for the archaeal and human enzymes, respectively (Araiso et al., 2009;
Sherrer et al., 2008a). This would then allow PSTK, SepSecS and tRNASec to form a
ternary complex in vivo similar to that of the transamidosome involved in prokaryotic
tRNA-dependent asparagine biosynthesis (Bailly et al., 2007).
Finally, the observations that the archaeal PSTK and SepSecS are able to act on E.
coli tRNASec in vivo, that human SepSecS can use E. coli tRNASec in vivo as well as the
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archaeal tRNASec in vitro (Yuan et al., 2006), and that the bacterial selenocysteine
synthase can use both archaeal and murine tRNASec in vitro (Xu et al., 2007) suggest that
the length of the acceptor-TWC arm of tRNASec, the position of the variable arm and the
mode of tRNASec recognition are likely to be conserved in all domains of life.
Taken together, the structure of the SepSecS-tRNASec complex in the presence of
Sep and thiophosphate provided key insights into the mechanism of Sec formation in
humans. (1) SepSecS can interact with tRNASec only as a tetramer. (2) The crystal
structure of human tRNASec revealed a novel fold distinct from other canonical tRNA
molecules. (3) The discriminator base G73, a 13 bp long acceptor-TWC arm and a long
variable arm, are the major recognition motifs for binding to SepSecS and may be critical
for binding to other Sec-specific proteins such as SerRS and the Sec-specific elongation
factors SelB or EFsec. (4) The epitope of human SepSecS autoantibodies is part of the
interface of the enzyme's active site and the acceptor arm of tRNASec. (5) SepSecS can act
only on Sep linked to tRNASec and not on free Sep or on Ser-tRNASec. (6) Both structural
and biochemical data support a PLP-dependent mechanism of Sep-tRNASec to SectRNASec conversion. The mechanism of selenocysteine formation and the general mode
of tRNASec recognition presented here is likely to be conserved in all other organisms
that encode selenocysteine.
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The trace element selenium is found in proteins as selenocysteine
(Sec), the 21st amino acid to participate in ribosome-mediated
translation. The substrate for ribosomal protein synthesis is selenocysteinyl-tRNASec. Its biosynthesis from seryl-tRNASec has been
established for bacteria, but the mechanism of conversion from
Ser-tRNASec remained unresolved for archaea and eukarya. Here,
we provide evidence for a different route present in these domains
of life that requires the tRNASec-dependent conversion of
O-phosphoserine (Sep) to Sec. In this two-step pathway, O-phosphoseryl-tRNASec kinase (PSTK) converts Ser-tRNASec to SeptRNASec. This misacylated tRNA is the obligatory precursor for a
Sep-tRNA:Sec-tRNA synthase (SepSecS); this protein was previously annotated as SLA/LP. The human and archaeal SepSecS genes
complement in vivo an Escherichia coli Sec synthase (SelA) deletion
strain. Furthermore, purified recombinant SepSecS converts SeptRNASec into Sec-tRNASecm vitro in the presence of sodium selenite
and purified recombinant E. coli selenophosphate synthetase
(SelD). Phylogenetic arguments suggest that Sec decoding was
present in the last universal common ancestor. SepSecS and PSTK
coevolved with the archaeal and eukaryotic lineages, but the
history of PSTK is marked by several horizontal gene transfer
events, including transfer to non-Sec-decoding Cyanobacteria and
fungi.
aminoacyl-tRNA | evolution | formate dehydrogenase |
pyridoxal phosphate

A

mino acids enter protein synthesis as aminoacyl-tRNAs
(aa-tRNAs). The identity of an amino acid inserted into the
nascent polypeptide is determined by two factors: the interaction
of the aa-tRNA anticodon with an appropriate mRNA codon,
and the correct pairing of amino acid and tRNA anticodon in the
aa-tRNA. Thus, faithful protein synthesis requires the presence
in the cell of a full set of correctly aminoacylated tRNAs (1). Two
routes to aa-tRNA synthesis exist (2): (/) direct acylation of the
amino acid onto its cognate tRNA catalyzed by an aa-tRNA
synthetase, and (H) tRNA-dependent modification of a noncognate amino acid attached to tRNA. Although the majority of
aa-tRNAs are made by direct aminoacylation, the indirect
pathway is also widely used, e.g., for Gln-tRNA Gln and AsntRNA Asn formation (3).
The biosynthetic route of aa-tRNA formation is understood
for all of the currently known cotranslationally inserted amino
acids. The sole exception is the case of selenocysteine (Sec) in
eukarya and archaea (e.g., refs. 4 and 5). The bacterial case was
solved in the 1990s when genetic and biochemical studies with
Escherichia coli revealed that bacterial Sec-tRNA Sec was synthesized by an indirect tRNA-dependent amino acid transformation
mechanism (6). Sec is cotranslationally inserted into proteins in
response to the codon UGA; thus the tRNA Scc species has the
corresponding anticodon UCA (7). This tRNA is misacylated
with serine by E. coli seryl-tRNA synthetase (SerRS) to form
Ser-tRNA Sec (8). Then a pyridoxal phosphate (PLP)-dependent
Sec synthase (SelA) catalyzes the Ser-tRNA Sec -> Sec-tRNA Sec
conversion using selenophosphate as selenium donor (Fig. 1
www.pnas.org/cgi/doi/10.1073/pnas.0609703104

Upper). For archaea and eukarya our understanding is still
fragmentary. Serylation of tRNA Scc by eukaryal (9-12) and
archaeal (13-15) SerRS enzymes has been well established.
However, the demonstration of an analogous reaction to the
bacterial pathway converting Ser-tRNA Sec —» Sec-tRNA Sec has
remained elusive. In particular, the archaeal protein MJ0158,
annotated as the ortholog to bacterial SelA, did not support in
vitro Sec formation (15).
Recently, a pathway for cysteine formation was discovered
in methanogens based on a tRNA-dependent conversion of
O-phosphoserine (Sep) to cysteine (16). This route involves
the attachment of Sep to tRNA Cys by SepRS and the subsequent Sep-tRNA^ 5 -* Cys-tRNA^ 5 transformation by SeptRNA:Cys-tRNA synthase, a PLP-dependent enzyme using a
still unknown sulfur donor (Fig. 1 Lower). The implications of
this pathway for Sec formation were obvious (16), especially
because a phosphoseryl-tRNA Sec kinase (PSTK) had just been
identified (17). Its activity was characterized in vitro for the
murine (17) and the Methanocaldococcus jannaschii (15) enzyme; this kinase phosphorylates specifically Ser-tRNA Sec to
Sep-tRNA Scc . This finding would lend credence to early reports of the existence of mammalian Sep-tRNA formed from
Ser-tRNA (18, 19). Because the initial search for a PLPdependent SelA activity as manifested by E. coli SelA was
unsuccessful (15), we considered other proteins. The most
promising candidate was the human protein SLA/LP (soluble
liver antigen/liver pancreas), which forms a ribonucleoprotein
antigenic complex with tRNA Sec in patients suffering from an
autoimmune chronic hepatitis (20). This protein was classified
computationally as a PLP-dependent serine hydroxymethyltransferase that might have SelA function (21). To lend further
credibility, this protein (22, 23) has very well conserved
archaeal orthologs but only in Methanocaldococcus jannaschii
(MJ0610), Methanococcus maripaludis (MMP0595), Methanopyrus kandleri (MK0672), Methanococcus voltae, Methanothermococcus thermolithotrophicus, and Methanococcus vannielii; these are the known archaea that use Sec. Considering
all of these data, it appeared probable that this protein was the
missing Sep-tRNA:Sec-tRNA synthase (SepSecS) (Fig. 1 Upper).
Here, we report the identification of the human SLA/LP and
Methanococcus maripaludis MMP0595 proteins as SepSecS enAuthor contributions: J.Y. and S.P. contributed equally to this work; J.Y., S.P., J.C.S., D. Su,
P.O., W.B.W., and D. Soil designed research; J.Y., S.P., J.C.S., D. Su, and P.O. performed
research; M.J.H., A.M.C., and W.B.W. contributed new reagents/analytic tools; J.Y., S.P., D.
Su, P.O., and D. Soil analyzed data; and J.Y., S.P., P.O., and D. Soil wrote the paper.
The authors declare no conflict of interest.
Abbreviations: aa-tRNA, aminoacyl-tRNA; BV, benzyl viologen; FDHH, formate dehydrogenase
H; IPTG, isopropyl p-D-thiogalactoside; PLP, pyridoxal phosphate; PSTK, phosphoseryl-tRNASec
kinase; Sec, selenocysteine; SelA, selenocysteine synthase; SelB, elongation factor SelB; SelD,
selenophosphate synthetase; Sep, O-phosphoserine; SepSecS, Sep-tRNA:Sec-tRNA synthase;
SerRS, seryl-tRNA synthetase.
§

To whom correspondence should be addressed. E-mail: soll@trna.chem.yale.edu.

© 2006 by The National Academy of Sciences of the USA

PNAS

|

December 12,2006

| vol.103

|

no. 50

|

18923-18927

Sec- tRNA 5 "

Ser- tRNA 5 "
Ser

SelA

°5°

Se<lonor + PLP

Sfy.

Sc'

=>e£
•I

'°4°

Sa-donor +

tRNA01

Cys- tRNA°

'

"

S*r + ATP AMP + PP, , - v

I

I

^-N

JZ '

Fig. 1. tRNA-dependent amino acid transformations leading to Sec and
cysteine. (Upper) The SelA route is the bacterial pathway (6). The PSTK/SepSecS
is the archaeal/eukaryal route. {Lower) The SepRS/Sep-tRNA:Cys-tRNA synthase (SepCysS) pathway operates in methanogens to synthesize cysteine (16).

zymes (encoded by spcS) that convert Sep-tRNA Sec —> SectRNA Sec .

Fig. 2. SepSecS genes restore FDHH activity in an E. coliselA deletion strain.
The E. coli JS1 strains complemented with the indicated SepSecS genes were
grown anaerobically on glucose minimal medium plates supplemented with
0.01 mM IPTG at 30°C for 2 days. FDHH activity was observed by overlaying top
agar containing formate and BV. Colonies with active FDHH reduced BV to a
blue color. The SepSecS genes were from Methanocaldococcus jannaschii
(MJ), Methanococcus maripaludis (MMP), human (HS), and E. coli selA (EC).
K284T denotes a mutant human SepSecS where the Lys residue critical to PLP
binding is changed to Thr.

K277A, Methanococcus maripaludis SepSecS K278A, and human
SepSecS K284A). Even in the presence of PSTK, the mutant
SepSecS genes were no longer able to complement the bacterial
selA deletion (the result for the human SepSecS mutant is shown in
Fig. 2). This finding strengthens the notion that the SepSecS
proteins need PLP to carry out the Sep -* Sec conversion.

Results

SepSecS Rescues Selenoprotein Biosynthesis in an E. coliselA Deletion
Strain. When grown anaerobically, E. coli produces the seleniumdependent formate dehydrogenase H ( F D H H ) . Its activity enables the cells to reduce benzyl viologen (BV) in the presence of
formate, which is usually observed in agar overlay plates under
anaerobic conditions (24). We therefore constructed an E. coli
selA deletion strain (JS1) in which selenoprotein production is
abolished. Complementation of the JS1 strain with archaeal
SepSecS genes from Methanococcus maripaludis (MMP0595)
and Methanocaldococcus jannaschii (MJ0610) and with the
human homolog (Q9HD40) allowed us to test the ability of these
genes to restore selenoprotein biosynthesis as detected by F D H H
activity. The E. coli cells were grown under anaerobic conditions
for 24 h and overlaid with top agar containing BV and formate.
Blue-colored cells indicated that BV was reduced and therefore
F D H H activity was present, whereas cells without F D H H activity
remained colorless. Neither the archaeal nor the human SepSecS
genes were able to complement the E. coli JS1 strain (Fig. 2).
However, complementation was achieved when the SepSecS
genes were cotransformed with the gene encoding Methanocaldococcus jannaschii PSTK; the latter gene alone was not able to
restore Sec synthesis in the E. coli JS1 strain. Confirmation of
these results was with MacConkey nitrate agar plates where cells
with inactive formate dehydrogenase N form dark red colonies
(data not shown). These data imply that Sec formation was
achieved by a two-step process: PSTK phosphorylates the endogenous Ser-tRNA Sec to Sep-tRNA Sec , and then this misacylated aa-tRNA species is converted to Sec-tRNA Sec by SepSecS.
Thus, the human and archaeal SepSecS enzymes are active in E.
coli. The data also demonstrate that Ser-tRNA Sec , present in E.
coli JS1, cannot be converted to Sec-tRNA Scc , and therefore is
not a substrate for SepSecS.
The bacterial SelA is a PLP-dependent enzyme with a critical
lysine residue engaged in PLP binding (25). As the archaeal and
eukaryal SepSecS proteins also have PLP binding domains (21), we
introduced Lys —» Ala mutations to replace the critical lysine
position in these enzymes (Methanocaldococcus jannaschii SepSecS
18924 | www.pnas.org/cgi/doi/10.1073/pnas.0609703104

"Selenium Incorporation into E. coli Proteins. To directly follow
selenoprotein production in E. coli, we labeled with 75Se the E.
coli JS1 transformants (with SepSecS genes). These JS1 transformant strains were grown anaerobically in the presence of
[75Se]selenite and formate. Subsequently, the cell extracts were
separated on a polyacrylamide gel and the radioactively labeled
FDHn was visualized by autoradiography. In agreement with the
BV assay results, 75Se-labeled FDHn was detectable in the
presence of archaeal SepSecS only in the strains also transformed with PSTK, whereas no labeling occurred when PSTK
was absent (Fig. 3). The relatively lower labeling efficiency
compared with the positive control, which was the transformant
with E. coli WT selA, may be caused by the inefficient expression
of the archaeal enzyme and the heterologous Sec biosynthesis

FDhL

Fig. 3. 75Se incorporation into the E. coli selenoprotein FDHH. Cells were
grown in the presence of [75Se]selenite in TGYEP medium (see Materials and
Methods) supplemented with 0.05 mM IPTG anaerobically at 37°C for 24 h. Cell
extracts were separated by 10% SDS/PAGE, and the formation of 75Secontaining FDHH was followed by autoradiography. The E. coli strain JS1 was
complemented with E. coli SelA (lane 1), empty plasmids (lane 2), Methanocaldococcus jannaschii SepSecS (lane 3), Methanocaldococcus jannaschii SepSecS with PSTK (lane 4), and Methanocaldococcus jannaschii SepSecS, PSTK
with Methanococcus maripaludis tRNASec (lane 5).
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tion by coexpressing archaeal tRNA Sec in the E. coli JS1 strain.
However, no significant increase in F D H H production was
observed, which suggests that the endogenous E.coli tRNA Scc is
a good substrate for archaeal SepSecS. As the secondary structure of tRNA Scc differs considerably among tRNA species from
the different domains, SepSecS might display a relaxed recognition of the tRNA moiety of the Sep-tRNA substrate.

Secya

SepSecS Converts Sep-tRNASec to Sec-tRNASec in Vitro. To prove that
SepSecS is a SelA that catalyzes a tRNA-dependent Sep —> Sec
synthesis we analyzed the conversion of [14C]Sep-tRNA to
[ 14 C]Sec-tRNA. To this aim Methanococcus
maripaludis
tRNA Sec was acylated with [14C]serine by using pure Methanococcus maripaludis SerRS (26). Phosphorylation was performed
with pure Methanocaldococcus jannaschii PSTK. The isolated
tRNA was then incubated under anaerobic conditions with
purified recombinant SepSecS and E. coli selenophosphate
synthetase (SelD) in the presence of selenite. After the reaction
aa-tRNA was deacylated, and the amino acids were identified by
TLC in two systems (one is shown in Fig. 4). The data show that
SepSecS from both Methanococcus maripaludis (Fig. 4, lane 3)
and human (Fig. 4, lane 4) were able to form Sec-tRNA Scc from
Sep-tRNA Sec , but not from Ser-tRNA Sec (Fig. 4, lane 5). Thus,
Sep-tRNA is the crucial precursor for Sec-tRNA formation in
archaea and eukarya.

I

Ser
|H|1

Sep

f

: I

1
Fig. 4.
Conversion o f in w'fro-synthesized Sep-tRNA S e c t o Sec-tRNA Sec . Phosp h o r i m a g e s o f TLC s e p a r a t i o n o f [ 14 C]Sep a n d [ 14 C]Sec recovered f r o m t h e
aa-tRNAs o f t h e SepSecS activity assay (see Materials and Methods).
Sec was
a n a l y z e d in its o x i d i z e d f o r m as selenocysteic acid (Secya). Lane 1, Ser m a r k e r ;
lane 2, Sep m a r k e r ; lane 3, Sep-tRNA S e c w i t h Methanococcus
maripaludis
SepSecS; lane 4, Sep-tRNA S e c w i t h h u m a n SepSecS; lane 5, Ser-tRNA S e c w i t h
Methanococcus
maripaludis
SepSecS; lane 6, r e a c t i o n o f lane 3 w i t h selenite
omitted.

system. The second labeled band with lower molecular weight
was likely caused by the degradation of FDHn considering the
cells were harvested in stationary phase.
In a different experiment we investigated the effect of a
homologous SepSecS:tRNA Sec system on selenium incorpora-

X. tropical is
X. laevis 1
I. nigrmiiidis
D. rerio
,
A

n£

B

//
P.

sapiens
troglodytes
P pygmaeus
M
mulatta
45
.
.,. .
( . tamihans

Evolution of Two Sec Biosynthesis Pathways. Although genetic coding of Sec is limited in organismal distribution, selenoproteins are
found in all domains of life. Phylogenetic evidence demonstrates
that the core Sec-decoding genes (tRNAScc, SelB, and SelD), and
thus translation of genetically encoded Sec, is an ancient process

-V aeg^pti
\.

norvegiius

M.

musculus

L-^

o.
"7

aegypti
\,
O.

gamliiae
meLmogaster
('.

-c;

r-^48

^1

I.

briggsae
elegans
hrucei

J. cru?i

• O.

I. majot

tauri

— C

reinhardtii

• D.
discoideum
•1
thermophila
r— P
falciparum
~~|
f- P. chabaudi
•— P. bcrghei
M. maripaludis
M. vannielii

52

• M. voltae
M.
-0.1
Fig. 5.

thermolithotrophicus

M.

jannaschii

M.

kandleri

mellifera

fd±m

8. tannic
R.

I
.
gjrnbiM

0.1

C. glabrata
C. albicans
Fungi
D. hansenii
S. pombe
Y. lipolytics
C. neoformans
r-C
briggsae 1
<-(... elegans 1
t. histol\ lica
discoideum
thermophila
M. maripaludis
M. vannielii
M.
thermolithotrophicus A r c h a e a
M. voltae
M. jannaschii
M. kandleri
,
H. sapiens •
.P.
troglodytes
M mulatta
. .
,
C familiar^
Mammals
B. taurus
r R. norvegicus
^M.
musculus
.
X. laevis 2
D.
melanogasler i. hriggsae 2
• C elegam 2
. japonicun)
I brucei
L&Z_
T cru/i
^ ^ - ^ ^ I major
• O tauri
variabilis
T A.
_ r ~ L Nostoc sp.
Cyanobacteria
~1
N. punch'forme
Synechocystis sp..
•
/ nigro\iridis
2
• *'
5. purpuratus

•('). -iatha

Phylogenies o f SepSecS (A) a n d PSTK (B). O r g a n i s m names are c o l o r - c o d e d a c c o r d i n g t o t h e d o m a i n o f life: Eukarya (green), Archaea (blue), a n d Bacteria

(red). Non-Sec-decoding organisms are l a b e l e d in b o l d . Scale bar shows 0.1 changes per site. Only b o o t s t r a p values < 9 0 are s h o w n .

Yuan et al.

PNAS

|

December 12,2006

| vol.103

|

no. 50

|

18925

that was already in existence at the time of the last universal
common ancestor (27-29). SelA is of bacterial origin and was
vertically inherited in that domain (30). Phylogenetic analysis of
SepSecS and PSTK reveals distinct archaeal and eukaryal versions
of these enzymes. This pathway can be traced back (at least) to the
evolutionary split between the archaeal and eukaryal sister lineages
(Fig. 5). SepSecS is confined to Sec decoding archaea and eukarya.
Its evolutionary history is consistent with vertical inheritance and
gene loss in non-Sec-decoding lineages (Fig. 5^4).
More interesting is the complex picture presented in the PSTK
phylogeny (Fig. 5B). Like SepSecS, PSTK shows an initial deep
divide between a strictly eukaryal group on the one hand and an
archaeal group on the other. The archaeal PSTK appears to have
been horizontally transferred to several of the Sec-decoding
eukarya. The unexpected association between Oryza sativa and
Strongylocertrotus purpuratus implies multiple horizontal gene
transfer events, whereas a single transfer to mammals early in
their evolution accounts for the clustering of these organisms
within the archaeal genre. An additional horizontal gene transfer
of the archaeal version to non-Sec-decoding Cyanobacteria is
also suggested. The eukaryal PSTK is clearly discernable in a
distinct group of non-Sec-decoding fungi that lack all other Sec
biosynthesis components. These fungi form a coherent cluster in
the eukaryal group, implying vertical inheritance. Retention of
PSTK in this group suggests that it was recruited to perform a
different function. Some eukarya (e.g., Caenorhabditis and Xenopus) retained both their native eukaryal PSTK and the
acquired archaeal version, whereas in other lineages, including
ancestors of mammals and trypanosomes, the archaeal version
displaced its eukaryal counterpart. Most surprisingly, Plasmodium falciparum is Sec-decoding (30, 31), yet neither the PSTK
nor SelA gene can be found, which contributes to the idea that
a third pathway for Sec formation may exist in some organisms.
In summary, the last universal common ancestor genetically
encoded Sec, and whether one or both pathways for converting
Ser-tRNA Scc —> Sec-tRNA Sec were present in the common
ancestor remains to be seen.
Discussion

SepSecS has been suggested to be involved in Sec synthesis in
eukarya since the early 1990s (20). In the current work, in vivo and
in vitro results revealed that SepSecS is indeed a SelA analog able
to catalyze the Sec-tRNASec formation. However, in contrast to
bacterial SelA that converts Ser-tRNA Sec directly to Sec-tRNASec,
SepSecS acts on the phosphorylated intermediate, Sep-tRNASec
(Fig. 1). Therefore archaeal and eukaryal Sec biosynthesis requires
three enzymes, SerRS, PSTK, and SepSecS, whereas bacteria
accomplish the same task without PSTK. Both SelA and SepSecS
are PLP-dependent enzymes. From a chemical standpoint a Sep —>
Sec conversion is desirable, as Sep would provide a better leaving
group (phosphate) than Ser (water) for replacement with selenium.
The detailed reaction mechanism of SepSecS should be subject to
future structural and biochemical investigations. Sep-tRNA is reported to be more stable than Ser-tRNA (17), which is known to
deacylate faster than any other aa-tRNA species (32). This fact
would greatly improve the overall efficiency of the selenocysteinylation reaction and the rate of production of Sec-tRNA in all
organisms that possess an extended selenoproteome. Most selenoprotein-containing bacteria only have one to three selenoproteins
that are expressed under specific environmental conditions and a
nonessential tRNA Sec (33). In contrast, humans have an essential
tRNA Sec and an extended selenoproteome whose 25 members have
been variously implicated in health and disease (4, 34).
Phylogenetic analyses showed that SelA is of bacterial origin,
whereas SepSecS is confined to archaea and eukarya, and PSTK,
principally an archaeal and eukaryal enzyme, has been horizontally transferred to the Cyanobacteria. tRNA Sec has distinct
secondary structure features: the long extra arm for recognition
18926
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by SerRS, the elongated acceptor stem for SelB binding (35), and
still unknown recognition sites for PSTK and SepSecS. Considering the number of proteins that tRNA Sec interacts with, the
clear division of bacterial and archaeal/eukaryal protein lineages
and the discernable differences in tRNA Scc structures in the
three domains of life, it is interesting to see that E. coli tRNA Sec
can be recognized by archaeal and human SepSecS at least in vivo
(35). Moreover, although the biological archaeal and mammalian selenium donors have not been characterized (6), our results
indicate that selenophosphate provided by E. coli SelD can be
used by SepSecS both in vitro and in vivo.
Are there other pathways? The absence of both PSTK and
SelA genes in P. falciparum brings out interesting questions: Is
there a third pathway or enzyme to make Sec? And why is Sec
the only amino acid among the 22 naturally cotranslationally
inserted protein building blocks that has not developed its own
aa-tRNA synthetase?
Materials and Methods

General. Oligonucleotide synthesis and DNA sequencing was
performed by the Keck Foundation Biotechnology Resource
Laboratory at Yale University. [14C]serine (163 mCi/mmol) was
obtained from Amersham Pharmacia Biosciences (Piscataway,
NJ). [75Se]selenite was purchased from the University of Missouri Research Reactor Facility (Columbia, MO).
Bacterial Strains and Plasmids. The selA deletion strain JS1 was
constructed by replacing the gene with kanamycin cassette in
BW25113 E. coli strain as described (36). The T7 polymerase
gene was inserted in the genome by PI transduction. The selC
deletion strain FM460 (37) was obtained from the Yale E. coli
Stock Center. SepSecS genes from Methanococcus maripaludis
(MMP0595) and Methanocaldococcus jannaschii (MJ0610) were
amplified from genomic DNA, and the human SepSecS gene
(GenBank accession no. BX648976) was amplified from an EST
clone [clone ID: DKFZp686J1361, obtained from the RZPD
German Resource Center for Genome Research, Berlin, Germany (38)] followed by cloning into the pET15b vector. E. coli
selD was cloned into pET15b vector. Methanococcus maripaludis
tRNA Sec and Methanocaldococcus jannaschii PSTK gene were
cloned into the pACYC vector individually or together. Human
SepSecS K284T was generated by using the QuikChange sitedirected mutagenesis kit (Stratagene, La Jolla, CA) according to
the manufacturer's directions.
Protein Expression and Purification. Human SepSecS, Methanococcus maripaludis SepSecS, and E. coli SelD were transformed into
BL21(DE3) cd+ strain. Cells were grown to A6oo = 1-0, and
protein production was induced by the addition of 0.5 mM
isopropyl )3-D-thiogalactoside (IPTG). The cells were grown for
20 h at 15°C and then spun down and resuspended in 50 mM
Hepes (pH 8.0), 300 mM NaCl, 10 mM imidazole, 3 mM DTT,
10 fiM PLP, and protease inhibitor mix (Roche, Indianapolis,
IN). After sonication, cell lysates were applied to Ni-NTA resin
(Qiagen, Valencia, CA). The resin was washed, and the Hisr,tagged proteins were eluted according to the manufacturer's
manual. Proteins were then thoroughly dialyzed against 50 mM
Hepes (pH 8.0), 300 mM NaCl, 10 mM DTT, 10 yM PLP, and
50% glycerol.
Complementation of an E. coli AselA Strain. Methanocaldococcus
jannaschii, Methanococcus maripaludis, or human SepSecS were
transformed into a AselA E. coli JS1 strain, with or without the
Methanocaldococcus jannaschii PSTK gene. The deletion strain
complemented with its own selA gene served as positive control.
E. coli AselA strain plus PSTK, SepSecS, or both genes was plated
on glucose-minimum medium agar plates with 0.01 mM IPTG
and grown anaerobically for 2 days at 30°C. The plates then were
Yuan ef a/.

overlaid with agar containing 1 mg/ml BV, 0.25 M sodium
formate, and 25 mM KH2PO4 adjusted to pH 7.0. The appearance of blue/purple color is the indication of active FDH H (24).
The same experiments were also carried out for SepSecS mutants. Formate dehydrogenase N activity was tested with MacConkey nitrate medium plates.
Metabolic Labeling with [7SSe]selenite. E. coli cells were grown
aerobically overnight and diluted (1:50) under anaerobic conditions in 5 ml of TGYEP medium (0.5% glucose, 1% tryptone,
0.5% yeast extract, 1.2% K 2 HP0 4 ,0.3% K H 2 P 0 4 , 0 . 1 % formate,
1 juM Na 2 Mo0 4 , pH adjusted to 6.5) (39) with 1 /uCi [75Se]selenite and 0.05 mM IPTG added. The cells were further grown
anaerobically at 37°C for another 24 h and harvested. Cell lysates
were prepared and subjected to SDS/PAGE, followed by autoradiography.
Preparation of tRNA Substrates. The Methanococcus maripaludis
tRNA Sec gene was cloned into pUC18 with T7 promoter and
terminator. The plasmid was transformed together with a pACYC vector encoding T7 RNA polymerase gene to the E. coli
selC deletion strain (FM460). tRNA Sec was overexpressed and
purified with biotinylated DNA oligonucleotides as described
(40). Purified tRNA Sec (10 /j,M) was serylated in the presence of
[14C]Ser (200 /LIM) and Methanococcus maripaludis SerRS (6
/xM) in reaction buffer (100 mM Hepes, pH 7.0/10 mM KC1/10
mM magnesium acetate/1 mM DTT/0.1 mg/ml BSA) at 37°C for
1 h. To prepare Sep-tRNA Sec , 3 ixM PSTK was added to the
reaction. Aminoacylated tRNA products were purified by phenol extraction and ethanol precipitation followed by G-25 desalting column application.
In Vitro Sep -» Sec Conversion. Purified recombinant SepSecS was
incubated in reaction buffer (100 mM Hepes, pH 7.0/300 mM
KCl/10 mM MgCl2) with Sep-tRNA Sec or Ser-tRNA Sec (10 /u,M),
1.
2.
3.
4.
5.
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DTT (1 mM), Na 2 Se0 3 (250 /J,M), and purified recombinant E.
coli SelD (100 yM) at 37°C for 30 min. The oxygen in the buffer
was removed, and the reaction was carried out in the anaerobic
chamber. After incubation, proteins were removed by phenol
extraction. The tRNAs were purified with G-25 column and
ethanol precipitation to remove small molecules and salts.
Purified tRNA products were deacylated in 20 mM NaOH at
room temperature for 10 min. The released amino acids were
oxidized with performic acid (16) and subjected to TLC analysis
[system 1: 85% ethanol; system 2: butanol/acetic acid/water
(4:1:1)].
Phylogenetic Analysis. Sequences, taken from the National Center
for Biotechnology Information nonredundant database or the
E R G O database, were aligned by using Multiseq in VMD 1.8.5
(41). The most parsimonious trees were generated with
PAUP4M0 (42). Gaps were counted as missing data and a
parsimony cost matrix, based on the Blosum45 substitution
matrix (43), was used. Of the 1,000 most parsimonious trees, the
topology with the maximum likelihood was chosen and branch
lengths were optimized with PHYML v.2.4.4 (44). The JTT+T
model with eight rate categories was used for amino acid
substitution, and adjustable parameters were derived from maximum-likelihood estimates. Bootstrap values were computed by
using the re-estimation of log likelihoods (RELL) method in
PROTML from the Molphy 3.2 package (45).
W e t h a n k R. Lynn S h e r r e r and Kelly S h e p p a r d (Yale University) for gifts
of e n z y m e s and experimental advice and C a r m e n Gelpi and L e n n a r t
R a n d a u for helpful discussions. M.J.H. held a F e o d o r Lynen Postdoctoral Fellowship of t h e A l e x a n d e r von H u m b o l d t Stiftung, and P.O. holds
a N a t i o n a l Science F o u n d a t i o n postdoctoral fellowship in biological
informatics. This work was s u p p o r t e d by National Institute of G e n e r a l
Medical Sciences G r a n t G M 2 2 8 5 4 and D e p a r t m e n t of E n e r g y G r a n t
DE-FG02-98ER20311.

23. Wies I, Brunner S, Henninger J, Herkel J, Kanzler S, Meyer zum Biischenfelde
KH, Lohse AW (2000) Lancet 355:1510-1515.
24. Lacourciere GM, Levine RL, Stadtman TC (2002) Proc Natl Acad Sci USA
99:9150-9153.
25. Tormay P, Wilting R, Lottspeich F, Mehta PK, Christen P, Bock A (1998) Eur
J Biochem 254:655-661.
26. Kim HS, Vothknecht UC, Hedderich R, Celic I, Soil D (1998) / Bacteriol
180:6446-6449.
27. Keeling PJ, Fast NM, McFadden GI (1998) / Mol Evol 47:649-655.
28. Foster CB (2005) Mol Biol Evol 22:383-386.
29. Zhang Y, Romero H, Salinas G, Gladyshev VN (2006) Genome Biol 7:R94.
30. Lobanov AV, Delgado C, Rahlfs S, Novoselov SV, Kryukov GV, Gromer S,
Hatfield DL, Becker K, Gladyshev VN (2006) Nucleic Acids Res 34:496-505.
31. Mourier T, Pain A, Barrell B, Griffiths-Jones S (2005) RNA 11:119-122.
32. Matthaei JH, Voigt HP, Heller G, Neth R, Schoch G, Kiibler H, Amelunxen
F, Sander G, Parmeggiani A (1966) Cold Spring Harb Symp Quant Biol
31:25-38.
33. Kryukov GV, Gladyshev VN (2004) EMBO Rep 5:538-543.
34. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R,
Gladyshev VN (2003) Science 300:1439-1443.
35. Baron C, Bock A (1991) J Biol Chem 266:20375-20379.
36. Datsenko KA, Wanner BL (2000) Proc Natl Acad Sci USA 97:6640-6645.
37. Sawers G, Heider J, Zehelein E, Bock A (1991) J Bacteriol 173:4983-4993.
38. Wiemann S, Weil B, Wellenreuther R, Gassenhuber J, Glassl S, Ansorge W,
Bocher M, Blocker H, Bauersachs S, Blum H, et al. (2001) Genome Res
11:422-435.
39. Begg YA, Whyte JN, Haddock BA (1977) FEMS Microbiol Lett 2:47-50.
40. Rinehart J, Krett B, Rubio MA, Alfonzo JD, Soil D (2005) Genes Dev
19:583-592.
41. Roberts E, Eargle J, Wright D, Luthey-Schulten Z (2006) BMC Bioinformatics 7:382.
42. Swofford D (2003) PAUP*: Phylogenetic Analysis Using Parsimony (*and Other
Methods) (Sinauer, Sunderland, MA), version 4.
43. Marsh TL, Reich CI, Whitelock RB, Olsen GJ (1994) Proc Natl Acad Sci USA
91:4180-4184.
44. Guindon S, Gascuel O (2003) Syst Biol 52:696-704.
45. Adachi M, Hasegawa M (1996) Comp Sci Monogr 28:1-150.

PNAS | December 12,2006 | vol.103

| no. 50 | 18927

PERSPECTIVE

nature
chemical biology

Natural expansion of the genetic code
Alexandre Ambrogelly, Sotiria Palioura & Dieter Soil

At the time of its discovery four decades ago, the genetic
code was viewed as the result of a "frozen accident." Our
current knowledge of the translation process and of the
detailed structure of its components highlights the roles
of RNA structure (in mRNA and tRNA), RNA modification
(in tRNA), and aminoacyl-tRNA synthetase diversity in the
evolution of the genetic code. The diverse assortment of codon
reassignments present in subcellular organelles and organisms
of distinct lineages has 'thawed' the concept of a universal
immutable code; it may not be accidental that out of more
than 140 amino acids found in natural proteins, only two
(selenocysteine and pyrrolysine) are known to have been added
to the standard 20-member amino acid alphabet. The existence
of phosphoseryl-tRNA (in the form of tRNA 0 '' 8 and tRNA Sec )
may presage the discovery of other cotranslationally inserted
modified amino acids.

Ribosomal protein synthesis is the pathway to most natural proteins.
Faithful decoding of the genetic message relies on the presence of an
aminoacyl-tRNA whose anticodon matches the mRNA codon, with
the cognate amino acid esterified to the tRNA's 3'-terminal adenosine.
Thus, synthesis of the correct aminoacyl-tRNA is critical in enabling the
genetic code. Aminoacyl-tRNA (aa-tRNA) synthesis is the task of the
aminoacyl-tRNA synthetases (aaRSs); each enzyme esterifies its cognate
amino acid to the corresponding tRNA species1. In certain cases, however, aa-tRNA synthesis is carried out by an evolutionarily older route
based on misacylation and subsequent tRNA-dependent amino acid
modification2. Although over 140 different amino acids are found in
natural proteins, most of them arise by post-translational modification
of the 20 canonical amino acids3. The biosynthesis of proteins containing modified amino acids, which has long been a subject of great interest,
relies on the existence of a designated codon and of enzymes that are
able to acylate a specific tRNA with the desired amino acid. Though
great strides have been made in introducing man-made amino acids into
proteins based on the development of such orthogonal pairs4 of aaRSs
and tRNA species5,6, there is also a natural expansion of the genetic code
beyond the 20-amino-acid repertoire that leads to the coding of modified amino acids. Here we review our current knowledge of the makeup
of the genetic code and the cotranslational insertion of noncanonical
amino acids into proteins.
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Diversity of genetic code includes modified amino acids

The apparent universality of the genetic code at the time of its elucidation was thought to attest to the principle of common descent of all life
from a single organism and provided support for Crick's "frozen accident" hypothesis regarding the evolution of the code itself7. According to
this theory, ambiguous decoding that inevitably leads to the generation
of a pool of "statistical proteins"8 (that is, by translation of any given
gene into a group of related proteins) must have been tolerated by early
life forms and may have even been advantageous for shaping the cellular machinery to its current state. However, in order to account for its
universality, the code was thought to be frozen to its existing form once
a certain level of cellular complexity was reached. The already improved
accuracy of protein synthesis at that stage, along with any further structural and functional refinement of the translation apparatus from there
on, would preclude additional codon reassignments because they would
inevitably lead to disruption of an organism's whole proteome; the vast
production of misfolded and aberrant proteins would greatly challenge
survival of any such organism.
It was only 15 years after its deciphering that the discovery of deviations from the universal code in vertebrate mitochondria (where AUA
was found to code for methionine and UGA for tryptophan) challenged
the concept of a frozen, nonevolving genetic code. Further genome analyses have revealed ten codon reassignments in prokaryotic and eukaryotic
nuclear codes and 16 changes in mitochondrial codes (reviewed in refs.
9-12) (Fig. 1). The correlation of mRNA codons with amino acids is the
product of the interpretation of the code by the translational machinery,
and therefore it is only static as long as the components of this machinery
do not change and evolve. It is not surprising then that the documented
codon reassignments can always be traced back to alterations in the
components of the translational apparatus that are primarily involved
in the decoding process: the aaRSs, which ensure correct acylation of
each tRNA species with its cognate amino acid1; the tRNA molecules,
whose anticodon base pairs with the correct mRNA codon by the rules
of the wobble hypothesis at the ribosome13'14; and the peptide chain
termination factors that recognize the termination codons15.
Interestingly, the same codon reassignments have been observed
in organisms from different lineages, and a predisposition for frequent reassignment of certain codons to several alternatives has also
been documented. This is particularly true for the termination (stop)
codons UAG, UAA and UGA, whose single occurrence per gene renders
them particularly good candidates for reassignment given that such a
change would cause minimal damage to the proteome. Examination
of Escherichia coli laboratory strains in the 1960s led to the discovery of nonsense suppression caused by tRNA species able to recognize the codons UAG (amber suppressor), UAA (ochre suppressor) or
UGA (opal suppressor) (reviewed in ref. 16). UGA is the only codon
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crassa mitochondrial genome revealed 27 tRNA genes. Lastly, mitochondria have only one tRNAMet (serving as initiator and elongator tRNA)
and decode AUA as methionine (with no need for a second tRNAIle).
In addition, the codon-anticodon pairing rules have been stretched by
the realization that anticodon conformation is shaped by the anticodon
loop and stem structure25, which is critically dependent on nucleotide
modification (reviewed in ref. 26). Moreover, targeting of tRNA modification enzymes or edited tRNAs to mitochondria allows for codon
reassignments specifically within this organelle without any effect in
the nuclear codes. This is indeed the case for the 7-mefhylguanosine
modification at the first anticodon position of tRNASerGCU that expands
its decoding from AGU to AGN and thus reassigns the arginine codons
AGA and AGG to serine in squid mitochondria27. A similar situation has
been documented in echinoderm mitochondria for the pseudouridine
modification at position 35 of the tRNAAsn anticodon that reassigns the
lysine AAA codon to asparagine28.

Figure 1 Summary of genetic code changes. Codons not affected by
reassignments are in black. Shown in red are codons that also have changed
assignments to the amino acids shown in the outer circle in blue (standard
amino acids) or red (noncanonical amino acids). Filled squares denote stop
codons. The blue asterisk indicates codons that may be unassigned in some
organisms or organelles.

with an ambiguous meaning in organisms from all three domains of
life; apart from functioning as a stop codon, an in-frame UGA also
encodes selenocysteine (Sec), the 21st cotranslationally inserted amino
acid17, through a recoding mechanism that requires a tRNA with a
UCA anticodon (tRNASec)18, a specialized translation elongation factor
(SelB) and an mRNA stem-loop structure known as the selenocysteine
insertion sequence element (SECIS)19. UAG is also ambiguous in the
Methanosarcinaceae, where in addition to serving as a translational stop
it also encodes pyrrolysine (Pyl), the 22nd cotranslationally inserted
amino acid20'21; in this case, a new tRNA synthetase, pyrrolysyl-tRNA
synthetase (PylRS)22'23, is essential for this recoding event.
The aforementioned genetic and biochemical studies of the translation machinery over the past four decades and the recent genome
analyses have made it clear that the genetic code is still evolving, even
though fixation of mutations that lead to codon reassignment is not
favored10. We should note that, curiously enough, the ten nuclear code
changes are a subset of the 16 mitochondrial ones; that is, every single
nuclear codon alteration has been observed in mitochondria as well.
Thus, the same type of changes seem to occur through a conserved
codon reassignment process for both nuclear and mitochondrial codes,
though mitochondrial idiosyncrasies, such as the small genome (for
example, 16 kilobases in humans) and the compartmentalized nature
of the organelle, may account for the different rate of such changes.
The mitochondrial genome is thought to be under significant pressure for genome minimization, and as such loss of a tRNA gene would
reduce genome size by about 1% and bestow any such organism with
a significant replication advantage. In fact, mammalian mitochondria
have only 22 tRNA species. This is explained by the wobble rules: if a
single tRNA can recognize up to three codons, then translation of the
61 sense codons requires a minimum of 32 tRNA species. Furthermore,
the unmodified uracil present in the first anticodon position of many
mitochondrial tRNAs can read all four codons in a box, thereby reducing
the required number to 24 (ref. 24); sequence analysis of the Neurospora
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The above observations underscore the importance of tRNA modifications for the generation of alternate codon assignments (Table 1). RNA
versatility, through post-transcriptional tRNA base modifications, thus
accounts for the generation of most of the nonstandard codes. Codon
reassignment in such a case would have to occur through an ambiguous decoding step in which mischarged tRNAs (if modification alters
the specificity of the aminoacylation reaction) or misreading tRNAs (if
modification alters codon recognition) compete with wild-type tRNAs
for mRNA codon binding at the ribosomal A site. This, in turn, implies
that reassignment also depends on the capacity of the organism to tolerate a somewhat destabilized proteome, which has traditionally been
thought to decrease survival fitness. In fact, ambiguous decoding may
not be as detrimental as it was once thought. The proteome of Candida
albicans is unstable because the tRNAo^j decodes the CUG codon as
both serine and leucine; this tRNA can be charged by both seryl-tRNA
synthetase (SerRS) and leucyl-tRNA synthetase29. Under environmental
stress, a destabilized proteome seems to be beneficial for such species29.
E. coli is able to cope with some mis-made proteins via an upregulated
heat shock response (B. Ruan and S.R, unpublished data) when subjected
to the survival stress of correcting the missense mutation in an essential
enzyme30. This indicates that ambiguous decoding is not necessarily
lethal and may even prove advantageous under certain conditions. The
flexibility that the genetic code can attain through tRNA modifications
and the cellular tolerance of an altered proteome has made possible the
engineering of microorganisms that can incorporate non-natural amino
acids into their protein repertoire31.
As a final point, we should note that a recently proposed theory of
collective evolution32 can account for the genetic code's universality and
optimality (with respect to codon assignments and amino acid relatedness) without prohibiting the propensity for additional evolvability.
In this theory, an innovation-sharing principle is proposed to govern
survival in the primordial communal world through horizontal genetransfer events involving translational components that would provide a
selective evolutionary advantage for the community as a whole. The universality of the code established at this stage provides the lingua franca
for efficient genetic information exchange. Darwinian vertical evolution
and its "survival of the fittest" dictum would in this case stem not from a
single organism but from a dynamically interacting, gene-sharing community that comprises the last universal common ancestor.
Selenocysteine: a versatile amino acid

Selenium is a dietary trace element required for animal and human
health. Its antioxidant properties account for its numerous health benefits. Selenium offers protection from diverse human ailments including
adverse mood states, cardiovascular disease, viral infections and cancer33.
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Selenium carries out its functions in proteins in the form of selenocys- selenide and ATP) the selenium donor monoselenophosphate44. This
teine, in which the sulfur-containing thiol group of cysteine has been compound reacts with the SelA-bound dehydroalanyl-tRNASec to form
replaced by the selenium-containing selenol moiety (Scheme l) 3 4 .
Sec-tRNA. Thus, selenocysteine is made by a tRNA-dependent amino
Biochemical studies and genomic analyses have established that sele- acid modification process.
nocysteine and selenoproteins are found in organisms from all three
Recoding of UGA as selenocysteine requires the presence of the SECIS
domains of life, though not in all species. In fact, most organisms do stem-loop mRNA structure and the specialized translation elongation
not use this amino acid. Except for its occurrence in Chlamydomonas factor SelB. In bacteria, the SECIS element is located immediately downspp.35 and the alga Emiliana huxleyp6, and the presence of tRNASec stream of the UGA codon within the selenoprotein coding region. The
in some plants37, selenocysteine is notably absent from fungi and general translation elongation factor Tu (EF-Tu) does not recognize
higher plants. Although the mammalian selenoproteome38 contains Sec-tRNASec effectively either in vivo45 or in vitro46. SelB performs two
more than 20 members that are implicated in health (for example, the functions mat are crucial for proper UGA recoding as selenocysteine:
essential antioxidant enzyme glutathione peroxidase and the thyroid (i) its N-terminal domain, which is homologous to EF-Tu, binds to
hormone deiodinase) and disease, only a limited number of prokary- Sec-tRNASec with high specificity—unlike EF-Tu it does not bind to any
otes contain selenocysteine39. For instance, within the 32 archaea with other aa-tRNA, and it is even able to discriminate against Ser-tRNASec
known genomes, only three species {Methanocaldococcus jannaschii, (ref. 47); and (ii) the binding of SelB to the SECIS element through its
Methanococcus maripaludis and Methanopyrus kandleri) encode C-terminal domain is required for delivery of Sec-tRNASec to the ribotRNASec.
somal A site, by outweighing release-factor binding to the UGA codon.
Although selenium and sulfur belong to the same group of elements Thus, the dual properties of SelB guard the fidelity of protein translation by
in the periodic table and hence share some chemical properties (for ensuring that only UGA codons in selenoprotein mRNAs are recoded.
example, electronegativity and major oxidation state), it is the different
electronic structure of these two elements that makes the selenolate Selenocysteine biosynthesis and incorporation in eukaryotes and
anion more stable than the thiolate one and gives selenoproteins their archaea. Because a selenocysteinyl-tRNA synthetase (an enzyme that
unique selenium-derived catalytic efficiencies. Indeed, the low pKa of would directly esterify selenocysteine to its cognate tRNASec) has
selenol relative to a thiol (5.2 versus 8.5, respectively) and selenol's lower never been found, tRNA-dependent conversion of serine is assumed
redox potential (-488 mV, versus -233 mV for the thiol) renders it fully to be the route to selenocysteine in eukaryotes and archaea (Scheme 1,
ionized at the physiological pH range and causes selenocysteine to be top). Indeed, serylation of tRNASec by SerRS has been shown in vitro
substantially more reactive than cysteine. Thus, it is not surprising that in both eukaryotes48"51 and archaea52"54 and is likely to occur in vivo
most known selenoproteins are oxidoreductases with an essential (for efficient catalysis)
selenocysteine active site residue. A selenocysTable 1 Some tRNA modifications and their effects on codon recognition
teine-to-cysteine mutation in such cases results
3rd codon position
in a > 100-fold reduction in catalytic turnover
1st anticodon base
recognized
Species or organelle
Structure
(reviewed in ref. 40). A recent bioinformatic
U,C,
AorG
Mitochondria,
chloroplasts,
U
approach took into account both the catalytic
mycoplasma spp.
advantage provided by selenocysteine and its
reactivity in the presence of oxygen to explain
its dynamic evolution41.

A

s

xo U

U, AorG

Bacteria, eukaryotes

Biosynthesis of selenocysteine and UGA
recoding in bacteria. Pretranslational amino
acid modification is the path to Sec-tRNASec xm5U
A>G
Bacteria, eukaryotes, mitochondria
(Scheme 1, top). Selenocysteine biosynthesis
commences with SerRS acylating tRNASec
with serine, but because of its unusual structure SerRS does so with only 1% efficiency as xm5s2U
A>G
Bacteria, eukaryotes
compared with the other five tRNASer isoacceptors42. Based on the requirement of E. coli
formate dehydrogenase for the presence of
selenocysteine for activity, a genetic system k2C (L)
A only
Bacteria
was developed that led to the identification of
four E. coli genes (selA, selB, selC and selD), all
of which are essential for selenocysteine insertion (reviewed in ref. 19). In addition to tRNA- f5C
AorG
Mitochondria of D. melanogaster,
Sec
nematode, Bos taurus
(SelC), selenocysteine synthase (SelA) and
selenophosphate synthetase (SelD) are needed
for conversion of Ser-tRNASec to Sec-tRNASec.
U, C, AorG
Echinoderm, squid mitochondria
SelA is a pyridoxal phosphate (PLP)-dependent n7G
enzyme with a conserved lysine residue that
catalyzes the formation of an enzyme-bound
dehydroalanyl intermediate with elimination
5
U, 5-hydroxymethyluridine derivative; xm5U, 5-methyluridine derivative; xm5s2U, 2-thio-5-hydroxymethyluridine derivative;
of a water molecule43. SelD synthesizes (from xo
k2C (L), lysidine; f5C, 5-formylcytidine; m7G, 7-methylguanosine. Only the base of the nucleotides is represented.
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Ser-tRNASac

Sec-tRNASec
See'

Ser
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Se donor + PLP

Ser

inability of the eukaryotic and archaeal homolog of SelB to bind to the SECIS element, and
the identification of other SECIS-binding proteins have led to the proposition of at least two
unconfirmed models (reviewed in ref. 55) that
may explain how the ribosome distinguishes
a selenocysteine UGA from a termination
codon and how the eukaryotic and archaeal
selenoprotein mRNAs elude nonsense-mediated decay.

SeH

is

COOH

H2N

Selenocysteine

Se donor + PLP
OP0 3 '

is

•COOH

H2N

tRNA0"8

Cys-tRNA0*8

Phosphoserine

Pyrrolysine: the 22nd amino acid

Methanogens are anaerobic archaea that produce methane commonly from carbon dioxSH
ide and dihydrogen. The Methanosarcinaceae
are unique among methanogenic archaea in
Ser
COOH
that they are capable of methanogenesis using
H2N
Ser +ATP
methylamines65. Methane production from
S donor + PLP
Cysteine
monomethylamine, for example, requires the
enzyme monomethylamine mefhyltransferase. The mtmBl gene encoding this enzyme
Scheme 1 tRNA-dependent amino acid transformations leading to selenocysteine and cysteine.
has an in-frame UAG codon that is translated
Top: the SelA route is the bacterial pathway19; the PSTK/SepSecS pathway is found in archaea and
eukaryotes62. Bottom: Cys-tRNAcys synthesis in methanogenic archaea69. The chemical structures of
in the Methanosarcinaceae, thereby producselenocysteine, O-phosphoserine and cysteine are shown on the side.
ing the full-length methyltransferase protein
(MtmB)66. The crystal structure of this protein from Methanosarcina barkeri revealed that
as well51,55. A recent bioinformatic analysis revealed the enzyme phos- the UAG-encoded residue is a lysine with a pyrroline-ring derivative
20 67
phoseryl-tRNASec (Sep-tRNASec) kinase (PSTK) to be present only in attached to its e-amino group ' ; this amino acid was named pyrrolygenomes of organisms that have a selenoproteome. The activity was sine (Scheme 2). An amino acid with the expected mass was found at this
68
characterized in vitro for both the mouse56 and the M. jannaschii52 position in the active site of the native MtmB enzyme ; pyrrolysine is a
66
Sec
enzymes; this kinase phosphorylates Ser-tRNA specifically to form crucial residue for the enzymatic reaction to proceed . Based on the curSep-tRNASec. This lends credence to the old finding of Sep-tRNASec in rently known genomes, pyrrolysine is found in the Methanosarcinaceae
mammalian cell extracts57'58. From a chemical standpoint, O-phospho- and in the bacterium Desulfitobacterium hafniense.
serine would provide a better leaving group (phosphate) than serine
(water) for replacement with selenium. Given that a PLP-dependent Pyrrolysine insertion requires an orthogonal aaRS-tRNA pair. The
selenocysteine synthase activity (as manifested by E. coli SelA44 for the discovery of a new M. barkeri amber suppressor tRNA gene suggested
conversion of Ser-tRNASec to Sec-tRNASec) has been elusive, the mecha- that pyrrolysine might be cotranslationally inserted into MtmBl durnistically similar SepCysS enzyme59 involved in Cys-tRNACys formation ing protein synthesis and therefore genetically encoded by UAG21. The
in methanogens (see below) might engage in a tRNA-dependent synthe- tRNAp>'1 gene (pylT) is located next to pylS, which encodes a protein
sis of selenocysteine from O-phosphoserine. Another possible enzyme similar to a class II aaRS. These two genes precede the pylB, pylC and
candidate is the human protein soluble liver antigen/liver pancreas pylD genes21.
(SLA/LP), which forms a ribonucleoprotein antigenic complex with
Initial experiments21 suggested that Pyl-tRNAp>'1 synthesis proceeds
tRNASec in people suffering from an autoimmune chronic hepatitis60. via Lys-tRNAp>'1 (formed by PylS) and a subsequent tRNA-dependent
Bioinformatic support for this idea suggested that SLA/LP, a member amino acid modification. Support for a possible indirect route was also
of the family of PLP-dependent transferases, may have selenocysteine provided by the finding that Lys-tRNAp>'1 can be made by the simulsynthase function61. Recently, biochemical and molecular genetic stud- taneous action of class I and class II lysyl-tRNA synthetases (LysRSs)
ies have established that human SLA/LP, as well as its M. maripaludis that exist in the M. barkeri genome69 (Scheme 2). However, direct
ortholog, convert Sep-tRNASec to Sec-tRNASec
in vivo and in vitro. Thus, the enzyme is a SeptRNA:Sec-tRNA synthase (SepSecS)62. The
natural selenium donor substrate for SepSecS
is unknown, but SPS1 and SPS2 are two mammalian candidate selenophosphate synthetase
tRNApy'
enzymes63'64.

X>>.

Regarding UGA recoding on the ribosome,
several distinguishing features account for a
more complex picture and a still-hazy understanding of the process in archaea and eukaryotes. In particular, the established presence of
the eukaryotic and archaeal SECIS elements in
the 3' untranslated region of the mRNA, the
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Scheme 2 Schematic representation of Pyl-tRNA y' formation. Chemical structures of lysine and
pyrrolysine are shown on the side.
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charging of pyrrolysine onto tRNAPyl could
not be overlooked, in particular because the
pylS gene product, which has all the features
of a bona fide class II aaRS, was a plausible
candidate for this task. Indeed, in vitro studies using synthetic pyrrolysine subsequently
showed that the PylS protein can charge pyrrolysine directly to tRNA1^1; lysine was not
a substrate for this enzyme22,23 (Scheme 2).
The reaction also occurs in vivo23. Because of
this enzymatic activity, the product of the py/S
gene was named pyrrolysyl-tRNA synthetase
(PylRS)22'23. This enzyme is the first example
of a tRNA synthetase that is specific for a
modified amino acid, and PylRS and tRNAPyl
are a naturally occurring aaRS-tRNA pair
that is effectively orthogonal to the canonical
genetic code.
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Pyrrolysine biosynthesis. Attempts at predictPotential Pyl precursors
ing the genes involved in pyrrolysine biosynthesis rested on the idea that, like pylS and py/T, Scheme 3 Comparison of proline biosynthesis and potential pyrrolysine precursors. Intermediate
their occurrence should be restricted to pyr- metabolites in proline biosynthesis ((SSJ-A^pyrroline-S-carboxylate) and pyrrolysine biosynthesis
1
rolysine-incorporating organisms; only pylD ((4S,5/?)-4-methyl-A -pyrroline-5-carboxylate) that share structural homology are boxed.
has these characteristics70. Although pylB and
pylC were found to have homology to biotin
synthase and D-alanine-D-alanine ligase, respectively, their conserved
PYLIS elements (RNA structures resembling SECIS elements) were
presence in the same transcriptional unit as pylT and pylS suggests some identified in M. barker?* and D. hafniense2 methylamine methyltranslevel of functional relevance to pyrrolysine metabolism or biosynthesis. ferase genes immediately downstream of the in-frame UAG codon.
Given the D stereoconformation of the pyrrolysine pyrroline ring, it is A synthetic oligonucleotide with sequence corresponding to the
tempting to speculate that PylC may be responsible for the ligation of M. barkeri mtmBl PYLIS element did fold in the predicted secondary
the pyrroline ring to the E-amino group of lysine. Although the pyrroline structure75. However, a bioinformatic analysis of the regions surroundring shares strong structural homology with the direct proline precursor ing putative SECIS and PYLIS elements suggested that selenocysteine
A'-pyrroline-S-carboxylate (Scheme 3), the absence of homology of and pyrrolysine have different decoding strategies70 and questioned
pylB and pylC to the proline biosynthetic genes (y-glutamylphosphate the functional significance of PYLIS elements. A recent study demonreductase and y-glutamyl kinase on one hand and ornithine amino- strated successful suppression of lacZ and rrpA amber mutants in E.
transferase on the other) might indicate that proline and pyrrolysine coli strains transformed with M. barkeri pylS and pylT and grown in
pyrroline ring biosynthesis do not share the same glutamate or ornithine a medium supplemented with N-e-cyclopentyloxycarbonyl-lysine, an
precursors. It is interesting to speculate whether the pyrroline ring is analog that substitutes for the commercially unavailable pyrrolysine76.
instead derived from the metabolite D-isoleucine (Scheme 3), which The production of active P-galactosidase and tryptophan synthetase
would free the organism of the need to conduct a difficult methylation enzymes in the absence of PYLIS elements suggests that this RNA motif
step. The S-methyl-A'-pyrroline-S-carboxylate species, a regioisomer of is not essential (at least in an E. coli context) to achieve sufficient UAG
the pyrrolysine precursor, has been previously obtained from L-leucine suppression. Future genetic studies in Methanosarcina spp. will provide
by a chemically analogous route71. The pyrrolysine precursor might a definitive answer to the question of the physiological significance of
also potentially be obtained from the catabolism of D-proline (Scheme PYLIS elements.
3). This reaction may be carried out by proline dehydrogenase72, which
performs this function for L-proline and whose gene is present in the Sep-tRNA: precursor to Cys-tRNA in methanogenic archaea
Methanosarcinaceae genomes.
Cysteine is part of the 20-canonical-amino-acid repertoire ubiquitously
used for protein synthesis. Though cysteine is present in proteins of M.
A stem-loop structure in mRNA is not essential for UAG recoding. A jannaschii, Methanothermobacter thermautotrophicus and M. kandleri to
currently unanswered question is whether the mtmBl UAG codon is an extent similar to that in other organisms, the genomes of these methaactively recoded to pyrrolysine (as is the case with UGA recoding to sele- nogens do not encode a canonical cysteinyl-tRNA synthetase (CysRS).
nocysteine19) or whether this is a standard nonsense suppression16 event This puzzle was solved when a new pathway (Scheme 1, bottom) for preCys
in which the presence of charged suppressor tRNA is sufficient to ensure translational amino acid modification was discovered for Cys-tRNA
59
70
a certain degree of UAG read-through . An active recoding mechanism synthesis in these organisms . The first enzyme, an unusual aaRS that
requires additional components (specific proteins or RNA elements) that is homologous to the phenylalanyl-tRNA synthetase a subunit, accuc s
a normal suppression event does not require. The cotranslational insertion rately and selectively acylates tRNA >' with O-phosphoserine. A second
0
2i
of pyrrolysine into M. barkeri MtmB observed in E. coli implies that bac- enzyme then converts Sep-tRNA ^ to Cys-tRNA^ in the presence of
terial elongation factors deliver Pyl-tRNA1^1 to the ribosome. This is also PLP and a still-unidentified sulfur donor. The two enzymes were named
supported by the fact that Thermus thermophilus EF-Tu can bind in vitro a phosphoseryl-tRNA synthetase (SepRS, encoded by sepS) and SeptRNA:Cys-tRNA synthase (SepCysS), respectively. Searches in genomic
mutant tRNA^1 (with a UUU anticodon) aminoacylated with lysine73.

NATURE CHEMICAL BIOLOGY

VOLUME 3

NUMBER 1 JANUARY 2007

33

PERSPECTIVE

O)
.0

g
jg

«
o

'E
(D

n
o

<0
(0

c
E
o
o
6
L_

3

c5
c
S
5
a

£
a
c

a.
z
(O

o
o

CM

©

databases revealed the presence of homologs of these proteins not only
in M. jannaschii, M. kandleri and M. thermautotrophicus but also in
genomes of other archaea such as M. maripaludis, Methanococcoides
burtonii, Methanospirillum hungatei, Archaeoglobus fulgidus and the
Methanosarcinaceae, organisms that also have the canonical CysRS59.
Biochemical examination showed that SepRS is a typical class II aaRS
specific solely for its substrates O-phosphoserine and tRNACys. After
PylRS, this is now the second natural aaRS that evolved for activating a
modified amino acid.
An indication of the physiological and evolutionary significance of
the SepRS/SepCysS pathway in these organisms has been provided by
genetic experiments in M. maripaludis. This organism contains CysRS,
horizontally transferred from bacteria, in addition to the indirect pathway of Cys-tRNA formation77. Although the inactivation of the cysS
gene encoding the canonical CysRS had no effect on cell growth in
different media78, an M. maripaludis strain containing a sepS deletion
showed cysteine auxotrophy59. The dispensability of the canonical
CysRS together with the auxotrophic nature of the M. maripaludis sepS
knockout strain demonstrates that (i) in the presence of exogenous cysteine the SepRS/SepCysS pathway and CysRS are functionally equivalent in Cys-tRNA synthesis, and (ii) the indirect route to Cys-tRNA is
the sole source of free cellular cysteine in this organism59. Thus, in M.
maripaludis the SepRS/SepCysS pathway provides the cell with both
Cys-tRNA^ and free cysteine.
Because M. maripaludis contains both CysRS and SepRS, the single
M. maripaludis tRNAcys species is aminoacylated by the two unrelated
synthetases—the class II enzyme SepRS (with O-phosphoserine) and
the class I enzyme CysRS (with cysteine). The existence of two unrelated
decoding systems allows a reexamination of the role of aaRSs in the
evolution of the genetic code. Biochemical analysis has established that
the major tRNACys identity elements are shared by both synthetases,
even though they belong to different classes79. In three other similar
cases distinct aaRSs recognize common major identity elements in tRNA
(tRNA1-^ (ref. 80), tRNASer (ref. 81) and tRNA01'' (refs. 82,83)). The evidence indicates convergence of the aaRSs to recognize a preestablished
tRNA identity. This RNA record supports the idea that the universal
genetic code evolved in the RNA world79.
Discovery of the tRNA-dependent cysteine biosynthetic route in M.
jannaschii may have implications that reach far beyond the problem of
how Cys-tRNACys is formed in three methanogenic archaea. Indeed,
the fact that cysteine biosynthesis in M. jannaschii proceeds via SeptRNA0^ and a subsequent conversion of O-phosphoserine to cysteine
catalyzed by SepCysS suggests that the same (or a similar) enzyme may
also carry out the transformation of O-phosphoserine to selenocysteine59 in archaea and eukaryotes, as discussed above.
Outlook

It is exciting to know that RNA modifications and specialized RNA
structures are essential in defining the coding response by fine-tuning
codon-anticodon interactions and by recoding stop codons, and it is
fascinating to visualize some of these structures in detail84. Indeed,
tRNA modifications seem to coevolve with the pattern of codon usage
seen in different organisms, thus facilitating codon identity change.
Imbalance of the proteome was once thought to be the prohibitive
factor in the introduction of new amino acids to the standard alphabet. The absence of a selenocysteinyl-tRNA synthetase and the use of
intricate machinery for selenocysteine incorporation was regarded
as further proof that the current code and amino acid repertoire are
hard to change. The ability of Candida spp. and E. coli to tolerate and
even benefit from a destabilized proteome and the unexpected existence of aaRSs specific for the noncanonical amino acids pyrrolysine
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and O-phosphoserine have revealed that the code can be adaptive to
evolutionary innovations. This, in turn, raises the possibility that additional encoded amino acids with particular functions might exist in
still-uncharacterized genomes.
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ABSTRACT

INTRODUCTION

The micronutrient selenium is present in proteins
as selenocysteine (Sec). In eukaryotes and archaea,
Sec is formed in a tRNA-dependent conversion
of O-phosphoserine (Sep) by O-phosphoseryltRNA:selenocysteinyl-tRNA synthase (SepSecS).
Here, we present the crystal structure of
Methanococcus maripaludis SepSecS complexed
with PLP at 2.5 A resolution. SepSecS, a member
of the Fold Type I PLP enzyme family, forms an (1x2)2
homotetramer through its N-terminal extension.
The active site lies on the dimer interface with
each monomer contributing essential residues. In
contrast to other Fold Type I PLP enzymes, Asn247
in SepSecS replaces the conserved Asp in binding
the pyridinium nitrogen of PLP. A structural comparison with Escherichia coli selenocysteine lyase
allowed construction of a model of Sep binding
to the SepSecS catalytic site. Mutations of three
conserved active site arginines (Arg72, Arg94,
Arg307), protruding from the neighboring subunit,
led to loss of in vivo and in vitro activity. The lack
of active site cysteines demonstrates that a
perselenide is not involved in SepSecS-catalyzed
Sec formation; instead, the conserved arginines
may facilitate the selenation reaction. Structural
phylogeny shows that SepSecS evolved early in
the history of PLP enzymes, and indicates that
tRNA-dependent Sec formation is a primordial
process.

The indirect tRNA-dependent pathways of aminoacyltRNA formation, in which a noncognate amino acid
bound to tRNA is converted to the cognate one, are
widely distributed in nature. In fact, the tRNA-dependent
pathways for Gin and Asn formation are evolutionarily
older than the corresponding direct aminoacylation
route catalyzed by the aminoacyl-tRNA synthetases (1).
Although selenocysteine occurs in organisms from all
three domains of life (2,3), Sec-tRNA is synthesized solely
by the indirect route; actually it is the only natural amino
acid found in proteins for which a cognate aminoacyltRNA synthetase did not evolve. Seryl-tRNA synthetase
(SerRS) forms Ser-tRNA Sec in bacteria (4), archaea (5,6)
and eukaryotes (7). Using the selenium donor selenophosphate bacteria convert this misacylated aminoacyl-tRNA
species to Sec-tRNASec by the action of the SelA protein, a
PLP-dependent selenocysteine synthase (3). Some methanogenic archaea harbor a gene that was thought to encode
a SelA homolog (e.g. MJ0158), but its product is unable to
synthesize Sec-tRNASec in vitro (6).
On the other hand, eukaryotes and archaea require an
additional phosphorylation step catalyzed by O-phosphoseryl-tRNA Sec kinase (PSTK) (8-10) and convert the
resulting Sep-tRNA Sec to Sec-tRNASec by Sep-tRNA: SectRNA synthase (SepSecS) (11,12). An unexpected and
important property of the human SepSecS protein is the
fact that it is the target antigen for soluble liver antigen/
liver-pancreas (SLA/LP) autoantibodies (13-15) that are
found in about a quarter of the patients with autoimmune
hepatitis (16). The reactions catalyzed by PSTK and
SepSecS are reminiscent of the indirect pathway of
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Scheme 1. Graphic representation of the reaction schemes. (A)
MMPSepSecS catalyzes the conversion of tRNA Sec -bound Sep to Sec.
(B) AFSepCysS mediates the tRNA Cys -dependent transformation of
Sep to Cys. (C) ECCsdB converts selenocysteine to alanine and
elemental selenium. (D) ECIscS converts cysteine to alanine and
elemental sulfur.

Cys-tRNA Cys synthesis in archaeal methanogens (17)
where Sep-tRNA Cys is converted to Cys-tRNA Cys by
Sep-tRNA:Cys-tRNA synthase (SepCysS), a PLP-dependent enzyme carrying out a P-replacement on tRNAbound Sep. The crystal structure of Archaeoglobus
fuldgidus SepCysS has been reported (18).
The initial characterization of SepSecS revealed that
this protein is a PLP-dependent enzyme (11,12). In nature
such enzymes are abundant; in some microbial genomes
they represent as much as 1.5% of all genes (19). They
have many diverse functions and are often involved in
amino acid biosynthesis (20). The structures of three other
PLP-dependent enzymes that use substrates (selenocysteine, cysteine) chemically similar to those of SepSecS
have been solved. One is the A. fulgidus SepCysS
(AFSepCysS) (18), while another one is Escherichia coli
selenocysteine lyase (ECCsdB) (21), an enzyme that
converts selenocysteine to alanine and elemental selenium
(22). The last enzyme is the E. coli cysteine desulfurase
(ECIscS) that catalyzes the desulfuration of cysteine (23).
The reactions catalyzed by these enzymes are illustrated in
Scheme 1; SepSecS and SepCysS carry out P-replacements
on tRNA-bound Sep, while selenocysteine lyase removes
the (3-substituent of Sec to form elemental selenium,
and cysteine desulfurase catalyzes the fragmentation of
cysteine to alanine and elemental sulfur. Biochemical data
on SepSecS and SepCysS currently do not exist.
Here, we report the crystal structure of Methanococcus
maripaludis SepSecS (MMPSepSecS) at 2.5 A resolution
and perform a structural comparison with ECCsdB and
AFSepCysS. We propose active site residues important for
the enzymatic function of MMPSepSecS by employing a
combination of mutational in vivo and in vitro activity
analyses. Finally, we present a structural phylogeny of the

Oligonucleotide synthesis and DNA sequencing was
performed by the Keck Foundation Biotechnology
Resource Laboratory at Yale University. [14C]Serine
(163mCi/mmol) and [oc-32P]ATP (lOmmol/uCi) were
obtained from Amersham Pharmacia Biosciences
(Piscataway, NJ, USA). The E. coli BL21-CodonPlus
(DE3)-RIL strain and the pUC18 vector were from
Stratagene (LaJolla, CA, USA). The pET15b and the
pACYC184 vectors were from Novagen (San Diego, CA,
USA). Nickel-nitriloacetic acid agarose was from Qiagen
(Valencia, CA, USA). Nickel-sepharose and Resource
PHE were from GE Healthcare Bio-Sciences KK (Tokyo,
Japan).
Bacterial strains and plasmids
Construction of the E. coli AselA deletion strain JS1
(DE3), cloning of the M. maripaludis SepSecS gene
(MMP0595) and the E. coli SelD gene into the pET15b
vector, of the M. maripaludis tRNA Sec gene into the
pUC18 vector, and of the M. jannaschii PSTK gene into
the pACYC184 vector were described previously (11). The
M. maripaludis SepSecS mutants R72A, R72Q, R72K,
R94A, R94Q, H166A, H166F, H166Q, R307A, R307Q,
R307K, Q102A, K278A, N247A, D277A, and K278A
were generated using the QuikChange site-directed mutagenesis kit (Stratagene) and cloned into the pET15b vector
with an N-terminal His-tag. An N-terminal Ai_34SepSecS
deletion mutant was constructed by PCR using the
primers
5'-CCGCTCGAGCATCGGAAAATTCCTGA
AAACGGAATTGATGACG-3' and 5'-GCTAGTTAT
TGCTCAGCGGTGGCAGC-3'
and
the P ET15bsepsecS plasmid DNA as the template. The resulting
DNA fragment was digested with BamHI and Xhol and
re-inserted into the pET15b vector.
Protein expression and purification
Expression and purification of the M. maripaludis wildtype and mutant SepSecS proteins and the E. coli SelD
(used for biochemical experiments) was done as described
previously using Ni-NTA column chromatography (11).
Purification of the wild-type SepSecS used for crystallization involved two chromatographic steps. Briefly,
pET\5b-sepsecS was transformed into the E. coli BL21CodonPlus (DE3)-RIL strain, cells were grown to
A^oo = 0.6 and gene expression was induced with
0.4 mM IPTG. After growth for 17 h at 20°C, cells were
harvested, resuspended in 50 mM Tris-HCl (pH 7.0),
300 mM NaCl, lOuM PLP, 5mM 2-mercaptoethanol,
10% glycerol, 1 mM PMSF and gently sonicated. After
centrifugation at 14000g for 30min, the supernatant was
collected and purified by sequential passage through a
Ni-Sepharose and a Resource PHE chromatography
column.
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Table 1. Data collection and phasing statistics
X-ray source

Data collection statistics
Wavelength (A)
Resolution (A)
Unique reflections
Redundancy
Completeness (%)
//s(7)
"sym

Phasing statistics
No. of Se sites
Phasing power
Iso (cen./acen.)
Ano

SPring-8 BL41XU
Peak

Edge

Reml

Remh

SeMet
0.9791
50-2.5 (2.54-2.5)
59 938
5.0 (2.4)
97.9 (86.1)
17.0 (2.9)
0.135 (0.258)

0.9793
50-2.5 (2.54-2.5)
59 274
4.9 (2.3)
97.6 (86.1)
16.4 (2.7)
0.127 (0.272)

0.9820
50-2.5 (2.54-2.5)
59463
4.8 (2.2)
97.0 (81.2)
16.3 (2.6)
0.125 (0.261)

0.9770
50-2.5 (2.54-2.5)
59123
4.8 (2.0)
96.6 (79.3)
15.3 (2.4)
0.127 (0.272)

31

31

31

31

0.633/0.587
1.399

-

1.006/0.879
0.107

0.706/0.653
0.811

0.896/0.833
0.754

-

0.713/0.767
0.987

0.749/0.794
0.89

0.79

^cullis

Iso (cen./acen.)
Ano
Mean FOM
Cen./Acen.

0.89

0.406/0.461

The numbers in parentheses are for the last shell.
R*
: E |/ - / f | / E '-•• ^cullis = E | I^PH + Ff | • I ' I / E I ^ P H I .

Gel filtration of MMPSepSecS
A 0.5 ml sample of a 1.5mg/ml purified solution of
selenomethionine-labeled MMPSepSecS was loaded onto
a HiPrep 16/60 Sephacryl S-300 HR column (GE
Healthcare). The column was run at 0.5ml/min in the
same buffer as crystallization, containing 20 mM HEPES
(pH 7.0), 300 mM NaCl, 10 uM PLP and 5mM DTT. The
elution volume of MMPSepSecS was compared to the
elution volumes of other oligomeric proteins according to
the GE healthcare web site (http://www.gelifesciences.
co .jp/catalog/pdf_attach/1810608 8 AC .pdf).
Crystallization, structure determination and refinement
The purified SepSecS was dialyzed against crystallization
buffer, containing 20 mM HEPES-NaOH (pH 7.0), 10 uM
PLP and 5 mM DTT, 300 mM NaCl and was concentrated.
Crystals of M. maripaludis SepSecS were grown within a
day at 20°C by the sitting-drop vapor diffusion method.
Drops were prepared by mixing equal volumes of the 6 mg/
ml SepSecS solution and the reservoir solution, containing
45 mM HEPES-NaOH (pH 7.0), 10 mM MES-HC1 (pH
6.5), 90 mM KC1, 9mM CaCl 2 , 160 mM MgS0 4 and 10%
PEG550MME. Selenomethionine-labeled SepSecS was
prepared by the conventional method and was purified in
the same manner as the wild-type.
The SepSecS crystals were flash-cooled in a nitrogen
stream at 100 K. All diffraction data sets were collected
at the BL41XU at SPring-8 (Harima, Japan), and were
processed with the HKL2000 suite. The crystals belong to
the primitive monoclinic space group P2\, with unit-cell
parameters a = 75.7, ZJ = 108.1, c = 1 1 0 . 4 A , (3 = 97°.
There are four SepSecS molecules in the asymmetric
unit. A multiwavelength anomalous dispersion (MAD)
data set of the selenomethionine-substituted crystals was
collected, and was used to search for the locations of
the selenium atoms by using the program SnB (24).

Subsequent phase refinements were performed with the
program SHARP (25), and the model was manually built
into the electron density maps by using the program O
(26). The model was refined against reflections up to 2.5 A
resolution by using the program CNS (27). The backbones
of all residues were clearly defined in the final 2F0—FC
electron density maps. Graphic representations were
prepared with CueMol (http://www.cuemol.org).
Statistics on data collection, phasing and refinement are
shown in Tables 1 and 2.
In vivo SepSecS assay
The M. maripaludis wild-type and mutant SepSecS genes
were transformed into the AselA E. coli JS1 strain with
or without the M. jannaschii PSTK gene. Aerobic overnight cultures were streaked in aerobic conditions on
LB-agar plates supplemented with 0.01 mM IPTG, 1 uM
Na 2 Mo0 4 , 1 uM Na 2 Se0 3 and 50 rnM sodium formate.
The plates were placed in an anaerobic incubation jar that
was flushed with an N 2 : C0 2 : H 2 (90: 5: 5) gas mix three
times to give an anaerobic atmosphere and then grown for
16 h at 37°C and 36 h at 30°C. The plates were then overlaid
with agar containing 1 mg/ml benzyl viologen (BV), 0.25 M
sodium formate and 25 mM KH 2 P0 4 adjusted to pH 7.0.
The appearance of a blue/purple color is the indication of
active formate dehydrogenase H (FDH H ).
Preparation and purification of tRNA gene transcripts
The M. maripaludis tRNA Sec used as substrate in the
in vitro assays was synthesized by in vitro T7 RNA
polymerase run-off transcription as described (28).
The tRNA Sec gene together with the T7 promoter was
constructed from overlapping chemically synthesized
oligonucleotides, cloned into the pUC18 plasmid and
purified from E.coli DH5a transformants using a
MaxiPrep plasmid purification kit (Qiagen). The purified

1190 Nucleic Acids Research, 2008, Vol. 36, No. 4

Table 2. Structure refinement statistics
Refinement statistics

Se-Met

Resolution (A)
No. of atoms
Protein
Water
PLP

50-2.5

so4
Luzzati coordinate error (A)
Cross-validated Luzzati coordinate error (A)
RMSD of
Bond length (A)
Bond angle (°)
Dihedral angle (°)
Improper angle Q
Average B factor (A2)
Ramachandran plot
Core region (%)
Additionally allowed regiorI ( % )
Generously allowed region (%)
Disallowed region (%)
" w o r k / *Hree

13 552
146
160
10
0.3
0.39
0.007
1.39
22.2
0.89
38.5
88.2
11.3
0.3
0.2
0.208/0.269

Rwork = £|-fo—Fc\jT,Fa for reflections of work set.
R rrcc = Y,\F0-Fc\jXF0 for reflections of test set (10% of
reflections).

total

Sep-tRNA Sec was ethanol precipitated at -20°C for
45min and collected as a pellet by centrifugation at
lOOOOg at 4°C for 30min. After washing the pellet with
70% ethanol, it was allowed to dry on ice in order to avoid
deacylation.
To check levels of serylation and Ser-^-Sep conversion
1 ul aliquots at the start and end of the reaction were
quenched on ice with 3ul of lOOmM sodium citrate
(pH 4.75) and 0.66mg/ml of nuclease PI (Sigma).
Following nuclease PI digestion at room temperature
for 1 h, 1.5 ul of the sample was spotted onto polyethyleneimine (PEI) cellulose 20 cm x 20 cm thin layer chromatography (TLC) plates (Merck). To separate the
Sep-[32P]AMP spot from [32P]AMP and any remaining
Ser-pP]AMP the plates were developed for 75min in
buffer containing lOOmM ammonium acetate, 5% acetic
acid. The plates were exposed on an imaging plate
(FujiFilms) for 14h, scanned using a Molecular
Dynamics Storm 860 scanner and quantified using the
ImageQuant densitometry software. The amount of
Sep-tRNA Sec formed can be calculated by dividing the
intensity of the Sep-[32P]AMP spot by the sum of the
intensities of all spots (Sep-[32P]AMP, [32P]AMP and
32Ser-["P]AMP).
r

L Scc

plasmid was digested with BstNl at 55°C for 16 h.
The in vitro transcription reaction was performed at
37°C for 5 h in buffer containing 40 mM Tris-HCl (pH 8),
22 mM MgCl 2 , 25 mM DTT, 2mM spermidine, 50ug/ml
BSA, O.lmg/ml pyrophosphatase, 4mM of each
nucleoside triphosphate, BstNI-digested vector containing
the tRNA Sec gene (60Lig/ml) and 1 mM T7 RNA
polymerase. The tRNA ec transcript was purified by
electrophoresis on a 12% denaturing polyacrylamide gel.
Full-length tRNA was eluted and desalted on Sephadex
G25 Microspin columns (Amersham). The tRNA
transcripts were refolded by heating for 5min at 70°C
in buffer containing lOmM Tris-HCl (pH 7.0), followed
by addition of 5mM MgCl 2 and immediate cooling
on ice (5).
Preparation of 32P-labeled Sep-tRNASec
Refolded tRNA Sec transcript was 32P-labeled on the
3' terminus by using the E. coli CCA-adding enzyme and
[a-32P]AMP (Amersham) as previously described with
some modifications (29). Briefly, 6ug of tRNA Sec transcript was incubated with the CCA-adding enzyme and
[oc- P]ATP (50 uCi) for 1 h at room temperature in buffer
containing 50 mM Tris-HCl (pH 8.0), 20 mM MgCl 2 ,
5mM DTT and 50 uM sodium pyrophosphate. After
phenol/chloroform extraction the sample was passed over
a Sephadex G25 Microspin column (Amersham) to
remove excess ATP (30).
The recovered [32P]-labeled tRNA Sec was serylated and
phosphorylated by M. maripaludis SerRS (5 uM) and
M. jannaschii PSTK (1 uM) for 75min at 37°C in buffer
containing 50mM HEPES (pH 7.5), lOmM MgCl 2 ,
20mM KC1, I m M DTT, 1 mM serine and lOmM ATP.
After phenol/chloroform
extraction
aminoacylated

In vitro conversion of Sep-tRNAsec to Cys-tRNA

Purified wild-type or mutant MMPSepSecS (1 uM) was
incubated with 1 uM 32P-labeled Sep-tRNA Sec in buffer
containing 50mM HEPES (pH 7.0), 20mM KC1, lOmM
MgCl 2 , 5mM DTT, 2uM PLP and 500 uM sodium
thiophosphate. Reactions were carried out anaerobically
at 37°C over 40min. At each time point taken, 1 ul
reaction aliquots were quenched on ice with 3 ul of
100 mM sodium citrate (pH 4.75) and 0.66mg/ml of
nuclease PI (Sigma). Following nuclease PI digestion,
1.5 ul of the sample was spotted onto PEI cellulose TLC
plates that were developed, scanned and quantified as
described above. To separate the Cys-[32P]AMP spot from
the Sep-[32P]AMP, the [32P]AMP and any remaining
Ser-[32P]AMP spots the plates were developed for 75 min
in buffer lOOmM ammonium acetate, 5% acetic acid. The
plates were exposed on an imaging plate (FujiFilms) for
14h, scanned using a Molecular Dynamics Storm 860
scanner and quantified using the ImageQuant densitometry software. The amount of Cys-[32P]AMP formed was
calculated by dividing the intensity of the Cys-[32P]AMP
spot by the sum of the intensities of all spots
(Cys-[32P]AMP, Sep-[32P]AMP, [32P]AMP and Ser[32P]AMP). The added elevated concentration of PLP
was used to assure that the mutant enzymes were
saturated with the cofactor.
In vitro conversion of Sep-tRNAScc to Sec-tRNASec
The Sep-to-Sec conversion reaction was carried out as
described before (11). Briefly, purified tRNA Sec (10 uM)
was incubated with M. maripaludis SerRS (6uM) and
M. jannaschii PSTK (3 uM) in reaction buffer containing
100 uM [14C]Ser, lOOmM HEPES (pH 7.0), lOmM KC1,
lOmM magnesium acetate, ImM DTT and O.lmg/ml
BSA at 37°C for 1 h. The aminoacylated Sep-tRNA Sec
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products were purified by phenol extraction followed
by passage over a Sephadex G25 Microspin column
(Amersham) and ethanol precipitation. Purified wild-type
SepSecS or the R72Q mutant was incubated with 10 uM
Sep-tRNA Sec and 100 uM purified E. coli SelD in reaction
buffer containing lOOmM HEPES pH 7.0, 300 mM KC1,
lOmM MgCl 2 , I m M DTT and 250 uM Na 2 Se0 3 . All
buffers were prepared anaerobically and the reaction was
carried out in an anaerobic chamber at 37°C. After 30min
incubation the reaction was stopped by phenol extraction
and the tRNAs were purified by application on a
Sephadex G25 Microspin column (Amersham) and
ethanol precipitation. Purified tRNA products were
deacylated in 20 mM NaOH at room temperature for
lOmin. The released amino acids were oxidized with
performic acid and spotted onto silica gel 60 TLC
aluminium sheets (Merck) that were subsequently developed in 85% ethanol.

enables the cells to reduce benzyl viologen (BV) in the
presence of formate; this is usually observed by a blue/
purple color in agar overlay plates under anaerobic
conditions (36). Furthermore, we employed two in vitro
tests. The first detects the enzyme's final reaction product,
Sec-tRNASec, as determined by TLC of Sec released
from tRNA Sec (11). Given the difficulty in working with
selenophosphate (availability and oxygen sensitivity) we
used thiophosphate as a surrogate substrate to measure
the time course of Cys-tRNA ec formation by SepSecS.
In this assay, 32P-labeled Sep-tRNA Sec was incubated
anaerobically with wild-type or mutant SepSecS proteins
and thiophosphate. After nuclease PI digestion of the
tRNA in the reaction mixture, the product Cys-[32P]AMP
was separated from Sep-[32P]AMP by TLC and
quantitated.

Alignment and phylogeny

The MMPSepSecS protein adopts an L-shaped structure
consisting of the N-terminal extension domain (1-130),
a catalytic domain (131-309) and a C-terminal domain
(353-436) (Figure 1A). Long, kinked helices (310-352)
connect the catalytic and C-terminal domains. The PLP
molecule is covalently bound to the conserved Lys residue
K278 (Figure 2) at the active site. As can be seen in
Figure 1, the overall architecture of MMPSepSecS is
similar to the Fold Type I (20) PLP enzymes AFSepCysS
(18) and ECCsdB (21) (Figure 1). These enzymes consist
of a catalytic domain similar to that of MMPSepSecS, and
a 'small domain', formed by the N-terminal polypeptide
and C-terminal polypeptide, which also resembles the
MMPSepSecS C-terminal domain (Figure IB and C)
(18,21). We constructed a structure-based sequence
alignment (Figure 2) in order to accurately compare
MMPSepSecS to three PLP enzymes, AFSepCysS,
ECCsdB and ECIscS, that act upon chemically similar
substrates. According to structural similarity measures
SepCysS, CsdB and IscS are significantly more closely
related to each other than they are to SepSecS (Figure 3).
Sequence relationships show a similar trend with SepCysS,
CsdB and IscS sharing 24 identical residues while these
proteins have only 8 residues in common with SepSecS
(Figure 2). The alignment also shows that the archaeal
SepSecS proteins lack the C-terminal extension that
has been identified as the major antigenic region for the
SLA/LP autoantibodies (37).

The STAMP (31) structural superposition algorithm in
the Multiseq 2.0 module of VMD 1.8.6 (32) was used to
establish a structure-based alignment between SepSecS
and the other members of the fold type I PLP-dependent
family. The structural similarity measure Q H (33) was
used to determine evolutionary distances between
members of the fold type I group for the structural
phylogeny shown in Figure 8. The tree was drawn using
the programs NEIGHBOR and DRAWTREE in the
Phylip 3.66 package (34). A similar structure-based
alignment was used for the structure-based sequence
alignment shown in Figure 2. First, SepSecS was
structurally aligned to SepCysS, IscS and CsdB. This
structure-based alignment was then supplemented with
three additional SepSecS sequences, which had been
previously aligned to MMPSepSecS with CLUSTAL
(35). Some alignment ambiguities were corrected by
manual adjustment to the structure-based sequence
alignment.
Accession numbers
The Protein Data Bank (http://www.rscb.org/pdb) accession number for the coordinates of MMPSepSecS
conjugated with PLP is 2Z67.
RESULTS
Experimental outline
The MMPSepSecS protein was overproduced in E. coli,
then purified by two column chromatographic steps, and
crystallized. Using selenomethionine-labeled protein the
structure was solved by the MAD method. The complex of
SepSecS with covalently-bound PLP was refined to an
.Rfree of 26.9% at 2.5 A resolution.
In this first characterization of M. maripaludis SepSecS
(MMPSepSecS) activity, we used the genetic complementation of an E. coli AselA deletion strain as an in vivo test.
When grown anaerobically, E. coli produces the seleniumdependent formate dehydrogenase FDH H . Its activity

Overall structure of M. maripaludis SepSecS

In solution, SepSecS is a tetramer as revealed by gel
filtration (Figure 4E). The asymmetric unit of the crystal
contains four SepSecS molecules (chains A, B, C and D)
related by non-crystallographic symmetry, suggesting that
SepSecS forms a homotetramer (dimer of homodimers)
(Figure 4A). The four molecules are mostly identical, with
root mean square (RMS) deviations of about 0.5 A
between the subunits. The N-terminal extension domain
of each subunit plays a pivotal role in the tetrameric
organization of SepSecS. These domains interact with
each other to form a hydrophobic core (chain A with
chain D, and chain B with chain C), which involves
inward-facing hydrophobic residues protruding from the
helices, otl, 0(2 and cx4 (Figure 4B). Thus, the N-terminal
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Figure 1. The overall architectures of SepSecS and related enzymes.
(A) Stereo view of the MMPSepSecS structure. The N-terminal domain
(residues 1-130), the catalytic domain (residues 131-309), the linker
helix (310-352) and the C-terminal domain (residues 353^134) are
colored yellow, green, blue and pink, respectively. The carboxyterminal two residues are disordered. The PLP molecule bound to the
active site is shown as a ball and stick model. (B) Stereo view of the
AFSepCysS structure in the same orientation as (A) (18). The small
domain, the linker helices and the catalytic domain are colored pink,
blue and green, respectively. (C) Stereo view of the ECCsdB structure
in the same orientation as (A) (21). The coloring scheme is the same
as in (B).

extension facilitates tetramer formation and its deletion is
predicted to produce a dimeric SepSecS. Interestingly,
AFSepCysS (18) and ECCsdB (21) lack the N-terminal
extension domain and form dimers (Figure 4C and D).
We investigated whether SepSecS would be active in a
homodimeric form by assaying the enzymatic activity of
an MMPSepSecS protein that lacks the N-terminal
extension residues 1-34. The A1_34SepSecS enzyme did
not form Sec-tRNA Sec in vivo (Figure 5). It was not able to
rescue selenoprotein biosynthesis in our in vivo complementation test of the E.coli AselA deletion strain. Since the
active site of SepSecS, like other PLP enzymes, is formed
at the dimer interface it is clear that SepSecS would not
function as a monomer. Why the tetrameric organization
of SepSecS is critical for function remains unclear, but it is
possible that the quaternary structure of SepSecS is
important for tRNA recognition. In such a scenario,
when a tRNA acceptor stem is bound to the active site of

As in other Fold Type I PLP enzymes the active sites of
MMPSepSecS lie on the dimer interface with each
monomer contributing essential residues (20). The active
site of chain A is formed by chains A and B that both
recognize the PLP molecule (Figure 6). The catalytic
domain harbors a seven-stranded (3-sheet, with only the
sixth (3-strand being antiparallel; this is a common feature
of Fold Type I PLP enzymes (20,38) including
AFSepCysS (18) and ECCsdB (21). In the MMPSepSecS
structure, PLP is covalently bound via a Schiff base to the
strictly conserved Lys278 (chain A) (Figure 2), which is
located between the sixth and seventh (3 strand in the
active site (Figure 6A). Indeed, a Lys278Ala mutation
abolishes MMPSepSecS catalytic activity as shown both
in vivo by the lack of BV reduction by FDH H (Figure 5),
and in vitro by the inability of the Lys278Ala mutant to
form Cys-tRNA Sec (Figure 7).
All known Fold Type I PLP enzymes possess a critical
aspartate that contacts the Nl atom of the pyridine ring
(39), which is thought to further increase the electron sink
character of the PLP cofactor. SepSecS is an exception
to this paradigm, Asn247 is found in the corresponding position, and it forms a hydrogen bond with the
pyridinium nitrogen (Figure 6). The other 'nonconforming' enzyme is SepCysS where the structure also
reveals a similar Asn contact with PLP (18). The
replacement of Asn247 with the uncharged Ala247 yields
a partially active enzyme (Figures 5 and 7). The phosphate
moiety of Sep appears to be such a good leaving group
that the presence of an Asp or Asn residue is not required
for the catalytic activity of SepSecS.
The aromatic pyridine ring of PLP is sandwiched
between His 166 (chain A) and Ala249 (chain A) through
hydrophobic interactions at the bottom of the catalytic
site (Figure 6). This recognition mode is commonly
observed in the structures of Fold Type I PLP enzymes
where the His residue increases the electron sink character
of PLP's pyridine ring through the stacking interactions
with it and may also play a role in substrate activation and
acid base catalysis. In the latter case, the His residue
makes a direct hydrogen bond with the critical aspartate
that contacts the Nl atom of the coenzyme pyridine ring
in all Fold Type I PLP enzymes (see above discussion) and
is thus thought to assist in the dissipation of the negative
charge generated around PLP's ring during catalysis (40).
Furthermore, the phosphate moiety hydrogen bonds with
the main-chain amide and carbonyl groups of Glyl40 and
Serl68, respectively (Figure 6B). The MMPSepSecS
mutant Hisl66Ala was partially active in forming SectRNA Sec in vivo (Figure 5). In vitro, the Hisl66Ala
MMPSepSecS mutant was partially active in forming
Cys-tRNA Sec as can be seen by the increase in intensity of
the Cys-[32P]AMP spot and the concomitant decrease of
the Sep-[32P]AMP spot during the course of the reaction
(Figure 7B). Obviously, the mutant enzyme with Alal66
has PLP still in a partially functional position. A mutation
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Figure 2. Structure-based amino acid sequence alignment. The alignment includes representative SepSecS sequences from two archaea
(M. maripaludis and M. kandleri) and two eukaryotes (H. sapiens and T. thermophila) as well as A. fulgidus SepCysS, E. coli IscS and E. coli
CsdB. Amino acids are colored according to residue types, and strictly conserved residues are marked (*). The secondary structure of MMPSepSecS
is illustrated above the alignment, and the active site arginines are highlighted in blue. The autoimmune antigenic region of human SepSecS (37) and
a eukaryotic specific insertion are shown in gray boxes.
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Figure 3. Structural phylogeny of the Fold Type I PLP-dependent enzyme family. The phylogenetic tree depicts the evolutionary history of the Fold
Type I family. Branch lengths in the tree are proportional to structural differences between the members of the family according to the structural
similarity measure QH (see 'Materials and methods' section). The subfamily clusters are denoted by arced lines and under each subfamily name
(e.g. AT I) a representative enzyme name (e.g. aspartate aminotransferase) is given in parentheses. Isofunctional subfamilies are labeled only by their
corresponding enzyme names. Protein structures used to build the tree are noted according to PDB (46) or SCOP (47) codes.

of the corresponding His residue (position 143) in E. coli
aspartate aminotransferase also led to a functional enzyme
(40). In contrast, both the Hisl66Gln and Hisl66Phe
mutants were inactive in vivo (Figure 5). The lack of
enzymatic activity of the Hisl66Phe mutant implicates
His 166 in the catalytic mechanism and not only in
structural ring stacking interactions with the pyridine
ring of PLP. It is interesting to note that with the
exception of Plasmodium all known eukaryotic SepSecS
proteins contain Gin at a homologous position to 166 in
their sequences (Figure 2 and data not shown).
Since the catalytic pocket is formed in the dimerization
interface, chain B also contributes residues that participate
in PLP recognition. In particular, the guanidinium group
of Arg72 and the main-chain amide group of Arg307
(from chain B) hydrogen bond to the phosphate moiety of
PLP (Figure 6B). Mutations of Arg72 and Arg307 to Ala,
Gin or Lys resulted in MMPSepSecS mutants that were
significantly less active in Sec-tRNA Sec formation in vivo

(Figure 5) and Cys-tRNA Sec formation in vitro
(Figure 7C). We also show that the Arg72Gln mutant
enzyme is unable to form Sec-tRNASec in vitro
(Figure 7A).
Such PLP recognition differs from that of AFSepCysS
(18) and ECCsdB (21) (Figure 8). Unlike in the
MMPSepSecS structure, the adjacent subunit of
ECCsdB does not come close to the active site. In
ECCsdB, an additional Poc(3 structural motif covers the
active site, presumably to stabilize the PLP and Sec
substrates inside the pocket. This motif also precludes
interaction between residues from the neighboring subunit
and the active site (Figure 8D). Although the active site of
AFSepCysS is formed by residues from chains A and B,
the chain B amino acids are located too distant for PLP
recognition (Figure 8E). The active sites of MMPSepSecS
and AFSepCysS are spacious enough to accommodate the
O-phosphoseryl-CCA end of the tRNA Sec or tRNA Cys
species, respectively.
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Phosphoserine binding model

Figure 4. The oligomeric states of SepSecS and related enzymes.
(A) The overall architecture of the MMPSepSecS tetramer. Chains A
and B, and chains C and D form dimers, respectively. The PLP
molecules bound to each subunit are shown as ball and stick models.
Chain A, chain B, chain C and chain D are colored pink, blue, green
and yellow, respectively. (B) The N-terminal extension domains of
chains B and C form a hydrophobic core that stabilizes the tetrameric
state of MMPSepSecS. Three a-helices (cd,a2,a4) are labeled. Chains B
and C are colored blue and green, respectively. (C) Stereo view of the
AFSepCysS dimer in the same orientation as (A) (18). Chains A and B
are colored pink and blue, respectively. The PLP molecules are shown
as ball and stick models. (D) Stereo view of the ECCsdB dimer in the
same orientation as (A) (21). The coloring scheme and the PLP representation are the same as in (C). (E) Gel filtration of selenomethioninelabeled SepSecS on Sephacryl S-300. Absorbance at 280 nm is shown as
a blue line. The elution volumes of other oligomeric proteins are
indicated in the chromatogram. The molecular weight of the
MMPSepSecS monomer is 50kDa. MMPSepSecS eluted at the size
expected for a tetrameric species.

Our crystallization solution contained 10 mM magnesium
sulfate. In the present structure, a strong electron density
(4.5cr), presumably corresponding to a sulfate ion, was
observed adjacent to the PLP molecule of chains A and B
(Figure 8A). The sulfate ion is recognized by Arg94,
Ser95, Gin 102 and Arg307 of chain B (Figure 8A). The
structure of ECCsdB with Sec bound to the active site
(Figure 8D) was reported (21). Using the CE program (41)
we superposed the active site structure of MMPSepSecS
onto that of ECCsdB. This allowed modeling of Sec from
CsdB into the MMPSepSecS active site (Figure 8B). The
distance between the selenium atom of the modeled Sec
and the sulfur atom of the bound sulfate is 3.74 A. We
overlaid a Sep molecule on the position of the modeled Sec
in the active site. The phosphate moiety of this modeled
Sep overlapped with the bound sulfate, suggesting that
this sulfate mimics the phosphate moiety of Sep attached
to tRNA Sec . This allowed us to construct the Sep-binding
model of MMPSepSecS (Figure 8C). Mutations of Arg94,
Gin 102 and Arg307 residues that according to our
Sep-binding model recognize the phosphate moiety of
Sep significantly decreased the catalytic activity of
MMPSepSecS both in vivo (Figure 5) and in vitro
(Figure 7). While the distance of the Schiff base linkage
between the C4oc atom of PLP and the N£ atom of Lys278
is 1.74 A, the PLP C4oe atom is 2.19 A away from the
amino group of the modeled Sep; thus, the amino group of
Sep forms a Schiff base with PLP as a reaction
intermediate.
The active site
We should first note that the active site of MMPSepSecS
lacks a Cys residue. In contrast, the crystal structures of
ECCsdB (21) and of AFSepCysS (18) each possess a
cysteine-active site residue; Cys364 in ECCsdB and
Cys247 in AFSepCysS (Figure 8). As revealed by a
structural study (21), Cys364 of ECCsdB recognizes Sec
and withdraws its selenium to form perselenide as an
intermediate. Cys364 of ECCsdB resides in the Pa(3
structural motif which does not exist in MMPSepSecS.
On the other hand, Cys247 (from the neighboring subunit)
of AFSepCysS is the candidate residue that forms a

Figure 5. In vivo assays of SepSecS mutants. Formation of Sec-tRNA Sec in vivo is assayed by the ability of the wild-type MMPSepSecS and its
mutant variants (N-terminal deletion Al-34, R72A, R72Q, R72K, R94A, R94Q, H166A, H166F, H166Q, R307A, R307Q, R307K, Q102A, K278A,
N247A, D277A, K278A) to restore the BV reducing activity of the selenoprotein F D H H in the E.coli selA deletion strain JS1. Cotransformation of
the PSTK gene (indicated with + ) from M. jannaschii is required for the formation of the Sep-tRNA Sec intermediate.
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persulfide that is the sulfur source for enzyme-catalyzed
Cys-tRNA Cys formation (18). The absence of such a Cys
active site residue indicates that the reaction mechanisms
and chemistries of SepSecS are fundamentally different
from those of CsdB and SepCysS. Interestingly, SepSecS

has an active site arginine (Arg307) in a homologous
position to Cys247 in SepCysS (Figure 2).
The MMPSepSecS structure reveals three conserved
arginines (Arg72, Arg94 and Arg307) that are located in
proximity of each other and close to the active site; they
recognize the phosphate groups of PLP and presumably of
Sep acylated to tRNA Sec (Figures 2 and 8A-C). Mutations
of Arg72, Arg94 and Arg307 to Ala, Gin or Lys yielded
MMPSepSecS enzymes that were unable to form SectRNA Sec in vivo (Figure 5). Asp277 interacts electrostatically with Arg72, and the Asp277Ala enzyme was also
inactive in vivo (Figure 5). The Arg72Gln, Arg94Gln and
Arg307Gln MMPSepSecS mutants were inactive in
forming Cys-tRNA Sec in vitro (Figure 7). In addition to
the PLP-conjugated Lys278, Sep-binding arginines may
also facilitate general acid/base catalysis as was shown for
the tRNA modification enzyme TrmH where an arginine
activated by a phosphate group acts as a general base (42).
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SepSecS is a PLP enzyme catalyzing a (3-replacement
(Scheme 1), leading to the exchange of a phosphate group
for a selenol moiety. We were interested to see if SepSecS
might employ a perselenide intermediate during catalysis,
which would require the presence of an active site cysteine.
There are four moderately-to-highly conserved cysteine
residues in the SepSecS sequences, which are found in
35-97% of the SepSecSs. Three of these cysteines (Cysl46,
Cys214 and Cys237 in MMPSepSecS) are distant from the
active site and have no chance to contribute to catalysis.

N247

Figure 6. PLP recognition. Stereo views of (A) Ribbon representation
of the active site of MMPSepSecS in the dimer interface between chains
A and B that are colored pink and blue, respectively. The PLP
molecule is covalently bound to Lys278 of chain A. The F0—Fc omit
map of the PLP molecule, contoured at 3.5 a, is shown. (B) The amino
acid residues that recognize the PLP molecule. The residues of chains
A and B are colored pink and blue, respectively. The F0—Fc omit map
(contoured at 3.5 o~) of all of the residues and PLP is shown.
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Figure 7. In vitro conversion of Sep-tRNA Sec to Sec-tRNA Sec or Cys-tRNA Sec . (A) Phosphorimages of TLC separation of [14C]Sep and [MC]Sec
recovered from the aa-tRNAs of the SepSecS activity assay (see 'Materials and methods' section). Sec was analyzed in its oxidized form as
selenocysteic acid (Secya). Lane 1, Ser marker; lane 2, Sep marker; lane 3, Sep-tRNA Scc with wild-type MMPSepSecS; lane 4, Sep-tRNA Scc with the
R72Q MMPSepSecS mutant. (B) Representative phosphorimage for the H166A SepSecS mutant of the separation of Ser-[32P]AMP, Cys-[32P]AMP,
[32P]AMP and Sep-[32P]AMP. At the indicated time points aliquots of the SepSecS reaction were quenched, digested with nuclease PI and spotted
onto PEI-cellulose TLC plates as described in the 'Materials and methods' section. (C) Plot of Cys-tRNA Scc formed versus time with 1 uM of wildtype and mutant SepSecS enzymes using Sep-tRNA Sec (1 uM) and thiophosphate (500 uM) as substrates. Following quantification of the intensities of
Ser-[32P]AMP, Cys-[32P]AMP, [32P]AMP and Sep-[32P]AMP using ImageQuant, the concentration of Cys-tRNA 8 " formed at each time point was
calculated by dividing the intensity of the Cys-f P]AMP spot by the total intensity. The experiment was carried out in duplicate.
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The least conserved of these residues is a strictly conserved
proline (Pro 169) in the archaeal sequences, while the
residue is conserved as a cysteine in 78% of the eukaryotic
sequences. Interestingly, Pro 169 in MMPSepSecS is in the
active^ site and in close contact with the PLP moiety
(3.77 A at closest approach), which would then mean that
most eukaryotic SepSecSs have a cysteine adjacent to
the PLP. It is unclear whether the eukaryotic sequences
make use of this cysteine in catalysis; nevertheless, this
position is an intriguing candidate for mutagenesis in the
eukaryotic context.
Concerning the archaeal SepSecSs, there are no cysteine
residues that could be involved in the formation of a
catalytically important perselenide intermediate. In contrast, SepCysS is proposed to use a persulfide mechanism
(18). Thus, SepSecS and SepCysS, two related PLP
enzymes that perform chemically analogous tRNAdependent transformations of Sep to Sec or Cys,
respectively, proceed with different selenium and sulfur
transfer mechanisms. Based on the observed active site
residues we propose that the arginine residues, that bind
the phosphate groups of PLP and of Sep, also recruit the
selenium donor selenophosphate. In this context, Arg307
in the present structure resides at a similar position to that
of Cys364 in ECCsdB and of Cys247 in AFSepCysS.
Structural phylogeny of Fold Type I PLP enzymes

Figure 8. The active site. Close-up stereo views of the active site regions
in MMPSepSecS, ECCsdB, and AFSepCysS. Chains A and B are
colored pink and blue, respectively. The PLP molecule (shown as a ball
and stick model) is covalently bound to chain A. (A) The recognition
manner of the sulfate ion in the active site of MMPSepSecS. The
sulfate ion is shown as a ball-and-stick model. The F0—Fc omit map of
the sulfate ion, contoured at 4.5 a, is shown. (B) Sec docking model
of MMPSepSecS, based on the structural comparison with ECCsdB.
(C) Sep binding model of MMPSepSecS, based on the locations of the
sulfate ion and Sep. (D) Close-up view of the active site region in
ECCsdB. The PLP molecule is covalently bound to Lys226 of chain A.
The orientation of the PLP molecule is the same as that in (A).
The chain A residues that recognize PLP are shown. The PLP molecule
is covered by the (3a(3 structural motif. (E) Close-up view of the
active site region in AFSepCysS. The PLP molecule is covalently
bound to Lys209 of chain A. The orientation of PLP is the same as
that in (A). The chain A residues that recognize PLP and sulfate are
shown.

SepSecS belongs to the largest and most diverse family of
PLP-dependent enzymes found in nature. The evolutionary history of the Fold Type I PLP-dependent enzymes,
also referred to as the oc-family, has been studied in
detail with sequence-based phylogenetic methods (43). By
applying the family profile analysis (FPA) technique (44),
the authors were able to use sequence-based phylogenetics
to partially capture the distant evolutionary events
recorded in the sequences of the members of this family,
some of whom share only 5% sequence identity. However,
the low level of sequence similarity may lead to artifacts in
the tree reconstruction process. Since crystal structures for
most members of this protein family exist, we applied
the technique of structural phylogeny (45) to explore the
history of the Fold Type I family. This technique derives
phylogenetic information directly from three-dimensional
structures and thus allows an accurate reconstruction
of the most distantly detectable evolutionary events. Our
structural phylogeny (Figure 3) is largely in agreement
with the previous sequence-based work, but some
significant rearrangements in the tree can be seen. For
example, the DC I and DC II subfamilies coalesce into a
single subfamily according to structural similarity, and the
y-lyase and CYS groups are not one but two evolutionary
distinct subfamilies.
There are two kinds of subfamilies in the Fold Type I
group. The first type includes several proteins with distinct
but related functions, which may have descended from a
progenitor with a promiscuous enzymatic function.
Examples of these progenitor enzymes include the four
distinct aminotransferases (AT I-AT IV), an amino acid
decarboxylase (DC I/II), a persulfide forming cysteine
desulfurase/sulfhydrylase and finally separate (3- and
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y-amino acid lyases. Subsequent evolution in each of these
subfamilies ultimately produced the specific enzymatic
functions observed in modern PLP-dependent enzymes.
The second kind of subfamilies are those that include a
set of isofunctional enzymes. The modern enzymes in
these subfamilies trace back to ancestors that had already
evolved their modern enzymatic specificity in the initial
evolutionary radiation of the Fold Type I family. These
isofunctional subfamilies include serine hydroxymethyl
transferase, alliinase and an archaeal SelA-like protein
(MJ0158), which is of unknown function.
Importantly, the structural phylogeny allows the
accurate placement of SepSecS within its family tree and
reveals how this enzyme came into being. SepSecS is also a
founding member of the Fold Type I family. It shows no
specific relationship to any of the other subfamilies and
emerges near the root of its family tree. While SepCysS,
CsdB and IscS are part of a multifunctional subfamily
(CYS in Figure 8) and these proteins have chemically
similar substrates to SepSecS, there is no special relationship between SepSecS and the CYS subfamily. This result
indicates that SepSecS is truly an ancient enzyme, and thus
tRNA-dependent selenocysteine biosynthesis is a primordial process.
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Summary
Selenocysteine (Sec) is the 21st genetically encoded amino
acid found in organisms from all three domains of life. Sec biosynthesis is unique in that it always proceeds from an aminoacyl-tRNA precursor. Even though Sec biosynthesis in bacteria
was established almost two decades ago, only recently the pathway was elucidated in archaea and eukaryotes. While other
aspects of Sec biology have been reviewed previously (Allmang
and Krol, Biochimie 2006;88:1561-1571, Hatfield et al., Prog
Nucleic Acid Res Mol Biol 2006;81:97-142, Squires and Berry,
IUBMB Life 2008;60:232-235), here we review the biochemistry
and evolution of Sec biosynthesis and coding and show how the
knowledge of an archaeal cysteine biosynthesis pathway helped
to uncover the route to Sec formation in archaea and
eukaryotes. © 2008 IUBMB
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INTRODUCTION
Since its identification as an element, selenium was only famous for its toxicity to animals and plants. Yet in 1954 selenium was found to be required for formate dehydrogenase activity in bacteria (1) and its presence in glutathione peroxidase
was demonstrated in 1973 (2). The occurrence of selenocysteine (Sec) as the selenium moiety in naturally occurring proteins was first discovered in 1976 (3). Subsequent work docuReceived 22 July 2008; accepted 7 August 2008
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mented the necessity of Sec in additional bacterial and eukaryotic proteins (4). Later Sec was identified as the catalytic
residue in the active site of glutathione peroxidase in 1978 (5).
Without the extensive genomic data on hand today the authors
already concluded that "it is highly unlikely that Se-Cys is
incorporated specifically via normal transcription and translation" (5).
Although later it was shown that Sec corresponds to certain
UGA codons (6), the final proof that Sec is a cotranslationally
incorporated amino acid came when the tRNA Scc in Escherichia coli was identified in 1988 (7). Many of the basic questions in this area (8) were addressed in the following years,
including elucidation of Sec biosynthesis and encoding in bacteria. There are several special requirements for Sec encoding
to occur: a PLP-dependent selenocysteine synthase (SelA) that
catalyzes the conversion of Ser-tRNASec to Sec-tRNAScc (9,
10) (Fig. IB), an mRNA secondary structure element (SECIS)
{11), an elongation factor (SelB) specific for Sec-tRNAScc (12,
13), and an enzyme (SelD) the produces selenophosphate (14).
Even though the counterparts of SelB, SelD, and SECIS have
all been found in archaea and eukaryotes (15, 16), the mechanism of Sec biosynthesis, however, remained unclear until
2006.

RNA-DEPENDENT CYSTEINE BIOSYNTHESIS
IN ARCHAEA
Cysteine (Cys) biosynthesis is one of the critical metabolic
processes. The two well-known Cys biosynthesis pathways are
the sulfur assimilation pathway, which is the sole route of making cysteine in most bacteria, all known plants, and at least one
fungus; and the trans-sulfuration pathway, which is present in
most fungi, nematodes, and vertebrates. In both cases Cys is
synthesized through multiple enzymatic steps, one of which is
catalyzed by a pyridoxal-phosphate (PLP)-dependent enzyme.
Following its synthesis, Cys is charged to tRNA Cys by cys-
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Figure 1. A: Cys-tRNA Cys formation via the archaeal route, O-phosphoseryl-tRNA synthetase (SepRS) forms the intermediate SeptRNA Cys and the PLP-dependent enzyme Sep-tRNA:Cys-tRNA synthetase (SepCysS) catalyzes formation of the cognate pair CystRNA Cys . B: In bacterial selenocysteine biosynthesis, SelA catalyzes the direct formation of Sec-tRNASec from Ser-tRNAScc, which
is produced by seryl-tRNA synthetase (SerRS). C: Like Cys-tRNA formation in archaea, the archaeal and eukaryotic route for SectRNA synthesis utilizes a Sep-tRNA Scc intermediate produced by phosphoseryl-tRNAScc kinase (PSTK) and the PLP-dependent
enzyme Sep-tRNA:Sec-tRNA synthetase (SepSecS) gives Sec-tRNA Sec . The initial substrate, Ser-tRNASec, is generated by SerRS.

teinyl-tRNA synthetase (CysRS) to make Cys-tRNA Cys , which
then enters ribosomal translation.
When the genomes of some methanogenic archaea, including
Methanocaldococcus
jannaschii
(17),
Methanothermobacter
thermautotrophicus (18), and Methanopyrus kandleri (19), were
sequenced, cysS was not found. It was believed then that CysRS
was present but not yet identified. Thus much effort was applied
in finding this mysterious CysRS. Two proteins, ProRS (20, 21)
and MJ1477 (22), were proposed to be the missing CysRS
based on in vitro charging experiments and in vivo complementation of an E. coli cysS mutant strain. Later findings placed the
complementation data into a different light because the strain
retained low CysRS activity (23). In addition, some of these
methanogens lacked recognizable cysteine biosynthesis genes
(24).
In 2005, the mystery was finally solved. By purification
coupled with enzymatic assays, our group identified two proteins in Methanocaldococcus jannaschii that work together to
make Cys-tRNA Cys (25). The first protein (a class II tRNA synthetase) ligates activated phosphoserine (Sep) onto tRNA Cys ,

while the second protein is a PLP-dependent enzyme that converts Sep-tRNACys to Cys-tRNA Cys (Fig. 1A). These two proteins were thus named O-phosphoseryl-tRNA synthetase
(SepRS) and Sep-tRNA:Cys-tRNA synthase (SepCysS). Deletion of SepRS in Methanococcus maripaludis yielded a cysteine
auxotroph, indicating that the RNA-dependent Cys-tRNA Cys
synthesis pathway is the sole route for Cys biosynthesis in
Methanococcus maripaludis.
SepCysS belongs to the fold Type I PLP-dependent enzyme
family, more specifically, the cysteine desulfurase subfamily,
based on sequence and structure comparisons (26, 27). With sodium sulfide present, SepCysS catalyzes the sulfuration of the
phosphoserine moiety of Sep-tRNA Cys . The natural sulfur donor
in this reaction remains unknown. Cysteine desulfurase catalyzes the removal of S or Se from Cys or Sec, utilizing a conserved Cys residue to form a persulfide or perselenide, respectively. These S or Se relay mechanisms in related proteins may
also operate in SepCysS, which contains several conserved Cys
residues in the vicinity of the active site (26, 27), some which
are required for its activity (unpublished data, (26, 27)).

SELENOCYSTEINE BIOSYNTHESIS IN HUMANS

SEP-tRNA IS AN INTERMEDIATE IN SEC
BIOSYNTHESIS IN EUKARYOTES AND ARCHAEA
As early as 1964, Sep-tRNA was found in chicken liver (28).
Later studies confirmed this finding (29) and suggested that SeptRNA was formed by phosphorylation of Ser-tRNA, not by direct
acylation of phosphoserine onto tRNA (30). In 1981, RNA
sequencing showed that the Sep moiety was carried by a putative
suppressor tRNA Ser (31), which was later identified as tRNA Sec
(32). Following the landmark discovery of E. coli tRNA Sec in
1988 (7), it was speculated that Sep-tRNA might be an intermediate in Sec-tRNAScc formation (8). In vitro synthesis of glutathione peroxidase in mouse extracts suggested that this was the case
(33). However, the successful identification and characterization
of E. coli SelA, the selenocysteine synthase that catalyzes SectRNA Sec formation directly from Ser-tRNASec (Fig. IB), showed
that the bacterial pathway does not involve Sep-tRNA (10). This
result may have influenced the interpretation of another study of
mammalian Sec-tRNA synthesis that concluded that the mammalian mechanism does not proceed through Sep-tRNA, and is similar to that in E. coli (34).
During the next decade little progress was made concerning
Sec-tRNA Sec formation in eukaryotes and archaea. A SelA-like
protein from M. jannaschii was investigated and even crystallized, but then shown to lack the hypothesized Sec synthase activity (35). As more genomic data became available, an in silico
search first identified a kinase that was only present in Secdecoding archaea (36). In vitro characterization of the mouse
enzyme, now called phosphoseryl-tRNA Scc kinase (PSTK),
showed that it converted Ser-tRNA Scc to Sep-tRNA Sec in an
ATP and Mg 2+ -dependent reaction (36). Yet the description of
this important enzyme did not resolve mammalian Sec formation, but deferred to future studies (36). However, the Sep moiety was again implicated as an intermediate in Sec synthesis,
when the two-step tRNA-dependent Cys biosynthesis pathway
(Fig. 1A) in archaea was discovered (25); the need for SeptRNA*^, the required precursor for Cys-tRNA Cys formation,
suggested that a similar mechanism may exist for Sec-tRNA Scc
formation in archaea and eukaryotes (25).
Given the chemical similarity between Cys and Sec, the
reaction from Sep-tRNA to Sec-tRNA seemed plausible, and
a single PLP-dependent enzyme could catalyze such a reaction. The soluble liver antigen/liver pancreas antigen (SLA/
LP) protein had long been suspected to be the missing Sec
synthase. SLA/LP coprecipitated with Sec-tRNA Sec by autoantibodies from autoimmune chronic hepatitis patients (37).
Although by the year 2000, the cDNA sequence of SLA/LP
was available (38, 39), workers in the field could only conclude that SLA/LP might be the Sec-tRNA synthase, a human
analog of the translation factor SelB, or perhaps a seleniumtRNA protecting factor (37-39). In the following year, using
a fold recognition algorithm, a bioinformatics analysis was
able to correctly classify SLA/LP as a PLP-dependent enzyme
and the group predicted its involvement in Sec-tRNA synthesis (40).
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Archaeal cysteine biosynthesis provided the conceptual
template for Sec-tRNA formation in archaea and eukaryotes,
and it quickly became clear that these two domains of life
share a homologous mechanism for Sec-tRNA formation that
was inherited from their distant common ancestor. Using an
in vivo complementation assay, we showed that SLA/LP is responsible for Sec-tRNA Scc formation (41). When grown under
anaerobic atmosphere E. coli produces the selenoprotein formate dehydrogenase, which reduces benzyl viologen in the
medium in the presence of formate. Reduced benzyl viologen
is clearly visible due to its purple color and can be used to
monitor selenoprotein biosynthesis inside E. coli cells. We
complemented a selA deletion strain of E. coli with archaeal
PSTK, with archaeal SLA/LP, or with both proteins, and
monitored the formate dehydrogenase activity. Only when
both PSTK and SLA/LP were present, the formate dehydrogenase activity was recovered from the AselA E. coli cells,
indicating that PSTK and SLA/LP constituted a two-step pathway to make selenocysteine. Metabolic labeling of the same
cells with Se supported the result, showing 75 Se incorporation into proteins only in the presence of both PSTK and
SLA/LP. These data established that the archaeal SLA/LP,
which was appropriately renamed Sep-tRNA: Sec-tRNA synthase (SepSecS), converts Sep-tRNA Scc to Sec-tRNA Scc (41).
Having established the archaeal system, we then tested the
mammalian SLA/LP protein. The human SLA/LP displayed
similar results in both the benzyl viologen and the 75 Se labeling assays, showing that mammals and archaea share a common mechanism for Sec biosynthesis. In vitro assays, both in
our laboratory (41) and independently by another group (42),
showed that SepSecS is responsible for the final step of SectRNA Sec formation.
Recently it was established that SepSecS is in the same
enzyme family as SepCysS (27, 41, 42) through phylogenetic
analyses based on both its sequence and structure from mouse
(43) and archaea (41), revealing an evolutionary linkage
between the tRNA-dependent Cys and Sec formation.

SEC ENCODING WAS AN ANCIENT BUT "LATE"
ADDITION TO THE GENETIC CODE
The discovery of Sec argues against components of two of
Crick's famous hypotheses: the wobble hypothesis (44) and the
"frozen accident" theory (45). Crick maintained that the wobble
hypothesis "does not permit UGA to code for any amino acid
other than cysteine or tryptophan." While Cys and Sec are
chemically similar, they are not universally interchangeable.
The substitution of Cys for Sec at a critical active site location
can have a severe effect on catalytic efficiency (46, 47). The
"frozen accident" theory states that "the code is universal
because at the present time any change would be lethal, or at
least very strongly selected against." If Sec encoding emerged
before the code was "frozen," then the code obviously has
never been "frozen" because it was shown that Sec decoding
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was later lost in certain organisms (48); if Sec encoding
emerged after the "freezing" of the genetic code, then the code
was not "frozen" per se. Our understanding of Sec evolution
based on phylogenetic data (27, 41, 49-52), indicates that the
genetic code expanded to include Sec at the time of the last universal common ancestor and was then independently lost in
many lineages during evolution.
Among the 22 known ribosome-incorporated amino acids,
including pyrrolysine, only Sec lacks its own aminoacyl-tRNA
synthase. A SecRS has apparently never evolved (and perhaps
never will) because typical protein substrate recognition, which
depends on distinct differences between the shape and charge of
cognate versus noncognate substrates, cannot differentiate Cys
from Sec (53, 54). The indirect route for Sec-tRNA formation
evolved, therefore, to ensure that critical Sec codons were read
with an exceedingly high fidelity by eliminating or minimizing
the possibility that Cys-tRNA Scc would be formed. Similarly,
since CysRS cannot discriminate Sec from Cys and can easily
form Sec-tRNA Cys , the presence of excessive free selenocysteine might be unfavorable for positions in the peptide chain
that require Cys instead of Sec. The Sec codon has a dual
meaning (also functioning as a stop codon), so the special translational components (SelB, SECIS) evolved to ensure that translation did not stop at Sec codons and that it terminated properly
in response to UGA stop codons.
Although Sec encoding is ancient, the evolution of the
genetic code is yet an older event; the biochemical and phylogenetic data indicate that Sec was a late addition to the code.
For the reasons mentioned above, it seems clear that Sec was
introduced only after UGA had acquired the termination meaning and possibly after Cys was added to the code. The additional coding machinery for Sec hints that Sec decoding represents a complication or addition to a pre-existing, simpler coding process—such as that applied to the 20 canonical amino
acids.
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The micronutrient selenium is found in proteins as selenocysteine
(Sec), the 21st amino acid cotranslationally inserted in response to
a UGA codon. In vitro studies in archaea and mouse showed that
Sec-tRNASec formation is a 3-step process starting with serylation
of tRNASec by seryl-tRNA synthetase (SerRS), phosphorylation of
serine to form phosphoserine (Sep)-tRNASec by phosphoseryltRNASec kinase (PSTK), and conversion to Sec-tRNASec by SeptRNA:Sec-tRNA synthase (SepSecS). However, a complete study of
eukaryotic selenoprotein synthesis has been lacking. Here, we
present an analysis of Sec-tRNASec formation in the parasitic
protozoon Trypanosoma brucei in vivo. Null mutants of either PSTK
or SepSecS abolished selenoprotein synthesis, demonstrating the
essentiality of both enzymes for Sec-tRNASec formation. Growth of
the 2 knockout strains was not impaired; thus, unlike mammals,
trypanosomes do not require selenoproteins for viability. Analysis
of conditional RNAi strains showed that SerRS, selenophosphate
synthase, and the Sec-specific elongation factor, EFSec, are also
essential for selenoprotein synthesis. These results with T. brucei
imply that eukaryotes have a single pathway of Sec-tRNASec
synthesis that requires Sep-tRNASec as an intermediate.
phosphoseryl-tRNASec kinase | selenocysteine tRNA |
Sep-tRNA:Sec-tRNA synthase | Trypanosoma brucei | selenoprotein

S

elenium is an essential dietary trace element. It is present in
proteins as selenocysteine (Sec), a cotranslationally-inserted
amino acid encoded by UGA. Sec is not attached directly to
tRNA Sec , but is formed by the tRNA-dependent conversion of
serine (reviewed in refs. 1-4). In the first step tRNA Scc is
misacylated by seryl-tRNA synthetase (SerRS). The subsequent
conversion to Sec proceeds by 2 different pathways in nature. In
bacteria Ser-tRNA Set is directly transformed to Sec-tRNA Sec in
a pyridoxal-5'-phosphate-dependent reaction by Sec synthase,
the selA gene product (5). Archaea and eukaryotes require an
additional step, the formation of the intermediate phosphoserine (Sep) by phosphoseryl-tRNA Scc kinase (PSTK). The
resultant Sep-tRNA Sec is then converted into the Sec-tRNA Sec by
the pyridoxal-5'-phosphate-dependent enzyme Sep-tRNA:SectRNA synthase (SepSecS) (6, 7). The Se donor for this reaction,
selenophosphate, is synthesized by selenophosphate synthase
(SPS2) (8). Then EFSec, the tRNASec-specific elongation factor,
carries the Sec-tRNA Sec to the ribosome (9) where a translational recoding process allows UGA to be read as Sec (Fig. 1).
Selenoproteins are found in organisms from all 3 domains of life.
Humans have 25 selenoproteins, many of them are essential for
organismal viability (10). Some selenoproteins are predicted to
be redox proteins containing catalytic Sec residues (e.g., glutathione peroxidase or thioredoxin reductase).
Most of our knowledge of eukaryotic Sec-tRNA Sec formation
comes from in vitro reconstitution experiments using components of mammalian cells (7). In vivo formation of eukaryotic
Sec-tRNA Scc has been addressed in a study that showed that
RNAi-mediated ablation of SepSecS in mammalian cells did not
completely abolish selenoprotein expression (11). Thus, the
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existence of an alternative SepSecS-independent pathway for
Sec-tRNA Sec formation could not be excluded. Moreover, the in
vivo role of PSTK has not yet been analyzed.
Here, we present a comprehensive analysis of the in vivo role
of the 5 major proteins required for eukaryotic Sec-tRNA Sec
formation and function. The study was done in the insect form
of the parasitic protozoon Trypanosoma brucei as double allelic
KO cell lines can easily be produced in this system by homologous recombination-directed gene replacements (12). Because
T. brucei is diploid, double KO cell lines are null mutants in both
alleles. Furthermore, RNAi-based methods for highly efficient
inducible ablation of proteins are also available (13). Moreover,
T. brucei is an excellent model for exploring eukaryotic diversity.
It represents a different branch of the eukaryotic evolutionary
tree than the phylogenetically more closely related classical
model organisms (e.g., mouse, Drosophila, Caenorhabitits
elegans, and yeast) (14).
Results

7". brucei Components Involved in Selenoprotein Formation. A bioinformatic analysis of the T. brucei genome predicts 3 selenoproteins. They include distant homologs of mammalian SelK and
SelT and a selenoprotein, termed SelTryp, that is specific for the
kinetoplastid line (15). Moreover, in silico screens by several
groups have identified Tb-tRNA Scc , Tb-SerRS, Tb-PSTK, TbSepSecS, Tb-SPS2, and Tb-EFSec, the trypanosomal orthologues of essentially all major components of the Sec-inserting
system (16). However, of these only Tb-SerRS, Tb-tRNA Sec
(16-18), and Tb-SPS2 (19) have been subject to preliminary
experimental analyses.
To analyze the Sec-tRNA Sec formation pathway in vivo and
establish its physiological importance for T. brucei vie. used RNAi
cell lines allowing inducible ablation of Tb-SerRS, Tb-SPS2, and
Tb-EFSec. Moreover, we prepared KO cell lines that lack either
Tb-PSTK or Tb-SepSecS, the 2 core components of the eukaryotic Sec-tRNA Sec formation pathway (Fig. SI). All cell lines were
analyzed for selenoprotein synthesis by labeling with radioactive
75
Se (Fig. 2). The Tb-SerRS-RNAi cell line had been analyzed
before by other methods, and it was shown that Tb-SerRS
activity is required to charge the Tb-tRNA Sec with serine (18).
Labeling of uninduced Tb-SerRS-RNAi cells with 75Se and
subsequent analysis by Tris-Tricine polyacrylamide gels revealed
3 bands whose molecular mass are consistent with the 3 predicted trypanosomal selenoproteins SelK, SelT, and SelTryp
(Fig. 2A). SelTryp migrated in some experiments slightly faster
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than expected (Fig. 2 B and C). We do not know why but the
simplest explanation is proteolytic clipping during sample preparation, which could also account for the simultaneous presence
of both bands as seen in Fig. 2B, lane 2d.
Induction of Tb-SerRS-RNAi causes, in line with the role of
SerRS in serylation of tRNA Sec , an efficient but incomplete
reduction of the selenoprotein labeling (Fig. 24). This finding is
in contrast to the Tb-PSTK KO and Tb-SepSecS KO cell lines in
which the labeling of the 3 selenoproteins was abolished (Fig.
2B). Moreover, tetracycline-inducible ectopic expression of Tb-

SepSecS in the Tb-SepSecS KO cell line restored 75Se labeling
of all 3 proteins. In the case of SelTryp and SelT the restoration
was to wild-type level, whereas in the case of SelK the complementation was not quantitative. These experiments show that
both Tb-PSTK and Tb-SepSecS are indispensable for selenoprotein synthesis.
Next, we isolated and analyzed aminoacylated tRNAs from
the different cell lines by acid urea polyacrylamide electrophoresis (Fig. 2E) (20). This technique allows the separation of the
faster-migrating Sep-tRNA Sec from the slower-migrating Ser-

SelTryp
89 kDa "

SelT
28.8 kDa
SelK
9.5 kDa"
Coomassie

Ser/Sec-tRNASec
Sep-tRNA
Fig. 2. Selenoprotein expression in various T. brucei cell lines. Expression was analyzed by 75Se labeling of living cells and subsequent analysis of the labeled
proteins by 10-20% polyacryamide Tris-Tricine gels. The following cell lines were analyzed. (A) Uninduced and induced Tb-SerRS-RNAi cells. (6) WT427 cells,
Tb-PSTK KO cells (Tb-PSTK-/-), Tb-SepSecS KO cells (Tb-SepSecS-/-), and a Tb-SepSecS KO cell line allowing inducible ectopic expression of Tb-SepSecS
(Tb-SepSecS - / - complem.). ( 0 Uninduced and induced Tb-SPS2-RNAi cells. (D) Uninduced and induced Tb-EFSec-RNAi cells. For the RNAi and the complemented
Tb-SepSecS - / - cell lines days of induction (d) by tetracycline are indicated. The putative identity of the 3 labeled selenoproteins and their molecular mass as
predicted insilico are indicated on the left. Molecular mass markers are indicated on the right. Segments of the tubulin region (=50-80 kDa) of the corresponding
Coomassie-stained gels are shown as loading controls, (f) Total RNA isolated for the cell lines analyzed in 6 and a Tb-SepSecS KO line capable of RNAi-mediated
ablation of Tb-PSTK (Tb-SepSecS -/-:Tb-PSTK RNAi) was separated on a long acidic urea gel and analyzed for the presence of the different forms of tRNASec by
Northern analysis (18). The positions of the Sep-tRNASec and the comigrating Ser/Sec-tRNASec are indicated.
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Fig. 3. Trypanosoma! selenoproteins are not essential. (A) Representative growth curves in standard culture medium SDM-79 of uninduced and induced (-Tet,
+Tet) clonal RNAi cell lines for Tb-SerRS (redrawn from ref. 18), Tb-SPS2, and Tb-EFSec. The Northern blots verifying mRNA ablation are indicated for the cell
lines not showing a growth arrest, (fi) (Left) Comparisons of doubling times of the Tb-PSTK KO cell line (Tb-PSTK-/-) and the parent WT strain 427 (WT). (Right)
Comparisons of doubling times of the Tb-SepSecS KO cell line (Tb-SepSecS-/-) and the corresponding cell line allowing tetracycline-dependent ectopic
Tb-SepSecS expression (SepSec - / - plus or minus complem.). The parent cell line for the Tb-SepSecS KO strain is T. bruce/29-13 that has a longer doubling time
than T. brucei 427. Standard errors (n = 6) are indicated.

tRNA Sec and Sec-tRNA Sec species. Distinction between the
latter 2 species is not possible as they comigrate. The Northern
blot analysis in Fig. 2E shows 2 tRNA Sec bands in wild-type cells.
The lower one corresponds to Sep-tRNA Sec and the upper
corresponds to Sec-tRNA Sec (as inferred from the pattern
observed in the PSTK and SepSecS KO cell lines). In the
Tb-PSTK KO cell line only the upper band is detected, which
most likely represents the Ser-tRNA Sec form, because this species is expected to accumulate in the absence of PSTK activity
(see Fig. 1). In the Tb-SepSecS-KO cell line, however, only the
Sep-tRNA Sec band is detected. Moreover, if Tb-PSTK is depleted by inducible RNAi in the Tb-SepSecS-KO cell line, a
time-dependent partial recovery of the upper band is observed,
which indicates that Ser-tRNA Sec accumulates as would be
expected in the absence of both PSTK and SepSecS. Moreover,
the upper band, which is absent in the KO cells, reappears if the
KO cell line is complemented by inducible ectopic expression of
Tb-SepSecS. Thus, the accumulation of distinct intermediates of
the Sec-tRNA Set synthesis pathway in the 2 KO cell lines
together with the 75Se-labeling experiments show that the TbPSTK and Tb-SepSecS act sequentially in the indicated order
(Fig. 1).
SPS2 generates selenophosphate, the Se donor required by
SepSecS. Mammalian SPS2, which itself is a selenoprotein, is
essential for selenoprotein synthesis in vivo (8). Tb-SPS2 an SPS2
orthologue capable of complementing SelA-deficient Escherichia coli has been identified in trypanosomatids (19). Like the
E. coli orthologue, but in contrast to its mammalian counterpart,
Tb-SPS2 is not a selenoprotein. Fig. 2C shows that RNAimediated ablation of the Tb-SPS2 severely impairs selenoprotein
synthesis, indicating that SPS2 (with a cysteine in place of the
Sec) is catalytically active in trypanosomes. Surprisingly, even
before the induction of RNAi we reproducibly see labeling of
SelTryp and SelT but not of SelK. It is possible that the
SPS2-RNAi cell line is leaky and that even in the absence of
tetracycline a fraction of the SPS2 mRNA is partially downregulated. If SelK labeling is more sensitive to SPS2 levels than
labeling of the other 2 trypanosomal selenoproteins its absence
could be explained. Indeed selenium labeling of SelK shows a
larger variation in the different cell lines than that of the other
2 selenoproteins, indicating that it might be quite sensitive to
small changes of the labeling conditions (compare Fig. 2A, lane
0 with Fig. IB, lane WT). However, without further experiments
this explanation must remain speculative at present.
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Sec-tRNA Sec is an elongator tRNA; however, it does not
interact with elongation factor la but requires its own elongation
factor, EFSec. Consequently, ablation of Tb-EFSec by RNAi
essentially abolishes selenoprotein synthesis (Fig. 2D).
Selenoprotein Synthesis in T. brucei Is Not Essential. Selenoproteins
are found in all 3 domains, indicating that they were acquired
early in the evolution of life (4). However, in all domains there
are many species that then lost the Sec-inserting system (e.g.,
fungi and plants), which raises the question of whether organisms
that possess a Sec-inserting system require selenoproteins for
viability. Clearly, this is the case in mammals, because a tRNA Sec
KO mouse has an embryonic lethal phenotype (21). In other
systems, however, this question has not been rigorously addressed. With our T. brucei cell lines described above we now can
ask whether selenoproteins are essential for this unicellular
eukaryote. Therefore, we analyzed the effects RNAi-mediated
ablation of Tb-SerRS, Tb-SPS2, and Tb-EFSec (Fig. 3/4) and the
effects the complete lack of Tb-PSTK and Tb-SepSecS (Fig. 3B)
have on T. brucei growth. Ablation of Tb-SerRS caused a growth
arrest, which can be explained by the down-regulation of SertRNA Ser levels with concomitant reduction and cessation of
protein synthesis (18). Growth of all other RNAi and KO cell
lines was not or only marginally impaired. For the RNAi cell lines
this is not very informative because of the possible residual
activity of the ablated enzymes. However, the normal growth of
the Tb-PSTK and Tb-SepSecS double KO cell lines clearly
demonstrates that T. brucei does not depend on selenoproteins.
Conserved Sec-tRNASec Formation in Eukaryotes and Archaea. When
grown anaerobically E. coli produces selenium-dependent formate dehydrogenase (FDH). Its activity can easily be visualized
on plates overlaid with benzyl viologen, because in the presence
of formate active FDH reduces benzyl viologen to a blue
substance (22). Using this assay it was shown that an E. coli selA
deletion strain could be rescued by coexpression of archaeal
PSTK and human or archaeal SepSecS (6). We extended these
studies and showed that Tb-PSTK in combination with either
endogenous T. brucei SepSecS or the corresponding archaeal or
human enzymes reconstitute selenoprotein synthesis in an E. coli
selA deletion strain (Fig. 4). Likewise, archaeal PSTK and
Tb-SepSecS also restored FDH activity in the special E. coli
strain. Taken together, these results underscore the highly
Aeby et al.

Fig. 4. Expression of SepSecS together with PSTK restores FDH activity in an
anaerobically-grown E. coli selA deletion strain. The indicated genes of the
following organisms were tested: T. brucei (Tb-PSTK, Tb-SepSecS), the
Archeaon Methanocaldococcus jannaschii (Mj-PSTK, Mj-SepSecS), and humans (Hs-SepSecS).

conserved nature of the PSTK/SepSecS pathway of Sec-tRNA Sec
formation in Archaea and eukaryotes.
Discussion

In vitro experiments indicate that PSTK and SepSecS are the
core components for Sec biosynthesis in eukaryotes (6, 7).
However, the in vivo analysis of Sec-tRNA Sec formation in
eukaryotes has been hampered by the lack of a suitable system.
Here, we have used T. brucei to produce KO cell lines for the
trypanosomal orthologues of PSTK and SepSecS. Analysis of
these cell lines has shown that formation of Sec-tRNA Sec in living
T. brucei requires the sequential action of Tb-PSTK and TbSepSecS. It remains unknown why eukaryotes use the additional
phosphorylation step and thus require 2 enzymes, even though
direct conversion of Ser-tRNA Sec to Sec-tRNA Sec is possible, as
exemplified in bacteria (5).
Our results also show that no alternative pathway for SectRNA Sec formation exists that is independent of Tb-SepSecS and
Tb-PSTK. Interestingly, RNAi-mediated ablation of SepSecS
had only a marginal effect on mammalian selenoprotein synthesis (11). However, the results obtained in T. brucei might not be
readily comparable with the study in mammalian cells for the
following reason. In T. brucei selenoprotein synthesis was assayed in a double KO cell line completely devoid of Tb-SepSecS,
whereas in mammalian cells the analysis might have been
obscured by the fact that RNAi cannot be relied on to completely
deplete protein levels. Thus, it is likely that even in mammalian
cells, just as in T. brucei, only a single pathway for Sec-tRNA Sec
formation is operational.
Insect-stage T. brucei lacking selenoproteins grew as well as
wild type in standard medium SDM-79, which shows that normal
growth of T. brucei does not require selenoproteins and indicates
that neither Tb-PSTK nor Tb-SepSecS have a second essential
role that is unlinked to Sec-tRNA Sec formation. The unimpaired
growth of selenoprotein-lacking T. brucei was unexpected, because it had been reported that both insect- and bloodstreamAeby et al.

stage T. brucei cells were sensitive to nanomolar concentrations
of auranofin, a compound suggested to inactivate selenoproteins
(15). T. brucei is the causative agent of human sleeping sickness.
Based on the reported auranofin experiments it was proposed
that selenoprotein synthesis might be a novel target for development of an antiparasitic drug (15). Because auranofin interacts with selenol and thiol groups (23), we suggest that auranofin-induced cell death might have been caused by the drug's
interaction with thiols. All of our experiments were carried out
in insect-stage T. brucei cells; therefore it is still possible that Sec
is essential in T. brucei bloodstream forms, but it seems unlikely
because all 3 predicted selenoproteins are already expressed in
the insect-stage form. Thus, the prospect of using the pathway of
Sec or selenoprotein synthesis as drug targets against T. brucei
is questionable. However, because T. brucei in its normal habitat
adapts to situations and environments that are difficult to
reproduce in the laboratory, selenoproteins may play a role
under such conditions.
In summary, this work illustrates that T. brucei is an experimentally highly-tractable system for examining the in vivo
formation of eukaryotic Sec-tRNA Sec . Our analysis revealed the
presence of a single pathway for Sec-tRNA Sec synthesis involving
SerRS, PSTK, and SepSecS and strengthens the notion that all
eukaryotes have only a single route to Sec. Furthermore, we
show that selenoproteins are dispensable for insect-stage T.
brucei under standard growth conditions.
Materials and Methods
Cell Culture. Procyclic T. brucei, strain 427 and strain 29-13, and the corresponding transgenic cell lines were grown at 27 °C in SDM-79 (24) supplemented with 5% and 15% FCS, respectively.
Transgenic Cell Lines. RNAi cell lines were produced by using pLew-100-based
stem loop constructs containing the puromycin resistance gene (25-27). As inserts
we used a 451-bp fragment (nucleotides 181-632) for the Tb-SPS2 gene and a
528-bp fragment of the Tb-EFSec gene (nucleotides 1-528). Production and initial
characterization of Tb-SerRS RNAi cell line has been described (18). The double
allelic replacements of the Tb-PSTK gene, in T. brucei 427, and of the Tb-SepSecS
gene, in T. brucei 29-13, are described in Fig.SL Inducible ectopic expression of
Tb-SepSecS was done by using pLew-100 carrying the phleomycin resistance gene
(25). Transfection, selection of transformants, and production of clonal cell lines
were done by using standard procedures as described (12).
"Selenium Labeling. A total of 5 x 107 cells was resuspended in 0.5 mL of
FCS-supplemented SDM-79. The cultures were labeled with 9.6 ^,Ci of Hepesneutralized [75Se] selenite (University of Missouri Research Reactor, Columbia)
in the presence of 100 ng/mL cysteine at 27 °C for 3 h (forthe KO strains) or 1 h
(for the RNAi cell lines). After the labeling, the culture was washed with PBS,
and the resulting pellet was resuspended in sample buffer and heated to
100 °C for 10 min. Finally, the labeled proteins (=»107 cell equivalents) were
analyzed on 10-20% Tris-tricine gels (Ready gel; Bio-Rad) and visualized with
a phosphoimager.
Acid Gel Analysis of tRNASK Population. Total RNA was isolated as described
(29) and resupended in 10 mM Na-acetate, pH 4. Isolated RNA corresponding
to 8 x 106 cell equivalents was run on a 50-cm-long acidic sequencing gel as
described (20). The gel was run at 4 °C in 0.1 M Na-acetate, pH 5 until the
xylene blue front migrated to «=28 cm from the top. The section of the gel
containing the RNA was blotted to a Genescreen plus membrane and analyzed
by Northern blots using oligonucleotide hybridization as described (28).
Benzyl Viologen Assay for Active FDH. Benzyl viologen-dependent FDH assays
were performed as described (6). The PSTK and SepSecS genes of the different
species were cloned into the pACYCDuet-1 and pET15b expression vectors
(Novagen), respectively. In strains expressing only 1 gene, the corresponding
empty plasmid was cotransformed as a control.
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Sec is UGA, which is normally a translational
stop signal (/). During translation of selenoprotein mRNAs, UGA is recoded by the interaction
of a specialized elongation factor, SelB in bacteria
and EFsec in humans, with a downstream Secinsertion sequence element that forms a stem
loop (/, 3).
The first step in Sec formation involves the
misacylatjon of tRNAScc by seryl-tRNA synthetase
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(SerRS) to give Ser-tRNA^ [reviewed in (3, 8)].
Although the tertiary structure of tRNASec was
unknown, it was proposed that the mischarging
reaction is possible because of similarities between the tRNA860 and tRNAScr structures (3, 8).
In archaea and eukaryotes, the y-hydroxyl group of
Ser-tRNA560 is subsequently phosphorylated by
O-phosphoseryl-tRNA kinase (PSTK) (9) to give
O-phosphoseryl-tRNA800 (Sep-tRNASec), which
is then used as a substrate for the last synthetic
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he 21st amino acid, selenocysteine (Sec),
is distinct from other amino acids not only
because it lacks its own tRNA synthetase,
but also because it is the only one that is synthesized on the cognate tRNA in all domains of
life [reviewed in (1-4)] in a process that is reminiscent of the tRNA-dependent synthesis of glu-

tamine, asparagine, and cysteine in prokaryotes
(4). The importance of Sec is illustrated by the
embryonic lethal phenotype of the tRNAScc knockout mouse (5) and by the presence of Sec in the
active sites of enzymes involved in removing reactive oxidative species and in thyroid hormone
activation (6, 7). It is intriguing that the codon for
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Fig. 1 . Structure of human SepSecS in complex with unacylated tRNA ec.
(A) Surface representation of the physiological complex of SepSecS with
tRNASec. The subunits of the catalytic dimer are dark and light blue, those
of the noncatalytic dimer are dark and light red; the backbone and the
bases of tRNASec are green and gray, respectively. (B) The catalytic dimer
interacts with the acceptor arm of tRNA through helices otl4 and a l 5
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(blue). The a l helix (red) of the noncatalytic dimer interacts with the rest of
the acceptor-TTC arm. The regions of tRNASec that interact with SepSecS are
shown in orange; the rest is green. One tRNASec molecule is shown for
clarity. (C) Interactions between the discriminator base G73 and the conserved Arg398 in the a l 4 - p i l loop. The protein side chains are gold, and
tRNASec is green.

SCIENCE

VOL 325

17 JULY 2009

321

REPORTS
enzyme, SepSecS (5, 10). SepSecS catalyzes
the conversion of the phosphoseryl moiety into
the selenocysteinyl group by using selenophosphate as the selenium donor. An early observation that autoantibodies isolated from patients

with type I autoimmune hepatitis targeted a ribonucleoprotein complex containing tRNASec led
to the identification and characterization of the
archaeal and the human SepSecS (2, 77). The
crystal structures of the archaeal and murine

SepSecS apo-enzymes and phylogenetic analysis
suggested that SepSecS forms its own branch
in the family of fold-type I pyridoxal phosphate
(PLP) enzymes that goes back to the last universal common ancestor (12, 13).
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the Schiff base. Arg 97 ,
Gin 105 , and Arg 313 coordinate phosphate, and
the carboxyl group interacts with Lys173. (D) The
amino group of Sepp interacts with Gin 1 7 and
is 3.5 A away from the
Schiff base. The carboxyl group interacts with
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In contrast to its closest homologue, SepCysS, phosphate (Thiop) to 2.8 A resolution. The obwhich functions as a dimer to convert Sep-tRNACys served intensity divided by its standard deviation
to Cys-tRNA^ in archaea (14,15), SepSecS forms [I/a(I)] of the x-ray diffraction data are 2 at 3.0 A
a stable tetramer (12,13). SepSecS acts on phos- resolution, but the data out to 2.8 A resolution,
phoserine that is linked to tRNASec and not on where I/a(l) drops to 1, were included in the strucfree phosphoserine or Ser-tRNASec (8,13). How- ture refinement.
ever, the molecular basis for substrate discrimiHuman SepSecS forms a tetramer that is
nation and the roles of PLP and tRNASec in the bound to two tRNASec molecules in the crystal
mechanism of Sep to Sec conversion are not clear. (Fig. 1, A and B, and fig. SI). Computational
To explore these questions, we have determined modeling suggests that the tetrameric enzyme
the crystal structure of the quaternary complex could potentially bind up to four tRNASec molebetween human SepSecS, unacylated tRNASec, cules (fig. S2), but these additional tRNAand a mixture of 0-phosphoserine (Sep) and thio- binding sites are blocked by crystal packing in

our crystal (16). Electron density for the 23
N-terminal and 15 C-terminal residues of SepSecS,
as well as for the anticodon loop (nucleotides 31
to 38) and A76 of tRNASec, was of poor quality,
and these residues were not included in the final
model. Each SepSecS monomer has a PLP cofactor covalently linked to the Ne-amino group of
the conserved Lys284 by means of formation of
a Schiff base (internal aldimine). Two SepSecS
monomers form a homodimer, and two active
sites are formed at the dimer interface. The two
homodimers associate into a tetramer through interactions between the N-terminal al-loop-a2
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Fig. 4 . The PLP-dependent mechanism of Sep to Sec conversion. (A) The phosphoseryl moiety of Sep-tRNA^ is bound to the active site similar to Sepp. The
amino group is oriented for attack on the Schiff base, whereas the phosphoryl
group is stabilized by the side chains of Ser98, Gin 105 , and Arg 313 . Hydrogen
bonds are shown in dashed lines. (B) After the formation of the external
aldimine, the side chain of Lys284 rearranges and abstracts the Cot proton from
Sep. The protonated pyridine ring of PLP stabilizes the carbanion. (C) Electron
delocalization leads to a rapid (3-elimination of phosphate and to the formation
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of dehydroalanyl-tRNA5™. Free phosphate dissociates, and selenophosphate binds
to the active site. (D) An unidentified base t B ) activates water that hydrolyzes
selenophosphate. Free phosphate dissociates again, and selenium attacks the
dehydroalanyl-tRNASec. Lys284 returns the proton to the Ca carbon, and the
selenocysteinyl moiety is formed. (E) The reaction of reverse transaldimination is
shown. Lys
forms the Schiff base, with PLP leading to a release of the oxidized
form of Sec-tRIMA^ (red box). (F) The free amino group of Sec-tRNA^ is protonated, and the active site of SepSecS is regenerated.
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motifs (Fig. IB). Given that SepCysS is a dimer
and that the active sites of one homodimer do
not communicate with the active sites of the
other homodimer in the apo-SepSecS tetramer
(12, 13), the reason for the tetrameric organization of SepSecS was not known. The mode of
tRNAScc binding to SepSecS provides an answer
to this question.
The CCA ends of both tRNASec molecules
point to the active sites of the same homodimer,
which we shall refer to as the catalytic dimer (Fig.
1 A). The other homodimer, which we shall refer
to as the noncatalytic dimer, serves as a binding
platform that orients tRNA " for catalysis (Fig.
1A). The structure reveals that SepSecS binds
only to the acceptor-, T'PC-, and variable arms of
tRNASec (Fig. IB and fig. S3 A). (¥, pseudouridine.) The tip of the acceptor arm interacts
with the C terminus of the catalytic dimer, whereas the rest of the acceptor-, TTC-, and variable
arms wrap around a monomer from the noncatalytic dimer (Fig. 1, A and B, and fig. S3 A). The
most important binding element is an interaction
between the discriminator base G73 of fRNAScc
and the conserved Arg of the catalytic dimer
(Fig. 1C). The guanidinium group of Arg398 forms
hydrogen bonds with the Hoogsteen face of
G73. The discriminator base G73 of tRNASec is
universally conserved in archaea and eukaryotes.
Neither adenine nor cytidine in position 73 could
form hydrogen bonds with Arg because they
have amino groups instead of the keto group.
Also, if a cytidine or uridine were in position 73,
the C5 and C6 atoms of the pyrimidine ring would
clash with the side chain of Thr397 and thus prevent the interaction of these bases with Arg398.

and the Ne-amino group of Lys is within the
hydrogen bonding distance from both the 02'hydroxyl group and the 02 atom of C64 (fig.
S3C), whereas the side chain of Lys interacts
with the phosphate oxygen of G50 from the T*FC
arm (fig. S3C). The interactions between SepSecS
and tRNA cc seen in the crystal are consistent
with in vivo activity assays of SepSecS mutants
(fig. S4A) (16). For example, replacing Arg398
with either alanine or glutamate renders the enzyme completely inactive, which suggests that
the interaction between the discriminator base
and the highly conserved Arg of the catalytic
dimer is critical for tRNA860 recognition (fig. S4A).
Human tRNAScc contains 90 nucleotides rather
than the conventional 75 nucleotides of canonical tRNA molecules. The structure shows that
human tRNASec adopts a unique 9/4 fold with a
13-base pair (bp) acceptor-T'FC arm (where 9
and 4 reflect the number of base pairs in the acceptor and T4*C arms, respectively) and a long
variable arm (Fig. 2) (16). This resolves a controversy between conflicting models in which
the 7/5 model suggested 12 bp in the acceptorT¥C arm, as found in all known tRNA structures
(18), whereas the 9/4 model suggested a unique
13-bp acceptor-TFC arm (19). The 13-bp acceptorTTC arm and a long variable arm are distinct
structural features that serve as major recognition motifs for binding to SepSecS (Fig. 1, A
and B, and fig. S3). Indeed, based on our modeling analysis with tRNA sp, we suggest that
tRNASer, which contains both the G73 discriminator base and a long variable arm, is not able to
bind to SepSecS because of its shorter acceptorT'FC arm (fig. S5, A, B, and C). This is reminis860
Moreover, the side chain of Lys463 from the cent of the rejection of tRNA by bacterial EF-Tu
(20).
However,
modeling
of
the SerRS-tRNA800
C-terminal helix al5 forms a hydrogen bond
with the backbone oxygen of G69 from the ac- complex based on the crystal structureSerof the
ceptor arm. We propose that autoantibodies bind bacterial SerRS in complex with tRNA (21)
the variable
to an interface that lies between the al5 helix suggests thatSecSerRS can recognize
Ser
of SepSecS and the tip of the acceptor arm of arm of tRNA similarly to tRNA , which proof SerRS
tRNASec (Fig. IB), which enables them to pre- vides an explanation for the inability
Scr
Scc
cipitate the entire ribonucleoprotein complex (77). to discriminate between tRNA and tRNA
(fig.
S5D).
Finally,
the
observations
that
the
The interaction of the antibody with a region that
PSTK and SepSecS can act on E. coli
lies close to the acceptor stem-active site interface archaeal
Sec
that human SepSecS can use
may inhibit the function of SepSecS. This would be tRNA in vivo;
Sec
E.
coli
tRNA
in
vivo, as well as the archaeal
similar to the mechanism of autoimmune hepatitis
500
type 2, where LKM-1 autoantibodies (anti-liver- tRNA in vitro (8); and that the bacterial selenocan use both archaeal and mukidney microsomal antibodies) inhibit cytochrome cysteine synthase
Soc
the length
P450 isoenzyme 2D6 (CYP2D6) and contribute rine tRNA in vitro (70) suggest that
of the acceptor-TVC arm of tRNASec, the posito the pathogenesis of the disease (17).
tion of the variable arm, and the mode of tRNASec
The tRNASec molecule is anchored to the
recognition are likely to be conserved in all doSepSecS tetramer, on one end by interactions
mains of life.
between the tip of its acceptor arm (G73) and
398
the catalytic dimer (Arg ) (Fig. 1C) and on the
To explore the mechanism by which the
other end by interactions between its variable arm phosphoryl group is converted to the selenocys(C46L) and the noncatalytic dimer (Arg271) (fig. teinyl moiety, we soaked crystals of the binary
S3B). The rest of the interactions between the SepSecS-tRNASec complex in a solution conal helix of the noncatalytic dimer of SepSecS taining a mixture of O-phosphoserine and thio(Arg26, Lys38, and Lys40) and the acceptor-T^C phosphate. Sep and Thiop were used as mimics
arm (C2, G50, and C64) further stabilize the of the phosphoseryl group attached to tRNASec
complex (fig. S3C). For instance, the side chain and selenophosphate, respectively. Although
of Arg26 forms hydrogen bonds with the phos- both ligands were used in the soaking experiphate backbone of C2-C3 of the acceptor arm ments, Sep bound only to the active sites of the
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catalytic dimer (Fig. 3A), whereas Thiop bound
only to the active sites of the noncatalytic dimer
(Fig. 3B), i.e., Sep can bind to an active site
only in the presence of tRNASec. Both Thiop
and the phosphoryl group of Sep bind to the
same binding pocket (Fig. 3, A and B), which
suggests that a specific active site can accommodate only one ligand at a time. Sep binds to
the catalytic active site in either of two different
orientations (Fig. 3A). The phosphoryl group
occupies a similar location in the two orientations, whereas the seryl moieties are rotated by
~90° around the phosphate group. In the nonproductive orientation of Sep (SepN), its seryl
group is sandwiched between the side chains of
Arg97 and Lys173 at the catalytic dimer interface, whereas its amino group lies ~12 A away
from the PLP Schiff base (Fig. 3C). Thus, it is
unlikely that SepSecS would act on SepN, unless
a PLP-independent mechanism is utilized. In
the productive-like orientation of Sep (Sepp),
the amino group of Sep is ~3.5 A away from
the Schiff base, yet it is not positioned for attack because of a hydrogen bond with Gin'72
(Fig. 3D). The carboxyl group of Sepp also forms a
hydrogen bond with the side chain of Gin17 ,
whereas its phosphoryl group anchors the ligand into the active site through its interactions
with the side chains of Ser98, Gin105, and Arg313.
That the phosphoryl group is required to properly position the ligand for catalysis explains
why the obligate substrate for SepSecS is SeptRNASec and not Ser-tRNASec, which is the physiological substrate for the bacterial selenocysteine
synthase.
A comparison of the catalytic and noncatalytic sites reveals that Sep binds to the active site
only in the presence of tRNA ^ because the conformation of the P-loop (residues Gly96 to Lys107)
differs between the two active sites (Fig. 3E). In
the noncatalytic dimer, the guanidinium group of
Arg97 and the side chain of Gin105 are rotated
toward the phosphate-binding groove, where they
coordinate Thiop (Fig. 3, B and E). in the catalytic
dimer, the side chain of Arg97 rotates away from
the phosphate-binding groove and forms a hydrogen bond with the 2'-OH group of C75. Gin105 also
rotates away from the phosphate, and this concerted
movement of Arg97 and Gin1 5 in the P-loop on
tRNA860 binding allows Sep to bind to the active
site (Fig. 3E). Free Sep enters the active site through
the gate formed by the side chains of Arg97, Gin105,
and Lys173 and gets trapped in the SepN orientation.
Electron density for both the amino and the carboxyl groups of Sep is weak, which suggests
higher mobility in this part of Sepp, presumably because offreerotation around the Ca-Cp" bond. This
explains why thefreeamino group of Sepp cannot
be positioned appropriately for attack onto the
Schiff base and why the reaction does not occur
in the crystal. Thus, the covalent attachment of
Sep to tRNASec is necessary for the proper placement of the Sep moiety into the active site and for
orienting the amino group of Sep for attack onto
the Schiff base of PLP (Fig. 3F).
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We used both in vivo and in vitro activity assays to investigate the mechanism of Sep-tRNA
to Sec-tRNA conversion by human SepSecS. First,
the reduction of the Schiff base by sodium borohydride to form a chemically stable secondary
amine and thus to cross-link PLP to Lys284 renders SepSecS completely inactive in vitro (fig.
S4B). The catalytic activity of SepSecS is also
quenched on removal of PLP by treatment with
hydroxylamine (fig. S4B). Some residual activity
that is observed after hydroxylamine treatment is
probably because of incomplete removal of PLP
(fig. S4B). Second, we show that the Arg75Ala,
Glnl05Ala, and Arg313Ala mutants are inactive
in vivo (fig. S4A). These residues are involved in
coordinating either the phosphate group of PLP
or that of Sep. Finally, the in vivo activities of the
Arg97Ala, Arg97Gln, Lys 173Ala, and Lysl73Met
mutants are indistinguishable from that of the
wild-type enzyme, which confirms that Arg and
Lys173 are involved only in the nonproductive
binding of free Sep (fig. S4A).
On the basis of our findings, we propose the
following PLP-based mechanism of Sep-tRNA to
Sec-tRNA conversion. The reaction begins by the
covalently attached Sep being brought into the
proximity of the Schiff base when Sep-tRNA860
binds to SepSecS. The amino group of Sep can
then attack the Schiff base formed between Lys284
and PLP, which yields an external aldimine (Fig. 4,
A and B). The reoriented side chain of Lys abstracts the Ca proton from Sep (Fig. 4C), and the
electron delocalization by the pyridine ring assists
in rapid ^-elimination of the phosphate group,
which produces an intermediate dehydroalanyltRNASec (Fig. 4, C and D). After phosphate dissociation and binding of selenophosphate, the
concomitant attack of water on the selenophosphate group and of the nucleophilic selenium onto

the highly reactive dehydroalanyl moiety yield an
oxidized form of Sec-tRNASec (Fig. 4D). The protonated Lys284, returns the proton to the Ca carbon
and then attacks PLP to form an internal aldimine
(Fig. 4E). Finally, Sec-tRNASec is released from
the active site (Fig. 4F).
This mechanism is clearly distinct from the
persulfide-intermediate mechanism in the SeptRNA*^ to Cys-tRNACys reaction (22) and explains why SepSecS does not group together with
its closest homolog, SepCysS, in the family tree
of fold-type I PLP enzymes (72). Moreover, the
proposed mechanism for SepSecS is similar to
the one used by the bacterial SelA that also proceeds through a dehydroalanyl-tRNASec intermediate (23). SepSecS therefore uses a primordial
tRNA-dependent catalytic mechanism in which
the PLP cofactor is directly involved, while using
a tetrameric fold-type I architecture as the scaffold for binding the distinct structure of tRNASec.
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Tiger Moth Jams Bat Sonar
Aaron ]. Corcoran,1* Jesse R. Barber,2 William E. Conner1*
In response to sonar-guided attacking bats, some tiger moths make ultrasonic clicks of their own.
The lepidopteran sounds have previously been shown to alert bats to some moths' toxic chemistry
and also to startle bats unaccustomed to sonic prey. The moth sounds could also interfere with, or
"jam," bat sonar, but evidence for such jamming has been inconclusive. Using ultrasonic recording
and high-speed infrared videography of bat-moth interactions, we show that the palatable tiger
moth Bertholdia trigona defends against attacking big brown bats (Eptesicus fuscus) using
ultrasonic clicks that jam bat sonar. Sonar jamming extends the defensive repertoire available to
prey in the long-standing evolutionary arms race between bats and insects.

he ability to pinpoint airborne insects in
darkness, by echolocation (1), allowed bats
to master nocturnal insectivory (2) and set
the stage for the evolution of defensive countermeasures by insect prey (3). Some insects gained
ears (4) and evasive maneuvering (5). Tiger moths
(Lepidoptera: Arctiidae) developed the ability to
click ultrasonically in response to attacking bats
(6, 7). Decades of research on moth click de-

T

fenses have led to three, not mutually exclusive,
hypotheses regarding their function—startle (8),
acoustic aposematism ("warning") (8-14), and
sonar interference ("jamming") (15-17). When
ultrasonic clicks are paired with unpalatable prey,
bats learn to perceive clicks as a warning of unprofitability (8, 10-14). Moth clicks also startle
inexperienced bats or bats that have not heard
clicks for multiple days (8). Because bats habit-
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uate to startle quickly, its effectiveness as a defense requires clicking moths to be rare. This
situation does not appear typical in nature (12).
Finally, moth clicks may disrupt the sonar of
an attacking bat (15-17). Clicks might diminish
a bat's acuity in determining target distance
(17-19) or feign echoes from objects that do not
exist (15). However, evidence that moth clicks
can disrupt bat attacks by jamming sonar is lacking. One recent study found that moth clicks had
no discernible effect on attacking bats unless
clicks were paired with defensive chemistry (13).
All previous studies, however, tested moths with
relatively low duty cycles, or sound production
per unit time (20). High-duty-cycle moth clicks,
such as those of Bertholdia trigona (Fig. 1 and
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Results and Discussion
The 9/4 fold of human tRNASee. The linker between the acceptor- and the D-stem is two residues long
(A8-U9) as was proposed earlier (7). The base of A8 interacts with the sugar-phosphate backbone of both
the variable and T^C arms, while the base of U9 stacks with A49 from the variable arm-TTC linker. The
first pair of the D-arm is a loose C10-G24 couple followed by a C11-G23 pair (Fig. 2C). A U12-G22
wobble pair follows and here the only hydrogen bond is formed between 02-U12 and N2-G22. This observation agrees well with the earlier findings that N3-U12 is reactive toward carbodiimide (7). Further, the Dstem contains a C13-U21 pair, and A14-C20 and G15-U19 wobble pairs (Fig. 2C). These interactions
explain why N1-A14, N1-G15 and N3-U21 were not reactive towards various chemical probes under native
conditions (7). Three nucleotides U16, G17 and G18 form the D-loop and they interact with C56, A57, A58
and U59 from the TYC loop closing the cloverleaf structure as proposed (7). The linker between the D-arm
and the anticodon stem is one residue longer than in the theoretical 9/4 model and is composed of two
unpaired nucleotides, G25 and U26. The anticodon arm begins with the G26-U43 base pair, whereas the
anticodon loop is disordered in our crystal. A44 and G45 link the anticodon and variable arms and are
modeled as single stranded. The rest of the tRNASec structure agrees well with the proposed model (7).
Results of the in vivo activity assays are consistent with the SepSecS-tRNASec interactions observed in
the crystal. Analyzing the activity of the SepSecS mutants in vivo assessed the importance of interactions
other than Arg398-G73, which is described in the main text. We find that the Thr397Ala mutant is completely active, Thr397Val is partially active, and Thr397Glu is inactive in vivo (Fig. S4A). Thus, Thr397
strengthens the interaction of the acceptor arm with the a l 4 helix through its interactions with Arg398. In
addition, the mutant Arg271Glu is partially active suggesting that the interaction between the variable arm
and the non-catalytic dimer is important for complex formation as well (Fig. S4A). When Lys38 is replaced
by Glu, the enzyme is partially active in vivo, whereas both the Arg26Ala and Arg26Glu mutants are completely active (Fig. S4A), suggesting that the Arg26-C2 interaction alone is not critical for complex formation. Finally, the human and archaeal SepSecS enzymes are completely inactive in vivo when the a l helix
is deleted (Fig. S4A) (2).
SepSecS, PSTK and tRNASec may form a ternary complex in vivo. The mode of tRNASec recognition by
human SepSecS is reminiscent of the tRNA-dependent amidotransferases GatDE and GatCAB that also
recognize only the acceptor stem of the cognate tRNA (tRNAGln) (3, 4). Given that SepSecS only binds to
one side of the acceptor-T^C arm of tRNASec it is plausible that PSTK would bind to a different side of the
1

acceptor-T*FC arm or to the D-stem as is proposed for the archaeal and human enzymes, respectively (5).
This would then allow PSTK, SepSecS and tRNASec to form a ternary complex in vivo similar to that of the
transamidosome involved in prokaryotic tRNA-dependent asparagine biosynthesis (6) or the SepRS,
SepCysS, tRNACys components engaged in Cys-tRNA formation in methanogens (7).

Canonical tRNAs with the G73 discriminator base cannot bind to SepSecS due to the shorter acceptor-'PFC arm. The structure of the human SepSecS in complex with tRNASec along with the in vivo mutagenesis data reveal that SepSecS can bind tRNASec only as a tetramer. We propose that the interaction
between Arg398 and G73 along with the longer 13 bp acceptor-TTC arm and the variable arm of tRNASec
secure binding of the tRNA to the enzyme. The only tRNA with a G73 discriminator base and a long variable arm yet with a 12 bp acceptor-T*PC arm is tRNASer. However, neither unacylated tRNASer nor SertRNASer is able to bind to SepSecS (8). To examine the importance of the length of the acceptor-T*PC arm
for SepSecS binding, we superimposed tRNAAsp onto tRNASec. The tRNAAsp was chosen because it is a canonical tRNA molecule with G73 as discriminator base and because the complete structure of the tRNASer
is not available. We used two approaches for superimposing the two tRNAs. In the first approach the atoms
of the sugar-phosphate backbone of the acceptor-, TTC- and anticodon arms were superimposed. Although
the secondary structure elements of tRNAAsp were oriented as observed in tRNASec, we find that G73 of the
tRNAAsp cannot reach Arg398 due to its shorter acceptor-TTC arm (Fig. S5A, B). In the second approach,
the discriminator base of tRNAAsp was first modeled to form hydrogen bonds with Arg398 with its Hoogsteen face, and then the tips of the acceptor arms (nucleotides 1-3 and 70-73) were superimposed. In this
case, we find that both the anticodon and variable arms oftRNAAsp are positioned away from the enzyme,
whereas its T*FC arm clashes with the al helix of the non-catalytic dimer (Fig. S5C), thus preventing the
formation of the SepSecS-tRNAAsp complex. In addition, the absence of a long and properly oriented variable arm in tRNAAsp diminishes further its capacity for interaction with SepSecS (Fig. S5A, C).

Asn252 in SepSecS plays a role of the conserved Asp252. From a mechanistic standpoint, SepSecS and
SepCysS are the only Fold Type I PLP enzymes that possess an asparagine in contact with the Nl atom of
the PLP pyridine ring (2). All other known Fold Type I PLP enzymes have an aspartate in the corresponding position that is critical for catalysis since it increases the electron sink properties of the PLP cofactor (9,
10). To test whether this Asn252 is also responsible for the discrimination that SepSecS exhibits towards
Ser-tRNASec we mutated it to an Asp. Finally, the replacement of Asn252 with Ala renders the enzyme
inactive, whereas the Asn252Asp mutant is completely active (Fig. S4A). Asn252, thus, plays the role of
the highly conserved Asp252 in the Fold Type I PLP enzymes, which protonates the pyridine ring of PLP.

2

The protonated PLP is critical for the stabilization of the covalently attached carbanion intermediate in the
reaction pathway. Though still active towards Sep-tRNASec, the Asn252Asp human SepSecS mutant is
inactive towards Ser-tRNASec (Fig. S4A).

Materials and Methods
Expression and purification of human SepSecS. The human SepSecS gene was cloned into the pET15b
(Novagen) expression vector with an N-terminal His-tag as described previously (77) The construct was
transformed into BL21(DE3) cd+ expression strain. Cells were grown in LB media at 37°C to A60o = -0.6
at which point the culture was induced with 0.5mM IPTG for an overnight expression at 15°C. The cells
were harvested by centrifugation at 5,000 rpm for 15 minutes and resuspended in 20 mM Tris, pH 8.0, 50
mM NaCl, 10% (v/v) glycerol, 1 mM 2-mercaptoethanol, 10 uM PLP in the presence of the protease inhibitor cocktail (Complete EDTA-free, Roche). The cell paste was lysed using a microfluidizer, the insoluble
material was separated by centrifugation at 32,000 rpm for 40 minutes, and the cleared supernatant was
loaded onto a Ni-IDA (GE-Healthcare) column pre-equilibrated with 20 mM Tris-HCl, pH 8.0, 300 mM
NaCl, 10 mM imidazole, 1 mM 2-mercaptoethanol, 10 (iM PLP. Any non-specifically bound protein was
washed away with 50 mM imidazole, while the His6-SepSecS was eluted with 500 mM imidazole. The
protein sample was diluted three-fold with 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, 10 uM
PLP, concentrated to 3 mL and loaded onto a S-200pg size-exclusion column. The protein eluted as a
tetramer, it was concentrated to ~2 mg/mL, flash frozen in liquid nitrogen and stored at -80°C.
In vitro transcription and purification of human tRNASec. The human tRNASec was cloned into pUC19,
expressed in E. coli DH5a and synthesized by in vitro T7 RNA polymerase run-off transcription as
described (72). The transcription reaction was performed at 37°C for 2h in buffer containing 40 mM TrisHCL pH 8.1, 22 mM MgCl2, 10 mM DTT, 1 mM spermidine, 0.01% Triton X-100, 50 ug/ml BSA, 4 mM
of nucleoside triphosphate, 16 mM GMP, BstNI-digested vector containing the tRNASec gene (70 ug/ml)
and 3 mM T7 RNA Polymerase. The reaction was briefly centrifuged to pellet the formed pyrophosphate,
the supernatant reaction mixture was loaded onto a Resource-Q column (GE-Healthcare) and tRNASec was
purified using a linear gradient of NaCl (0.2-1 M) in 20 mM Tris-HCl, pH 8.0. Human tRNASec eluted at
-0.6 M NaCl. The purity of the tRNASec-containing fractions was checked by electrophoresis on a 12%
denaturing polyacrylamide gel. Pure tRNA

ec

fractions were ethanol precipitated and kept at -80°C.

Purification and crystallization of the SepSecS-tRNASec complex. The complex was prepared by mixing
SepSecS with a 1.5-fold molar excess of tRNASec. Thus, for each SepSecS tetramer there were 6 molecules
of tRNASec available. The mixture was concentrated to - 1 mL, loaded onto a S-200pg column (XK 16/60)
3

and eluted with 20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, 10 uM PLP. The first peak contained
the SepSecS-tRNASec complex, whereas the second peak contained the unbound tRNASec. The complex was
concentrated to ~7.5 mg/mL. The complex was crystallized by sitting-drop vapor-diffusion method at 12°C
by mixing equal volumes of the complex sample with the well buffer containing 0.3 M tri-lithium citrate,
18% (w/v) PEG 3,350. Addition of various additives to the mother liquor such as sorbitol, D-galactose,
NDSB-201, Cymal-7, MPD and phenol improved both the crystal size and the quality of diffraction.

Ligand soaks and data collection. A mixture of thiophosphate and phosphoserine was added to the binary
complex crystals to the final concentration of 1 mM and incubated for lh prior to freezing. Crystals were
cryoprotected for 5 minutes in the presence of 20% (v/v) ethylene-glycol and then frozen in liquid propane.
Data were collected at the NE-CAT 24IDE beamline (APS, Argonne National Laboratory, Chicago) and
processed using HKL2000 (Supplementary Table 1) (13).

Structure determination and refinement. The crystal structure of the complex between human SepSecS
and tRNASec was solved by molecular replacement using Phaser (14) and by using a monomer of the murine SepSecS (PDBID: 3BC8) (15) as a search model. The asymmetric unit contained four SepSecS molecules, which we shall refer to as the crystallographic tetramer (Fig. SI A). After a round of rigid-body refinement strong positive electron density peaks for tRNASec, Thiop and Sep appeared in the Fo-Fc electron
density map. The tRNASec molecule was bound to the crystallographic tetramer in two alternate orientations
and both orientations were modeled and refined (Fig. SI A). The actual physiological tetramer contains a
half of the crystallographic tetramer and two other symmetry related SepSecS molecules (Fig. SIB). Consequently, the actual physiological SepSecS tetramer has two tRNASec molecules bound each with half
occupancy. The physiological tetramer is discussed in the manuscript. Structure refinement was done in
Phenix (16), while model and map inspection was done in Coot (17). The final model had an excellent
geometry with 94% and 6% residues in preferred and allowed regions of the Ramachandran plot, respectively. The final RciySt was 20.3% and Rfree was 23.8% (Table 1). All figures were generated in Pymol (18).

Modeling of the SepSecS-tRNAAsp and SerRS-tRNASec complexes. A model of SepSecS-tRNAAsp was
generated using the crystal structure of AspRS-tRNAAsp (PDBID: 1C0A) (19). tRNAAsp was superimposed
onto tRNASec using two approaches. On one hand the atoms of the sugar-phosphate backbone of the
acceptor-, T*PC- and anticodon arms were used for superpositioning, whereas in the other approach, G73 of
tRNAAsp was first modeled as found in tRNASec and then only the nucleotides 1-3 and 70-73 were superimposed. The CCA-end of both tRNAAsp and tRNASec was excluded from the calculation. A model of SerRStRNASec complex was generated using the crystal structure of SerRS-tRNASer complex (PDBID: 1SER)
4

(20). The atoms of the sugar-phosphate backbone of tRNA

ec

were superimposed onto the corresponding

Ser

atoms of tRNA . The tip of the acceptor arm (nucleotides 1-2, 71-76) was excluded from the calculation.
All calculations were done in Lsqman (21).
Modeling of CCA-Sepp in the catalytic site of SepSecS. Modeling of CCA-Sepp was done in Coot (17).
The 03'-hydroxyl group of A76 replaced the carboxyl oxygen of Sepp, thus forming an ester bond. The
base of A76 was positioned between the side-chains of Arg97 and Lysl73, while the side-chain of Arg97
and the entire P-loop was kept is in the same conformation as found in the catalytic active site.

In vivo SepSecS assay. The human SepSecS mutants (R26A, R26E, K38A, K38E, R75A, R97A, S98A,
Q105A, K173A, K173M,N252A, N252D, R271A, R271E, R313A, T397A, T397E, T397V, R398A and
R398E) were generated using the QuikChange site-directed mutagenesis kit (Stratagene) and cloned into
the pET15b vector with an N-terminal His-tag. An N-terminal Ai_37SepSecS deletion mutant was
constructed by PCR with the pET\5b-sepsecS plasmid as the template and with the following primers: 5'GGAATTCC ATATGAAGGGC AAGTGTCC AGAGAATGGCTGGGATGAAAGTACAC-3',
CGCGGATCCTCATGAAGAAGCATCCTGGTATGTGTCAAGAAGTACATTATC-3'.

and

5' -

The resulting

DNA fragment was subcloned into the pET20b vector (Novagen) with a C-terminal His-tag. Construction
of the E. coli AselA deletion strain JS1 (DE3) and cloning of the M. jannaschii PSTK gene into the
pACYC-Duet vector were described previously (77). The human wild type and mutant SepSecS genes were
transformed into the E. coli AselA deletion strain JS1 (DE3) with or without the M. jannaschii PSTK gene.
Aerobic overnight cultures were streaked on LB-agar plates and/or M9 minimal medium-agar plates supplemented with 0.01 mM IPTG, 1 uM Na 2 Mo0 4 , 1 uM Na 2 Se0 3 as described previously (2, 11). The LBagar plates also contained 50mM sodium formate. The cells were grown anaerobically for 5h at 37°C and
20h at 30°C. The plates were then overlaid with agar containing 1 mg/ml benzyl viologen, 0.25 M sodium
formate, and 25 mM KH2PO4, pH 7.0. The appearance of a blue/purple color is the indication of active
formate dehydrogenase H.

In vitro SepSecS assay. For this assay, following in vitro transcription as described above, the human
tRNASec transcript was purified by electrophoresis on a 12% denaturing polyacrylamide gel. Full-length
tRNA was eluted and desalted on Sephadex G25 Microspin columns (Amersham). The tRNASec was
refolded by heating for 5 min. at 70°C in buffer containing 10 mM Tris-HCl (pH 7.0), followed by addition
of 5 mM MgCL: and immediate cooling on ice. Refolded tRNASec (10 pM) was serylated and phosphorylated by M. maripaludis SerRS (5 uM) and M. jannaschii PSTK (3 uM) for 75 min. at 37°C in buffer
containing 50 mM HEPES (pH 7.2), 10 mM MgCl2, 20 mM KC1, 1 mM DTT, 10 mM ATP and 300 uM
5

[ C]Ser. After phenol/chloroform extraction Sep-tRNA

ec

was purified by application on a Sephadex G25

Microspin column (Amersham) and ethanol precipitation. The conversion of Sep to Cys was done under
anaerobic conditions using wild-type human SepSecS and human SepSecS treated with either hydroxylamine or NaBH4. For the hydroxylamine treatment the SepSecS sample was dialyzed for 5 hr against the
buffer containing 50 mM HEPES pH 7.2, 250mM NaCl, ImM DTT, 7.5 mM hydroxylamine, whereas for
the borohydride treatment the SepSecS sample was incubated in the dark for 1 hr in the presence of 100
mM NaBfLt. The excess of hydroxylamine and borohydride was removed from the samples by dialysis
against 50 mM HEPES pH 7.2, 250 mM NaCl, 1 mM DTT. SepSecS (20 ug) was incubated with 10 uM
Sep-tRNASec in buffer containing 50 mM HEPES pH 7.2, 20 mM KC1, 10 mM MgCl2, 1 mM DTT and 250
uM sodium thiophosphate. All buffers were prepared anaerobically and the reaction was carried out at 37°C
inside an anaerobic chamber over 40 min. The reaction was stopped by phenol/chloroform extraction, the
aqueous phase was applied to a Sephadex G25 Microspin column (Amersham) and the eluted aminoacyltRNAs were ethanol precipitated. The purified aa-tRNAs were deacylated in 20 mM NaOH for 10 min at
22°C. The released amino acids were oxidized with performic acid as described previously (22). The final
samples were spotted onto silica gel 60 TLC aluminium sheets (Merck) that were developed in 85% ethanol. To detect the labelled amino acids the TLC plate was dried and then exposed on an imaging plate
(FujiFilms) for 60 hr. The imaging plate was scanned using a Molecular Dynamics Storm 860 scanner.
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Supporting Figure legends
Figure SI. Asymmetric unit of the SepSecS-tRNASec complex crystal. (A) Ribbon diagram of the crystallographic tetramer composed of two halves of the physiological SepSecS tetramer with one tRNASec
molecule bound in two alternate orientations. Catalytic monomers are colored in blue, non-catalytic monomers are shown in red, and the two conformations of tRNASec are colored in green and orange. The definition of the monomers is as in the text. The cofactor PLP is shown as sticks and colored in red and blue in
the catalytic and non-catalytic active sites, respectively. (B) A half of the asymmetric unit and two symmetry related molecules (shown in light blue and light pink) make up the physiological SepSecS tetramer.
Figure S2. The SepSecS tetramer can accommodate four tRNASec molecules. (A) Ribbon diagram of
the physiological SepSecS tetramer in a putative complex with four tRNASec molecules bound. The catalytic dimer (blue) with two tRNASec molecules (green) bound was superimposed onto the non-catalytic
dimer (red) and the complex was generated. The generated tRNASec molecules are shown in orange. (B)
The view in B is rotated -90° clock-wise around the vertical axis relative to A. The SepSecS-tRNASec
complex is in the same orientation as in Figure 1 of the manuscript.
Figure S3. Interactions between SepSecS and the "PFC- and variable arms of tRNASec. (A) The ribbon
diagram of the complex showing interactions between parts of the variable arm of tRNASec (orange) and the
a9 helix (red) of SepSecS. The rest of the tRNASec is green. The view is rotated -90° clockwise around the
vertical axis relative to Fig. 1A. (B) Arg271 (a9) in the non-catalytic dimer interacts with the variable arm
(nucleotides C46L-A47). (C) The side-chains of Lys38 and Lys40 (al-a2 loop) interact with the T*FC arm.
Lys38 and Lys40 interact with C64 and G50, respectively. In B and C, tRNASec is green and the protein
side-chains are gold.

Figure S4.

In vivo formation of Sec-tRNASec by SepSecS mutants and in vitro conversion of Sep-

tRNASec to Cys-tRNASec by wild type and PLP-cross-linked SepSecS. (A) In vivo assays of SepSecS
mutants. Formation of Sec-tRNASec in vivo is assayed by the ability of the wild-type human SepSecS and its
mutant variants (N-terminal deletion Al-37, R398A, R398E, R26A, R26E, K38A, K38E, T397A, T397E,
T397V, R271A, R271E, K173A, K173M, S98A, R97A, Q105A, R313A, R75A, N252 and N252D) to
restore the benzyl viologen reducing activity of the selenoprotein FDHH in the E. coli selA deletion strain
JS1. The M. jannaschii PSTK is co-transformed, except where indicated with a "-", to provide the necessary Sep-tRNASec intermediate. (B) In vitro assays of SepSecS. Phosphorimages of TLC separation of
[14C]Sep and [l4C]Cys recovered from the aminoacylated-tRNAs of the SepSecS activity assays. Cysteine

was analyzed in its oxidized form as cysteic acid (Cya). Lane 1, Ser marker; lane 2, Sep marker; lane 3,
Cys marker; lane 4, Sep-tRNASec with human SepSecS in the absence of thiophosphate; lane 5, SeptRNASec with wild-type human SepSecS; lane 6, Sep-tRNASec with human SepSecS treated with 7.5 mM
hydroxylamine; lane 7, Sep-tRNASec with human SepSecS treated with 100 mM sodium borohydride.

Figure S5. Selectivity of SepSecS and SerRS. (A) Modeling of the complex between SepSecS and
canonical tRNAs. tRNAAsp (orange) was superimposed onto tRNASec (green) using the sugar-phosphate
backbone atoms of the acceptor-, T*FC- and anticodon arms. The long variable arm of tRNASec interacts
with the non-catalytic dimer of SepSecS (shades of red). The box delineates the close-up view shown in B.
(B) The short acceptor-TTC arm of canonical tRNAs prevents binding to SepSecS. G73 of tRNAAsp
(orange) cannot reach Arg398. (C) Steric clashes (asterisk) between the a l helix of the non-catalytic-dimer
of SepSecS (shades of red) and the W C arm of tRNAAsp (orange) prevent the SepSecS-tRNAAsp complex
formation. G73 from tRNAAsp was modeled to form hydrogen bonds with Arg398 using its Hoogsteen face.
Only the tip of the acceptor arm (nucleotides 1-3 and 70-73) was used in the superposition. Arrows show
the movement of both the anticodon and T^C arms in tRNAAsp relative to its orientation shown in A. (D)
Modeling of the SerRS-tRNASec complex. tRNASec was superimposed onto the tRNASer that is in complex
with SerRS. SerRS is a non-discriminating aminoacyl-tRNA synthetase because it recognizes variable arms
of both tRNASer (red) and tRNASec (green).
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Table 1
Data collection and refinement statistics
Crystal
Space group

P3jl2

Cell dimensions

a=6=166.8 A, c=236.3 A, a=p=90° 7=120°

Data collection
Resolution limit (A)

40.0-2.8

Unique reflections

89,336

Completeness (overall / last shell; %)

97 (94)

RSym (overall / last shell; %)

17.0 (94.0)

1/ I (overall / last shell)

6(1)

Redundancy (overall / last shell)

5.4 (4.3)

Refinement
Average B-factor (A2)
Protein

56.5

Nucleic acid

94.3

Number of atoms (protein and nucleic acid)

17,150

Number of atoms (ligand)

141

Number of solvent molecules

301

Rcr y s «(|F|>0u;%)

20.3

Rfree(|F|>0 ..; %)

23.8

R.m.s. deviations from ideality
Bond lengths (A)

0.006

Bond angles (°)

1.126
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A B S T R A C T

Selenocysteine and pyrrolysine, known as the 21st and 22nd amino acids, are directly inserted into
growing polypeptides during translation. Selenocysteine is synthesized via a tRNA-dependent pathway and decodes UGA (opal) codons. The incorporation of selenocysteine requires the concerted
action of specific UNA and protein elements. In contrast, pyrrolysine is ligated directly to tRNAPyl
and inserted into proteins in response to UAG (amber) codons without the need for complex re-coding machinery. Here we review the latest updates on the structure and mechanisms of molecules
involved in Sec-tRNA^0 and Pyl-tRNAPy> formation as well as the distribution of the Pyl-decoding
trait.
© 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

1. Selenocysteine biogenesis
Selenocysteine (Sec) is the major biological form of the element
selenium, which in trace amounts is essential for human health.
Sec is incorporated into polypeptides to form selenoproteins during translation. The 21st amino acid is typically found in catalytic
centers of selenoproteins where it plays a functionally essential
role. Unlike most amino acids, Sec is universally synthesized on
its cognate tRNA [1-4]. During translation, selenocysteinyl-tRNASec
(Sec-tRNASec) is delivered to the ribosome by a specific translation
factor that requires a characteristic stem-loop structure in the
mRNA to actively recode an in-frame UGA from stop codon to
Sec sense codon. The human genome encodes only 25 selenoproteins [5], yet variations in these Sec-containing proteins or their
synthetic machinery is linked to a range of human disorders
including cancer and numerous diseases affecting the nervous, immune, and endocrine systems [6].
The machineries to synthesize Sec and incorporate it into selenoproteins are divergent in bacteria compared to archaea and
* Corresponding authors.
E-mail addresses: jing.yuan@yale.edu (J. Yuan), patrick.odonoghue@yale.edu (P.
O'Donoghue).
1
Both authors contributed equally.

eukaryotes. In bacteria, serine (Ser) as the precursor of Sec is initially attached to tRNASec by seryl-tRNA synthetase (SerRS). The
resulting Ser-tRNASec is then converted to Sec-tRNASec by selenocysteine synthase (SelA) in the presence of the selenium donor
selenophosphate. This pathway has been well characterized in
Escherichia coli [7] and extensively reviewed before [8,9].
The pathway for Sec biosynthesis in archaea and eukaryotes
(Fig. 1) was revealed only in the last few years. The missing component was an archaeal/eukaryotic analog of SelA, since no clear
sequence-based homolog could be found. An additional enzymatic
step is involved in Sec biosynthesis in archaea and eukaryotes. Ophosphoseryl-tRNA kinase (PSTK) [10] catalyzes the phosphorylation of Ser-tRNASec to form 0-phosphoseryl-tRNASec (Sep-tRNASec).
The Sep-tRNA:Sec-tRNA synthase (SepSecS), an independently
evolved protein that is distantly related to SelA [11], then forms
the final product Sec-tRNASec from selenophosphate and SeptRNASec [2-4]. Phylogenetic analysis indicated that PSTK and SepSecS co-evolved and are restricted to the archaeal and eukaryotic
domains [2,12]. An interesting similarity, as reviewed previously
[13], exists between the archaeal and eukaryotic Sec biosynthetic
pathway and archaeal tRNA-dependent cysteine biosynthesis,
which also proceeds via a Sep-tRNA intermediate [14]. In the first
section of this paper, we focus on recent biochemical and structural work that further elucidated the mechanism and specificity

0014-5793/S36.00 © 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
doi:10.1016/j.febslet.2009.11.005
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Fig. 1. The Sec biosynthesis pathway in archaea and eukaryotes. Sec is synthesized on tRNASec in three steps. (1) The unacylated tRNASec is serylated by SerRS; (2) the
resulting Ser-tRNASec is phosphorylated by PSTK forming Sep-tRNASec; (3) the phosphorylated intermediate is converted to the final product Sec-tRNASec by SepSecS. The
crystal structures of tRNA and enzymes in this pathway are presented: tRNASec (ribbon) from Homo sapiens [19], SerRS (ribbon) with AMP (stick) from Pyrococcus horikoshii
[64], PSTK (ribbon) from M.jannaschii ]26], and SepSecS (ribbon) with tRNASec (stick, only one tRNA is shown) from Homo sapiens [18J.

of the tRNA and enzymes involved in Sec biosynthesis in archaea
and eukaryotes.
2. tRNAScc has a distinct structure
tRNASec was identified more than two decades ago [1 ]. It is the
longest tRNA with an extended acceptor stem resulting from an
abnormal RNase P cleavage specificity [15]. tRNASec has an 8-bp
acceptor stem and 5-bp T-stem (a 8/5 secondary structure) in bacteria and a 9/4 arrangement in archaea and eukaryotes, and both
can fold into a 13-bp long acceptor-TvPC helix (Fig. 2A). In contrast,

canonical tRNAs typically have a 7-bp acceptor stem and a 5-bp Tstem forming a 12-bp acceptor-T*PC helix. Several other features of
tRNASec, including an elongated D-stem (6-bp instead of 4-bp), a
smaller D-loop (4-bp instead of 8-bp), a long variable arm, and
the absence of the highly conserved U8 residue, make tRNASec distinct from canonical tRNAs.
The tertiary structures of E. coli and eukaryotic tRNASec were
investigated by chemical and enzymatic probing during the
1990s [16,17]. Very recently, the first tRNASec crystal structure
was solved. The unacylated human tRNASec transcript was crystallized in complex with human SepSecS [18] and in an unbound state
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Fig. 2. Binding to SepSecS promotes a conformational change in tRNASec. (A) The secondary structure of human tRNASec with bases mentioned in the text highlighted in bold.
The correct tRNASec sequence is shown here (Fig. 2C in Ref. [18] omitted a base from the D-arm). (B) Superposition of the sugar-phosphate backbone of both the D- and
anticodon arms of free tRNA5" (blue) on the corresponding atoms of tRNASec complexed with SepSecS (red) reveals a conformational change in the tRNA molecule on binding
to the enzyme. The variable arm of tRNASec rotates by 33°, the T arm swings 17° and the acceptor arm rotates by 6° around the axis that runs parallel to both the D- and
anticodon arms. The free tRNASec conformer cannot bind to SepSecS because the tip of its acceptor arm would clash with the helix al and the variable arm would be
positioned away from the helix a9. (C) The acceptor arm also slides down towards the anticodon arm on binding to SepSecS through a 24° rotation around the axis that is
parallel to the variable arm. This movement positions G73 to interact with Arg398 in the helix al4 and orients the CCA end toward the active site. Free tRNASec is blue, tRNASec
complexed with SepSecS is red and SepSecS is beige. Only the secondary structure elements of SepSecS that interact with tRNA are shown. The view is first rotated ~30°
clockwise around the horizontal axis, and then another 30° anticlockwise around the vertical axis relative to panel B.
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[19]. The tertiary structure confirms the predicted distinct features
of the acceptor, T and D-stems. Compared to canonical tRNAs, the
overall structure of tRNASec is less compact due to the lack of tertiary interactions from the D-arm and the variable arm, i.e., absence of the G15:C48 base pair, which creates a hole in the
tertiary core [18,19]. The D-stem does not stack perfectly along
the axis formed by the anticodon stem and the T-loop and shifts
to the minor groove side of the tRNA. The long variable arm protrudes from the tertiary core on the side of tRNASec opposite from
the D-arm [18,19]. Remarkably, despite different secondary and
tertiary interactions, the relative position of the T-stem and the
variable arm in the free tRNASec is almost indistinguishable to that
in tRNASer. The variable arm is one of the major identity elements
for the recognition of tRNA5" and tRNASec by seryl-tRNA synthetase (SerRS), and these observations in part explain the dual specificity of SerRS for tRNASec and tRNASer [18]. Another model of the
SerRS-tRNASec complex suggests that SerRS may also recognize
both the G19:C56 base pair and the discriminator base of tRNA5"0
[19]. Thus, all the major identity elements for tRNA serylation
are present and can be recognized in tRNASec.
Uridine at position 8 is highly conserved and forms a tertiary base
pair with Al 4 in all other mature tRNAs. This conserved U8: Al 4 base
pair defines the elbow region of the tRNA [20] and U8 acts as a sensor
for the response mechanism to UV exposure [21 ]. The tRNASec has an
adenosine at position 8 instead. An A8:A14:U21 base triple was suggested from the chemical and enzymatic probing data [17], yet A8
does not appear to interact with other bases in the two recently reported tRNASec crystal structures [18,19]. A tertiary base interaction
change is observed when comparing the SepSecS-bound and the
free tRNASec crystal structures. In the unbound tRNASec, the base of
U20 stabilizes interactions between the D and V¥C loops by forming
a base triple with the G19:C56 Watson-Crick base pair [19]. In the
SepSecS-bound state the base of U20 does not participate in the base
triple. Its electron density is weak, suggesting increased mobility in
this part of the D-loop. Thus, the base triple stabilizes an unbound
conformation of tRNASec, whereas on binding to SepSecS the base
triple breaks apart. Besides canonical tertiary base interactions
(i.e., G18:U55 and G19:C56), unique tertiary interactions are present in tRNASec such as the U16:U59 base pair, which stacks on top
of A15:A20a and forms a 13-bp stacking helix together with the D
and anticodon stems.
Further analysis, based on superimposing the two solved structures of tRNASec, reveals that while the individual arms of tRNA5"
adopt the same structure, their relative orientations differ in the
SepSecS-bound state and unbound state. Indeed, the acceptor, Tand variable arms undergo a conformational change upon binding
to SepSecS (Fig. 2B): (i) the variable arm makes a 33° rotation
around the axis that is parallel to the anticodon arm, (ii) the Tarm moves in the same direction, but to a somewhat lesser extent
(17°), and (iii) the acceptor arm makes a 6° rotation around the
anticodon stem as well as a 24° rotation around the axis that is parallel to the variable arm (Fig. 2C). The conformational change facilitates the interaction between tRNASec and SepSecS and
presumably orients the CCA end toward the active site. It will be
interesting to see if tRNASec undergoes a similar conformational
change as it binds to other components of the Sec biosynthetic
apparatus and the translating ribosome.
tRNA5" plays a pivotal role in the Sec biosynthesis pathway. It
interacts with Sec specific proteins including PSTK and SepSecS
in archaea and eukaryotes. The distinct structural features of tRNASec
are proven to be major recognition elements throughout Sec
biosynthesis as detailed below. It is unknown, however, if these
features of tRNASec are also important for Sec incorporation, which
requires the participation of multiple protein factors in Sec decoding during translation.

3. PSTK is a tRNA^-dependent kinase
In archaea and eukaryotes, PSTK catalyzes the second step of
Sec biosynthesis (Fig. 1, center), the phosphorylation of Ser-tRNASec
to Sep-tRNA5ec in a reaction requiring ATP and magnesium. Such
kinase activity was first observed in rat and rooster liver lysate almost 40 years ago [22,23]. In 2004, the identity of this elusive kinase as PSTK was finally revealed in mouse via a comparative
genomic approach [10]. Subsequently the archaeal homolog was
shown to have the same activity [24], and the biochemical and
structural properties of the Methanocaldococcus jannaschii PSTK
(MjPSTK) have been extensively studied [12,24-26].
MjPSTK is a homodimeric enzyme with each monomer consisting of a N-terminal kinase domain and a C-terminal domain that is
putatively involved in tRNA binding. PSTK is a member of the Ploop kinase family with the conserved Walker A and B motifs
and the RX3R motif that are responsible for the recognition of the
Mg2+-ATP complex [12,26]. Mutations to either the Walker A or B
motifs ablate PSTK activity both in vitro and in vivo [26]. Mutagenesis also revealed that the distal Arg residue in the RX3R is critical
for catalysis both in vivo and in vitro. Interestingly, the kinase
activity is not highly specific for the phosphate donor, since all four
rNTPs and even dATP are competent substrates [12]. Structural
analysis of the PSTK:AMPPNP complex supported this observation
since the adenosine ring makes few specific contacts, with the
exception of a cation-rc interaction involving the RX3R motif [26).
The conserved Asp residue (Asp41) in the Walker B motif plays
an essential role in MjPSTK catalysis. Mutation of Asp41 to Asn
leads to total loss of activity [26]. The structure shows that
Asp41 stabilizes the ATP bound Mg2* ion via a water mediated
hydrogen bond, while modeling of the Ser substrate suggests direct
contact between Asp41 and the hydroxyl group of Ser [26]. Based
on these reports, we can propose a plausible reaction mechanism
for PSTK. The reaction begins when both substrates, Ser-tRNA5ec
and Mg2+-ATP, are bound to the enzyme. Asp41 then attracts a proton from the hydroxyl group of the Ser in the substrate. The deprotonated Ser nucleophilically attacks the y-phosphate of the ATP
yielding a pentavalent transition-state intermediate. Finally, the
phosphodiester bond between the ji and y phosphate in the ATP
is broken to complete the transphosphorylation reaction, and the
product Sep-tRNASec is formed. Mg2+ aids in the departure of the
leaving group ADP.
The enzyme activity of PSTK is strictly tRNASec-dependent. PSTK
does not hydrolyze ATP in the absence of tRNA nor in the presence
of Ser-tRNASer. The binding of tRNASec, however, promotes ATP
hydrolysis [12]. This suggests that tRNA5ec might play an essential
role in positioning the Ser moiety for initiating phosphoryl transfer. Compared to aminoacyl-tRNA synthetases, PSTK has approximately 20-fold higher affinity toward its substrate, Ser-tRNASec
(Km = 40 nM) [12], which may compensate for the low abundance
of tRNASec in vivo. The concentration of tRNA5ec in vivo is at least
10-fold lower than tRNA5er in tRNASec-rich tissues such as liver,
kidney and testis in rat [27].
The crystal structure of PSTK reveals an unusual large central
groove that is formed in the MjPSTK dimer interface, a feature
not observed in other P-loop kinases previously. The central groove
exposes the monomer active sites at either end, and contains many
positively charged residues. Computational docking suggested that
the central groove provides a complementary surface for the two
tRNASec substrates. The model places archaeal PSTK identity elements (G2:C71 and the C3:G70 [25]) within contact of the protein
dimer interface. Interestingly, the second base pair in the acceptor
stem is highly conserved as C2:G71 in eukaryotic tRNASec,
and mutation of G2:C71 to C2:G71 in archaeal tRNASec resulted
in a Ser-tRNASec variant that is phosphorylated inefficiently [25].
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Moreover, the eukaryotic PSTK has been reported to recognize the
unusual D-arm of tRNASec as the major identity element for phosphorylation [28], and phylogeny indicates a deep divide between
the archaeal and eukaryotic PSTK proteins [12]. Given these observations, it is quite likely that the eukaryotic PSTK/tRNA complex
may involve interactions that are distinct from its archaeal counterpart. Future co-crystal structures of tRNASec with the archaeal
and eukaryotic PSTKs will provide a definitive picture of these
differences.
4. SepSecS requires Sep-tRNA561 as the precursor for Sec
biosynthesis
The conversion of phosphoseryl-tRNASec (Sep-tRNASec) to selenocysteinyl-tRNASec (Sec-tRNASec) is the last step of Sec biosynthesis
in both archaea and eukaryotes, and it is catalyzed by O-phosphoseryl-tRNA:selenocysteinyl-tRNA synthase (SepSecS). SepSecS
forms its own branch in the phylogenetic tree of the fold type I
family of the pyridoxal phosphate (PLP)-dependent enzymes and
displays a distinct homotetrameric (feh) quaternary structure
[11]. Two active sites are formed at each homodimer interface
and each active site contains a PLP-binding pocket. Thus, the tetrameric SepSecS has four active sites and four PLP molecules bound.
The PLP cofactor forms a reversible Schiff-base linkage (internal
aldimine) with a highly conserved Lys284. The PLP-dependent enzymes form a functionally diverse group, which is responsible for
more than 140 distinct activities [29]. Remarkably, almost all the
PLP-dependent enzymes utilize a catalytic mechanism that proceeds through a carbanion intermediate, which is, in turn, stabilized by PLP [30]. Based on both in vitro and in vivo activity
assays, a catalytic mechanism of SepSecS that is dependent on
PLP was recently proposed [11,18,31].
The tetrameric SepSecS is distinct from all other members of its
family including 0-pnosphoseryl-tRNA:cysteinyl-tRNA synthase
(SepCysS). SepCysS acts on a tRNA-based substrate (Sep-tRNACys),
but it does so as a dimer [11]. Moreover, SepSecS is a highly specific
enzyme that acts on Sep-tRNASec, and not on Sep-tRNACys, SertRNASec, or free Sep. Crystal structures of both the archaeal and
murine apo-SepSecS [11,31] and that of the human SepSecS-tRNASec
complex [18] have provided insights into the substrate specificity and the catalytic mechanism of SepSecS.
SepSecS binds both the unacylated tRNASec and Sep-tRNASec
with comparable affinities in vitro [4], which presumably allowed
crystallization of the human complex between SepSecS and unacylated tRNASec. The SepSecS/tRNASec complex structure revealed
that one SepSecS homodimer interacts with the sugar-phosphate
backbone of both the acceptor-PFC and the variable arms of tRNASec
, while the other homodimer interacts specifically with the tip of
the acceptor arm through interaction between the conserved
Arg398 and the discriminator base G73 of tRNASec [18]. Thus, one
homodimer measures both the length of the acceptor-T^C arm
and the distance between the variable arm and the CCA end,
whereas the other homodimer ensures that the correct tRNA is
bound to the enzyme. The latter homodimer also provides the catalytic site that would act on the Sep moiety. Finally, structural
modeling revealed that canonical tRNAs, including tRNASer (which
is the closest structural homolog of tRNASec), cannot bind to SepSecS due to the shorter acceptor-TTC arm. These observations explain why only the SepSecS tetramer can bind tRNASec and why
SepSecS cannot bind canonical tRNAs.
Unlike its bacterial counterpart SelA, SepSecS cannot directly
convert Ser-tRNASec to Sec-tRNASec and has a significantly reduced
affinity for Ser-tRNASec in vitro [4]. This argues that the phosphate
group of Sep plays an important role in substrate binding. Indeed,
the crystal structure of SepSecS/tRNASec complex in presence of
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free Sep shows extensive hydrogen bonding between the active
site and the phosphate group of the free Sep [18]. This suggests
that the phosphate group may serve as an anchor to bring Sep in
close proximity of the cofactor PLP. However, the ot-amino group
of the free Sep appears quite flexible in the structure and it is not
oriented properly for the nucleophilic attack on the Schiff-base
[18]. Thus, the covalent attachment of Sep to tRNASec may restrain
the conformation of the Sep moiety as well as facilitate the proper
orientation of the a-amino group for efficient PLP-dependent catalysis to occur. This would explain why SepSecS could not act on
either free Sep or Ser-tRNASec, as both molecules bear only one
anchoring moiety.
Sec biosynthesis in all domains of life is achieved by RNAdependent amino acid modification. As such it is reminiscent of
other pathways of tRNA-dependent amino acid synthesis that form
Asn-tRNA, Gln-tRNA and Cys-tRNA in many organisms [32]. The
individual reactions in this stepwise process may actually be carried out in a large tRNA: protein complex. One example is the transamidosome [33], a complex of tRNA^", aspartyl-tRNA synthetase,
and Asp-tRNAAsn amidotransferase, that provides an efficient route
to bacterial Asn-tRNAAsn formation. The complex architecture
should also aid protein quality control, as it may prevent release
of mis-acylated aminoacyl-tRNA that would be used in protein
synthesis. A similar complex possibly involving tRNASec, SerRS,
PSTK and SepSecS may exist to facilitate efficient selenocysteine
formation.
5. Pyrrolysine, the uncommon 22nd amino acid
Evidence for the genetic encoding of pyrrolysine (Pyl) is only
present in 1% of all sequenced genomes thus far. The rarity of Pyl
is matched by its unique chemical structure, a lysine in NE-linkage
to a pyrroline ring. Pyl was first observed in a crystal structure at
the active site of the monomethylamine methyltransferase
(MtmBl) from the methanogenic archaeon Methanosarcina barken
[34]. Pyl has now been characterized in three distinct methylamine
methyltransferases from the Methanosarcinaceae that allow these
methanogens to utilize the unique growth substrates mono-, diand trimethylamines [35]. Although each of the genes encoding
these methyltransferases contains a in-frame amber (TAG) codon
(a stop codon in most organisms) the methylamine methyltransferase genes are read-through to the next opal or ochre stop codon
and Pyl is inserted in-response to the in-frame amber codon. Due
to its proximity to the active site, Pyl was hypothesized to be a
key catalytic residue in these Pyl-proteins [36].
While some work has attempted to address the mechanism of
stop codon suppression in Pyl-decoding organisms [37-39], it remains unclear whether all amber codons in these organisms encode Pyl or whether some are translational stop signals. In recent
work [40], Pyl was also found in the tRNAHls guanylyltransferase
(Thgl) from Methanosarcina acetivorans. Thgl is responsible for
addition of the key identity element for His-tRNA formation, a
Gl residue ligated to the 5'-end of immature tRNAH,s. Interestingly,
Pyl does not play a role in the catalytic action of Thgl and represents the first example of a dispensable Pyl residue. Efficient
read-through of the in-frame amber codon in Thgl, without the
apparent presence of re-coding signals, indicates that Pyl insertion
may be more similar to natural stop codon suppression [41 ] than
to the more elaborate re-coding of UGA codons that is known to occur for selenocysteine [9].
Previous reviews focused on how Pyl enters the genetic code
[42,43], namely by the catalytic action of a pyrrolysyl-tRNA synthetase (PylRS) that ligates pyrrolysine to the amber codon decoding tRNA^1 [44,45]. Since that time the most dramatic advances
have been the structural characterization of PylRS and tRNAPyl. This
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work, which is reviewed in detail below, revealed the unique nature of the Pyl binding pocket and provided atomic detail for the
PylRS/tRNAPyl interaction which underlies the specific and exclusive association between the protein and tRNA. This section of
the review concludes with an overview of an expanded number
of possible Pyl-decoding organisms uncovered from recently sequenced genomes and metagenomic surveys.
6. Recognition of Pyl by PylRS
While PylRS was first crystallized in 2006 [46], the first structure was solved independently the following year [47]. This structure of PylRS was determined in complex with Pyl and the Pyl
analog N-E-[(cyclopentyloxy)carbonyl]-L-lysine (Cyc). As for all
PylRS structures reported to date the highly insoluble N-terminal
domain was not included (annotated as pylSn below and in
Fig. 3). This and other structures reported subsequently describe
the unique organization of the binding pocket for the large Pyl side
chain, thus elucidating the principles governing Pyl recognition by
PylRS [47,48]. The core catalytic domain contains the typical features of the class II aaRS family, and structural phylogeny suggested the divergence of PylRS from an ancestral version of

PheRS early in evolution, i.e., during the time of the last common
ancestor of all life on earth [47].
The structure also revealed that hydrophobic interactions account for most of the contact surface between PylRS and the Pyl
or Cyc substrates, but specific recognition is derived from hydrogen
bonds formed between PylRS and the amino acid substrate
(Fig. 3A). The interactions of two residues (Asn346 and Arg330 in
Methanosarcina mazei numbering) with the primary and secondary
carbonyl of the substrate were noticed in complexes with Pyl or
Cyc. Although the cyclic components of both substrates were
bound in a roughly equivalent position in the hydrophobic pocket
of PylRS, subtle differences in the interactions are likely responsible for a significantly greater charging efficiency of tRNAPyl with
Pyl as opposed to Cyc [45,49]. The residue Tyr384 in PylRS is believed to play an important role in orienting Pyl into the binding
pocket through its hydrogen bond to the pyrrole ring nitrogen.
Tyr384 is located on a mobile loop that only appears ordered in
the presence of the cognate substrate Pyl [47,48]. A report of the
first bacterial PylRS crystal structure revealed a somewhat more
sterically constrained active site that can nevertheless accommodate Pyl [50]. The large active site of PylRS has been shown to
accommodate several Pyl analogs [51-53], including some that
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can be chemically altered post-translationally using "click chemistry" to specifically attach fluorescent probes [54,55].
7. Molecular basis for the PylRS:tRNAPyl orthogonality
As is typical for class II aaRSs, PylRS is a dimer of two identical
subunits, each of which bind one tRNA molecule from the major
groove side. Each tRNA1^' interacts with one subunit and makes
few specific contacts with the second protomer. Since PylRS and
tRNAPyl display no significant cross reactivity with other aaRS/
tRNA pairs in native or heterologous contexts [38,56,57], they are
said to be orthogonal to other aminoacylation systems. Several unique structural features in both the protein and its substrate RNA
have emerged in the course of evolution that explain the specificity
of PylRS for its tRNA (Fig. 3B).
In both archaea and bacteria, the amber suppressor tRNAPyl has
several unique structural features when compared to canonical
tRNAs. These include an anticodon stem of six base pairs instead
of five, a short variable loop of only three bases, a single base separating the acceptor and D-stems, a small D-loop with only five
bases, the absence of the almost universally conserved G18G19 sequence in the D-loop and the T 54VP55C56 sequence in the T-Loop,
and a small number of post-transcriptional base modifications. M.
barkeri tRNA1^' was found to have only a 4-thiouridine at position 8
and a 1-methyl-pseudouridine at position 50 [45].
Crystallization of the Desulfitobacterium hafniense PylRS
(DhPylRS) in complex with its cognate tRNA provided the first view
of a naturally evolved orthogonal aaRS/tRNA pair. The structure
supports what was predicted from sequence, that PylRS/tRNAPyl,
unlike engineered orthogonal pairs, is highly distinct from even
the most closely related aaRS/tRNA pair [57]. The structure showed
that while the unusual features of tRNAPyl do not prevent the formation of the expected L-shape tertiary structure fold, they result
in a unique core more compact than those seen in canonical tRNAs.
To match the structural peculiarity of its tRNA substrate, PylRS has
evolved unique protein domains from which residues emerge and
engage in specific interactions with tRNAPyl core nucleotides. The
tRNA core comes in contact with one side of the protein hence
termed core binding surface. This surface groups the tRNA binding
domain 1 (N-terminus of pylSc domain), the C-terminal tail and
helix a6 on the second protomer (Fig. 3B, upper).
Structural data identified the tRNA core nucleotides involved in
specific interactions with the protein. Nucleotide G9 and D-stem
nucleotide pairs G10:C25 and A11:U24 are engaged in a series of
hydrogen bonding interaction with PylRS amino acid side chains.
Earlier biochemical evidence had indicated the importance of these
particular nucleotides for tRNAPyl aminoacylation [49,58]. Their
mutation resulted in dramatic decrease in aminoacylation efficiency both in vitro and in vivo. It was, however, unclear whether
the deficient aminoacylation resulted from destabilization of the
tRNA structure or the direct disruption of specific contacts with
PylRS. Structural data now unambiguously identify these nucleotides as key elements contributing to the orthogonality of PylRS/
tRNA1^1.
The tRNA binding domain 1, C-terminal tail and bulge domain
of the opposite subunit form a U shaped concave structure complementary to the acceptor helix of the tRNA that directs its 3'-terminus toward the PylRS catalytic site (Fig. 3B, lower). The structural
data also show how PylRS selectively recognizes, through a network of specific hydrogen bonding interactions, the discriminator
base and the Gl :C72 base pair at the top of the acceptor stem.
Compelling biochemical evidence demonstrating the critical
importance of the same nucleotides for the aminoacylation of
tRNAPyl with pyrrolysine in vitro and in vivo were also obtained
[49,58]. The discriminator base G73 and the Gl :C72 base pair along
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with those of the core domain define the complete tRNA^1 identity
set. Transfer of these nucleotides is able to convert a catalytically
non-competent tRNA substrate into a pyrrolysine accepting tRNA
[49]. Although biochemical studies have shown that tRNAPyl anticodon nucleotides are dispensable for the formation of PylRS/
tRNAPyl complex and tRNA aminoacylation, the two bases adjacent
to the anticodon (U33 and A37) were shown to be identity elements for the M. mazei PylRS [49]. These two bases are possibly
recognized in a sequence-specific manner by residues from the
N-terminal domain, a domain lacking in the DhPylRS and all other
PylRS crystal structures.
The strict orthogonality of the PylRS/tRNA^1 system, which
has been demonstrated [57], and available crystal structures
have already been exploited for the genetic encoding, and thus
site-specific incorporation of typically post-translationally modified amino acids directly into proteins. PylRS variants were selected to generate a mutant that specifically charges tRNA^1
with N-acetyl-lysine [59]. Wild type PylRS was employed to aminoacylate tRNA1'5'1 with a reactive Pyl analog which was chemically converted to the common histone modification N-methyllysine [60].
8. Expanding the Pyl-decoding biosphere
Data from newly sequenced genomes and metagenomic projects has doubled the potential number of Pyl-decoding organisms.
The Pyl-decoding trait is associated with the presence of the Pyl
operon, which includes genes for the tRNAPyl {pylT) and the PylRS
{pylS) followed by genes that encode the putative Pyl biosynthetic
machinery (pylBCD). The Pyl operon is sufficient to encode the
Pyl-decoding trait as shown by transformation of the operon into
a heterlogous E. coli context that then supported translational
read-through of amber codons [38,56]. Earlier reports [37] found
the Pyl-decoding trait confined to five archaeal organisms from
the Methanosarcinaceae family and one bacterial organism
(D. hafniense), while later studies [47,58,61 ] identified components
of the Pyl operon in a (5-proteobacterial endosymbiont of the
marine worm Olavius algarvensis, based on sequence data from a
metagenomic survey [62].
There are now four additional examples of the bacterial version
of the Pyl-trait, and one additional Methanosarcinaceae {Methanohalophilus mahii) is shown to have the complete Pyl operon
(Fig. 3C). For reasons unknown, only M. barkeri among the archaea
appears to deviate from the otherwise strict operonal organization
and includes a small (100 codon) ORF that is a mutated duplication
of the 3'-end of pylC. The bacterial examples show greater diversity
in Pyl operon structure. In keeping with this observation, an updated phylogeny of the PylRS sequences continues to show a clear
divide between the bacterial and archaeal type PylRSs, with a statistically significant root placed between the bacterial and archaeal
clades according to an alignment with other subclass IIC aaRSs.
While the archaeal Pyl-decoding trait is confined to the Methanosarcinaceae, bacterial examples appear in only a few members of
the phyla Clostridia and <5-proteobacteria.
A key difference between the archaeal and bacterial PylRS is
that the bacteria encode the N-terminal domain (about 100 amino
acids) of PylRS as a separate gene, often at the 3'-end of the operon,
leading to the organization (pylT, pylSc, pylBCD, pylSn). While the
evolutionary scenario for the pylS gene split and operonal rearrangement was previously unclear, the newly sequenced and
deepest branching bacterial Pyl-decoding representative Acetohalobium arabaticum, appears to display a transitional form. In this
organism, pylSn terminates 11 bases upstream of and is thus outof-frame with pylSc. The phylogeny indicates that the split pylS
evolved after the divergence of the archaeal and bacterial pylS
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genes and that the re-arrangement (placement of pylSn at the 3'end of the operon) occurred later in bacterial evolution.
Only two organisms interrupt the Pyl operon with other genes.
A. arabaticum encodes the Pyl-containing trimethylamine methyltransferase (MttB) and cognate corrinoid protein (MttC) in the operon as well as a gene related to N-methylhydantoinase (hyuA) and
5-oxoprolinase between pylB and pylC. The gene has close homologs in most Pyl-decoding organisms and various bacteria. Proteins
from this superfamily (hyuA) are typically involved in the breakdown of cyclic amines (similar to the pyrroline ring of Pyl), and this
gene could be the first example of a catabolic Pyl enzyme. Desfulotomaculum acetoxidans encodes an unknown iron-sulfur protein
between pylT and pylSc and an exact copy of the 3' 30 bases of
tRNA^1 downstream of the operon, which is an indication that
the Pyl operon is on a mobile genetic element [63]. Finally, the
complete genome of Desulfobacterium autotrophicum contains the
first example of a degraded Pyl operon, only pylSc and pylB are
present. Gene loss has been assumed to explain in part the sparsity
of the Pyl-operon, and this example provides the first evidence of a
transitional form towards loss of the Pyl-decoding trait.
9. The 21st and 22nd amino acids promise exciting new
directions
The enzymes involved in the archaeal and eukaryotic Sec biosynthesis pathways achieve specificity for tRNASec by recognizing
distinct structural features of the tRNA substrate. While a similar
theme is observed in the Pyl-decoding system, Sec and Pyl followed different evolutionary and metabolic routes to enter the genetic code. Sec relied on a specialized tRNA that is recognized by a
canonical aaRS and on the evolution of enzymes that specifically
modify the aminoacyl-tRNA to ultimately form Sec-tRNASec. In contrast, Pyl entered the code as a result of the establishment of a
tRNA-independent biosynthetic pathway and co-evolution of a
aaRS/tRNA pair that is quite different from its closest known relatives. Despite their differences, both systems will be important for
future biotechnological applications. Just as detailed biochemical
and structural investigation of the PylRS:tRNAPyl system facilitated
the engineering of this orthogonal pair to incorporate other noncanonical amino acids, the archaeal/eukaryotic Sec-tRNA^0
synthesis machinery, specifically the intermediate Sep-tRNASec,
provides another possible means to incorporate phosphoserine or
possibly other phosphorylated amino acids directly into a growing
polypeptide chain.
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